sample	study	diagnosis	group	age	sex	bmi	country	region	pcr_primers	platform	disease_name	title	disease_name_ab	host_body_mass_index	site	subject_id
DRR151663	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151664	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151665	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151666	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151667	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151668	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151669	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151670	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151671	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151672	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151673	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151674	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151675	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151676	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151677	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151678	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151679	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151680	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151681	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151682	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151683	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151684	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151685	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151686	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151687	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151688	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151689	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151690	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151691	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151692	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151693	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151694	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151695	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151696	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151697	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151698	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151699	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151700	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151701	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151702	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151703	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151704	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151705	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151706	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151707	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151708	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151709	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151710	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151711	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151712	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151713	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151714	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151715	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151716	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151717	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151718	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151719	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151720	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151721	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151722	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151723	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151724	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR151725	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD			
DRR111002	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111003	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111004	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111005	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111006	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111007	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111008	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111010	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111011	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111012	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111013	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111014	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111015	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111016	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111017	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111018	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111019	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111020	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111021	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111022	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111023	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111024	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111025	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111026	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111027	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111028	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111029	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111031	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111032	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111033	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111034	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111035	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111036	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111037	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111038	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111039	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111040	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111041	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111042	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111043	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111044	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111045	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111046	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111047	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111048	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111049	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111050	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111051	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111052	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111053	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111054	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
DRR111055	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD			
ERR2836373	PRJEB28687	Overweight	0.0			28.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836366	PRJEB28687	Normal	0.0			21.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836367	PRJEB28687	Normal	0.0			19.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836368	PRJEB28687	Normal	0.0			20.1	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836369	PRJEB28687	Overweight	0.0			25.13	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836370	PRJEB28687	Normal	0.0			22.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836371	PRJEB28687	Obese	1.0			30.84	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836372	PRJEB28687	Normal	0.0			22.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836374	PRJEB28687	Normal	0.0			23.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836376	PRJEB28687	Normal	0.0			23.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836377	PRJEB28687	Overweight	0.0			27.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836378	PRJEB28687	Overweight	0.0			26.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836379	PRJEB28687	Overweight	0.0			27.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836380	PRJEB28687	Obese	1.0			30.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836381	PRJEB28687	Normal	0.0			19.78	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836382	PRJEB28687	Normal	0.0			19.42	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836383	PRJEB28687	Overweight	0.0			26.53	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836384	PRJEB28687	Normal	0.0			24.6	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836385	PRJEB28687	Overweight	0.0			26.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836386	PRJEB28687	Normal	0.0			24.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836387	PRJEB28687	Normal	0.0			22.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836388	PRJEB28687	Overweight	0.0			27.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836389	PRJEB28687	Overweight	0.0			27.85	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836390	PRJEB28687	Overweight	0.0			28.78	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836391	PRJEB28687	Overweight	0.0			27.58	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836392	PRJEB28687	Overweight	0.0			25.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836393	PRJEB28687	Normal	0.0			23.01	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836394	PRJEB28687	Overweight	0.0			28.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836395	PRJEB28687	Overweight	0.0			27.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836396	PRJEB28687	Overweight	0.0			28.59	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836397	PRJEB28687	Overweight	0.0			29.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836398	PRJEB28687	Overweight	0.0			28.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836399	PRJEB28687	Normal	0.0			24.84	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836400	PRJEB28687	Normal	0.0			20.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836401	PRJEB28687	Normal	0.0			23.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836402	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836404	PRJEB28687	Normal	0.0			24.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836405	PRJEB28687	Normal	0.0			21.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836406	PRJEB28687	Normal	0.0			24.41	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836407	PRJEB28687	Normal	0.0			24.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836408	PRJEB28687	Obese	1.0			31.08	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836409	PRJEB28687	Overweight	0.0			27.73	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836411	PRJEB28687	Overweight	0.0			25.96	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836412	PRJEB28687	Overweight	0.0			25.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836413	PRJEB28687	Normal	0.0			23.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836414	PRJEB28687	Overweight	0.0			25.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836415	PRJEB28687	Overweight	0.0			25.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836416	PRJEB28687	Overweight	0.0			25.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836417	PRJEB28687	Overweight	0.0			27.11	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836418	PRJEB28687	Normal	0.0			21.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836419	PRJEB28687	Overweight	0.0			29.99	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836420	PRJEB28687	Normal	0.0			23.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836421	PRJEB28687	Normal	0.0			19.57	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836422	PRJEB28687	Normal	0.0			23.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836423	PRJEB28687	Overweight	0.0			25.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836424	PRJEB28687	Normal	0.0			19.79	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836425	PRJEB28687	Normal	0.0			21.04	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836426	PRJEB28687	Normal	0.0			22.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836427	PRJEB28687	Normal	0.0			17.98	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836428	PRJEB28687	Normal	0.0			17.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836429	PRJEB28687	Normal	0.0			20.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836430	PRJEB28687	Overweight	0.0			26.6	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836431	PRJEB28687	Overweight	0.0			29.97	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836432	PRJEB28687	Overweight	0.0			25.46	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836433	PRJEB28687	Normal	0.0			23.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836435	PRJEB28687	Overweight	0.0			28.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836436	PRJEB28687	Overweight	0.0			28.0	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836437	PRJEB28687	Normal	0.0			24.53	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836438	PRJEB28687	Normal	0.0			18.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836439	PRJEB28687	Obese	1.0			40.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836440	PRJEB28687	Overweight	0.0			28.94	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836441	PRJEB28687	Obese	1.0			33.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836442	PRJEB28687	Obese	1.0			30.9	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836443	PRJEB28687	Overweight	0.0			25.52	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836444	PRJEB28687	Normal	0.0			23.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836445	PRJEB28687	Obese	1.0			32.23	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836446	PRJEB28687	Normal	0.0			23.38	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836447	PRJEB28687	Obese	1.0			39.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836448	PRJEB28687	Obese	1.0			30.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836449	PRJEB28687	Overweight	0.0			25.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836450	PRJEB28687	Overweight	0.0			29.74	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836451	PRJEB28687	Normal	0.0			22.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836452	PRJEB28687	Normal	0.0			22.48	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836453	PRJEB28687	Normal	0.0			24.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836454	PRJEB28687	Normal	0.0			22.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836455	PRJEB28687	Overweight	0.0			28.0	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836456	PRJEB28687	Overweight	0.0			27.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836457	PRJEB28687	Overweight	0.0			29.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836458	PRJEB28687	Normal	0.0			22.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836459	PRJEB28687	Normal	0.0			19.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836460	PRJEB28687	Normal	0.0			24.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836461	PRJEB28687	Overweight	0.0			26.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836462	PRJEB28687	Obese	1.0			33.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836463	PRJEB28687	Normal	0.0			21.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836464	PRJEB28687	Normal	0.0			18.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836465	PRJEB28687	Normal	0.0			22.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836466	PRJEB28687	Normal	0.0			18.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836467	PRJEB28687	Overweight	0.0			28.42	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836468	PRJEB28687	Obese	1.0			30.28	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836469	PRJEB28687	Overweight	0.0			26.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836470	PRJEB28687	Obese	1.0			35.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836471	PRJEB28687	Obese	1.0			34.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836472	PRJEB28687	Overweight	0.0			27.14	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836473	PRJEB28687	Normal	0.0			17.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836474	PRJEB28687	Overweight	0.0			27.96	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836475	PRJEB28687	Normal	0.0			21.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836476	PRJEB28687	Normal	0.0			21.96	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836477	PRJEB28687	Overweight	0.0			25.6	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836478	PRJEB28687	Overweight	0.0			29.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836479	PRJEB28687	Normal	0.0			24.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836480	PRJEB28687	Overweight	0.0			28.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836481	PRJEB28687	Overweight	0.0			25.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836482	PRJEB28687	Normal	0.0			20.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836483	PRJEB28687	Normal	0.0			24.94	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836484	PRJEB28687	Normal	0.0			22.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836486	PRJEB28687	Normal	0.0			20.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836487	PRJEB28687	Overweight	0.0			27.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836488	PRJEB28687	Overweight	0.0			28.89	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836489	PRJEB28687	Overweight	0.0			28.59	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836490	PRJEB28687	Overweight	0.0			27.99	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836491	PRJEB28687	Overweight	0.0			29.42	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836492	PRJEB28687	Normal	0.0			21.0	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836493	PRJEB28687	Normal	0.0			23.75	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836496	PRJEB28687	Overweight	0.0			29.87	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836499	PRJEB28687	Normal	0.0			24.66	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836500	PRJEB28687	Obese	1.0			33.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836502	PRJEB28687	Normal	0.0			24.97	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836503	PRJEB28687	Normal	0.0			20.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836504	PRJEB28687	Normal	0.0			22.48	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836505	PRJEB28687	Obese	1.0			31.05	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836507	PRJEB28687	Obese	1.0			33.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836508	PRJEB28687	Normal	0.0			23.23	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836509	PRJEB28687	Normal	0.0			22.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836510	PRJEB28687	Normal	0.0			24.57	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836511	PRJEB28687	Overweight	0.0			28.89	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836513	PRJEB28687	Obese	1.0			30.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836515	PRJEB28687	Overweight	0.0			25.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836516	PRJEB28687	Normal	0.0			23.19	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836517	PRJEB28687	Obese	1.0			38.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836518	PRJEB28687	Obese	1.0			33.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836519	PRJEB28687	Obese	1.0			36.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836520	PRJEB28687	Normal	0.0			21.69	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836521	PRJEB28687	Overweight	0.0			25.35	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836522	PRJEB28687	Overweight	0.0			29.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836523	PRJEB28687	Overweight	0.0			25.28	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836524	PRJEB28687	Overweight	0.0			26.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836525	PRJEB28687	Normal	0.0			22.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836526	PRJEB28687	Normal	0.0			24.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836527	PRJEB28687	Overweight	0.0			28.31	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836529	PRJEB28687	Overweight	0.0			25.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836530	PRJEB28687	Normal	0.0			21.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836531	PRJEB28687	Normal	0.0			21.14	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836532	PRJEB28687	Normal	0.0			20.52	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836533	PRJEB28687	Normal	0.0			21.11	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836534	PRJEB28687	Normal	0.0			24.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836535	PRJEB28687	Normal	0.0			19.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836536	PRJEB28687	Overweight	0.0			27.75	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836537	PRJEB28687	Normal	0.0			24.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836538	PRJEB28687	Obese	1.0			34.29	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836539	PRJEB28687	Obese	1.0			30.34	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836540	PRJEB28687	Obese	1.0			31.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836541	PRJEB28687	Overweight	0.0			25.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836542	PRJEB28687	Obese	1.0			37.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836544	PRJEB28687	Obese	1.0			38.41	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836545	PRJEB28687	Overweight	0.0			29.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836546	PRJEB28687	Overweight	0.0			28.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836547	PRJEB28687	Overweight	0.0			28.55	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836548	PRJEB28687	Normal	0.0			19.46	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836549	PRJEB28687	Overweight	0.0			25.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836551	PRJEB28687	Normal	0.0			24.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836552	PRJEB28687	Overweight	0.0			27.67	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836554	PRJEB28687	Overweight	0.0			27.34	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836555	PRJEB28687	Obese	1.0			31.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836556	PRJEB28687	Overweight	0.0			28.34	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836557	PRJEB28687	Overweight	0.0			29.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836558	PRJEB28687	Obese	1.0			31.84	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836560	PRJEB28687	Normal	0.0			20.68	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836561	PRJEB28687	Overweight	0.0			29.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836562	PRJEB28687	Overweight	0.0			26.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836563	PRJEB28687	Normal	0.0			23.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836564	PRJEB28687	Overweight	0.0			26.9	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836565	PRJEB28687	Normal	0.0			22.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836566	PRJEB28687	Overweight	0.0			28.35	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836567	PRJEB28687	Overweight	0.0			28.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836568	PRJEB28687	Obese	1.0			34.01	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836570	PRJEB28687	Obese	1.0			32.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836571	PRJEB28687	Obese	1.0			34.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836572	PRJEB28687	Normal	0.0			23.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836574	PRJEB28687	Overweight	0.0			26.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836575	PRJEB28687	Normal	0.0			24.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836576	PRJEB28687	Obese	1.0			34.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836577	PRJEB28687	Obese	1.0			33.28	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836578	PRJEB28687	Overweight	0.0			28.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836579	PRJEB28687	Normal	0.0			21.64	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836580	PRJEB28687	Obese	1.0			34.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836581	PRJEB28687	Obese	1.0			33.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836582	PRJEB28687	Overweight	0.0			27.96	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836583	PRJEB28687	Overweight	0.0			27.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836584	PRJEB28687	Obese	1.0			30.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836585	PRJEB28687	Obese	1.0			35.13	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836586	PRJEB28687	Normal	0.0			18.59	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836588	PRJEB28687	Normal	0.0			21.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836589	PRJEB28687	Obese	1.0			33.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836590	PRJEB28687	Overweight	0.0			26.31	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836591	PRJEB28687	Normal	0.0			21.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836592	PRJEB28687	Overweight	0.0			27.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836593	PRJEB28687	Overweight	0.0			29.05	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836594	PRJEB28687	Overweight	0.0			29.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836595	PRJEB28687	Obese	1.0			32.87	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836596	PRJEB28687	Normal	0.0			21.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836597	PRJEB28687	Obese	1.0			30.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836598	PRJEB28687	Normal	0.0			23.29	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836600	PRJEB28687	Overweight	0.0			28.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836601	PRJEB28687	Normal	0.0			24.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836603	PRJEB28687	Normal	0.0			22.42	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836605	PRJEB28687	Normal	0.0			24.46	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836606	PRJEB28687	Normal	0.0			18.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836607	PRJEB28687	Normal	0.0			18.44	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836608	PRJEB28687	Overweight	0.0			28.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836609	PRJEB28687	Normal	0.0			20.85	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836610	PRJEB28687	Normal	0.0			23.6	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836611	PRJEB28687	Obese	1.0			43.35	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836612	PRJEB28687	Overweight	0.0			28.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836614	PRJEB28687	Overweight	0.0			27.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836615	PRJEB28687	Overweight	0.0			28.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836616	PRJEB28687	Normal	0.0			23.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836617	PRJEB28687	Overweight	0.0			27.86	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836618	PRJEB28687	Normal	0.0			21.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836619	PRJEB28687	Normal	0.0			21.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836620	PRJEB28687	Normal	0.0			19.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836622	PRJEB28687	Overweight	0.0			29.68	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836623	PRJEB28687	Obese	1.0			32.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836624	PRJEB28687	Overweight	0.0			26.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836625	PRJEB28687	Normal	0.0			23.84	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836626	PRJEB28687	Overweight	0.0			26.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836628	PRJEB28687	Normal	0.0			21.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836629	PRJEB28687	Normal	0.0			22.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836631	PRJEB28687	Normal	0.0			19.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836633	PRJEB28687	Normal	0.0			18.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836634	PRJEB28687	Overweight	0.0			29.08	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836635	PRJEB28687	Overweight	0.0			28.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836637	PRJEB28687	Normal	0.0			21.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836638	PRJEB28687	Overweight	0.0			25.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836640	PRJEB28687	Normal	0.0			20.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836641	PRJEB28687	Overweight	0.0			25.08	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836642	PRJEB28687	Overweight	0.0			28.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836643	PRJEB28687	Obese	1.0			43.14	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836644	PRJEB28687	Overweight	0.0			26.85	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836645	PRJEB28687	Obese	1.0			30.19	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836646	PRJEB28687	Overweight	0.0			26.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836647	PRJEB28687	Normal	0.0			24.45	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836648	PRJEB28687	Normal	0.0			23.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836649	PRJEB28687	Overweight	0.0			25.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836650	PRJEB28687	Obese	1.0			30.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836651	PRJEB28687	Obese	1.0			36.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836652	PRJEB28687	Obese	1.0			31.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836655	PRJEB28687	Normal	0.0			24.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836656	PRJEB28687	Obese	1.0			34.11	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836657	PRJEB28687	Obese	1.0			33.64	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836660	PRJEB28687	Overweight	0.0			27.94	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836661	PRJEB28687	Obese	1.0			32.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836662	PRJEB28687	Obese	1.0			30.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836663	PRJEB28687	Overweight	0.0			28.48	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836664	PRJEB28687	Overweight	0.0			27.52	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836665	PRJEB28687	Normal	0.0			23.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836666	PRJEB28687	Normal	0.0			20.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836667	PRJEB28687	Obese	1.0			41.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836668	PRJEB28687	Overweight	0.0			25.78	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836669	PRJEB28687	Obese	1.0			30.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836671	PRJEB28687	Normal	0.0			21.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836672	PRJEB28687	Obese	1.0			34.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836673	PRJEB28687	Overweight	0.0			29.64	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836674	PRJEB28687	Obese	1.0			35.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836675	PRJEB28687	Obese	1.0			31.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836676	PRJEB28687	Obese	1.0			31.83	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836677	PRJEB28687	Normal	0.0			16.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836678	PRJEB28687	Normal	0.0			19.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836680	PRJEB28687	Overweight	0.0			29.59	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836682	PRJEB28687	Obese	1.0			34.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836683	PRJEB28687	Normal	0.0			24.97	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836684	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836685	PRJEB28687	Normal	0.0			18.95	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836688	PRJEB28687	Overweight	0.0			29.78	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836689	PRJEB28687	Obese	1.0			33.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836690	PRJEB28687	Obese	1.0			33.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836693	PRJEB28687	Normal	0.0			20.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836694	PRJEB28687	Normal	0.0			23.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836695	PRJEB28687	Normal	0.0			21.3	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836696	PRJEB28687	Obese	1.0			32.75	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836697	PRJEB28687	Normal	0.0			19.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836698	PRJEB28687	Normal	0.0			21.45	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836699	PRJEB28687	Normal	0.0			24.62	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836701	PRJEB28687	Normal	0.0			23.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836702	PRJEB28687	Normal	0.0			23.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836703	PRJEB28687	Normal	0.0			22.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836704	PRJEB28687	Normal	0.0			20.55	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836705	PRJEB28687	Overweight	0.0			29.28	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836706	PRJEB28687	Normal	0.0			22.67	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836707	PRJEB28687	Normal	0.0			22.85	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836708	PRJEB28687	Normal	0.0			21.56	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836709	PRJEB28687	Normal	0.0			18.01	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836710	PRJEB28687	Normal	0.0			20.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836711	PRJEB28687	Obese	1.0			38.92	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836712	PRJEB28687	Normal	0.0			24.23	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836713	PRJEB28687	Normal	0.0			19.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836714	PRJEB28687	Obese	1.0			50.9	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836715	PRJEB28687	Overweight	0.0			28.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836717	PRJEB28687	Normal	0.0			22.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836718	PRJEB28687	Overweight	0.0			25.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836719	PRJEB28687	Normal	0.0			22.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836720	PRJEB28687	Normal	0.0			22.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836722	PRJEB28687	Normal	0.0			22.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836725	PRJEB28687	Normal	0.0			17.1	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836726	PRJEB28687	Normal	0.0			17.1	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836730	PRJEB28687	Normal	0.0			17.1	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836733	PRJEB28687	Overweight	0.0			25.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836734	PRJEB28687	Overweight	0.0			25.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836735	PRJEB28687	Overweight	0.0			25.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836736	PRJEB28687	Overweight	0.0			25.63	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836740	PRJEB28687	Normal	0.0			24.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836741	PRJEB28687	Normal	0.0			24.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836742	PRJEB28687	Normal	0.0			24.32	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836743	PRJEB28687	Normal	0.0			21.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836744	PRJEB28687	Normal	0.0			21.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836746	PRJEB28687	Normal	0.0			21.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836752	PRJEB28687	Normal	0.0			21.29	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836753	PRJEB28687	Normal	0.0			21.29	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836754	PRJEB28687	Normal	0.0			21.29	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836755	PRJEB28687	Normal	0.0			22.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836756	PRJEB28687	Normal	0.0			22.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836758	PRJEB28687	Normal	0.0			22.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836759	PRJEB28687	Normal	0.0			22.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836766	PRJEB28687	Normal	0.0			19.03	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836773	PRJEB28687	Normal	0.0			23.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836774	PRJEB28687	Normal	0.0			23.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836777	PRJEB28687	Normal	0.0			23.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836778	PRJEB28687	Normal	0.0			23.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836779	PRJEB28687	Obese	1.0			34.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836780	PRJEB28687	Obese	1.0			34.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836781	PRJEB28687	Obese	1.0			34.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836782	PRJEB28687	Obese	1.0			34.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836787	PRJEB28687	Normal	0.0			20.97	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836790	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836791	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836792	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836793	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836794	PRJEB28687	Normal	0.0			18.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836796	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836797	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836798	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836799	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836800	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836801	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836802	PRJEB28687	Overweight	0.0			26.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836805	PRJEB28687	Normal	0.0			22.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836806	PRJEB28687	Normal	0.0			22.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836807	PRJEB28687	Normal	0.0			22.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836808	PRJEB28687	Normal	0.0			22.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836809	PRJEB28687	Normal	0.0			22.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836810	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836812	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836813	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836814	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836815	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836816	PRJEB28687	Obese	1.0			30.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836817	PRJEB28687	Normal	0.0			16.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836818	PRJEB28687	Normal	0.0			16.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836820	PRJEB28687	Normal	0.0			16.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836821	PRJEB28687	Normal	0.0			16.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836822	PRJEB28687	Normal	0.0			16.8	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836823	PRJEB28687	Normal	0.0			21.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836824	PRJEB28687	Normal	0.0			21.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836825	PRJEB28687	Normal	0.0			21.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836826	PRJEB28687	Normal	0.0			21.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836829	PRJEB28687	Normal	0.0			21.54	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836831	PRJEB28687	Overweight	0.0			26.05	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836832	PRJEB28687	Normal	0.0			24.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836834	PRJEB28687	Overweight	0.0			25.04	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836836	PRJEB28687	Obese	1.0			32.52	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836837	PRJEB28687	Overweight	0.0			28.38	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836838	PRJEB28687	Overweight	0.0			25.25	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836839	PRJEB28687	Normal	0.0			23.23	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836840	PRJEB28687	Overweight	0.0			27.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836842	PRJEB28687	Normal	0.0			21.42	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836843	PRJEB28687	Overweight	0.0			25.26	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836844	PRJEB28687	Overweight	0.0			26.76	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836845	PRJEB28687	Normal	0.0			23.26	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836848	PRJEB28687	Normal	0.0			24.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836849	PRJEB28687	Normal	0.0			24.35	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836850	PRJEB28687	Normal	0.0			21.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836851	PRJEB28687	Normal	0.0			24.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836852	PRJEB28687	Obese	1.0			30.1	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836853	PRJEB28687	Overweight	0.0			29.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836854	PRJEB28687	Normal	0.0			23.75	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836855	PRJEB28687	Normal	0.0			19.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836858	PRJEB28687	Overweight	0.0			26.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836859	PRJEB28687	Overweight	0.0			28.83	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836860	PRJEB28687	Normal	0.0			24.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836861	PRJEB28687	Normal	0.0			22.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836862	PRJEB28687	Obese	1.0			31.37	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836863	PRJEB28687	Overweight	0.0			29.73	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836864	PRJEB28687	Normal	0.0			21.38	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836865	PRJEB28687	Overweight	0.0			25.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836867	PRJEB28687	Normal	0.0			18.48	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836868	PRJEB28687	Normal	0.0			21.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836869	PRJEB28687	Obese	1.0			32.18	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836870	PRJEB28687	Overweight	0.0			26.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836872	PRJEB28687	Normal	0.0			21.13	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836873	PRJEB28687	Overweight	0.0			26.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836874	PRJEB28687	Normal	0.0			22.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836875	PRJEB28687	Obese	1.0			37.13	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836876	PRJEB28687	Normal	0.0			23.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836877	PRJEB28687	Overweight	0.0			26.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836878	PRJEB28687	Normal	0.0			20.87	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836881	PRJEB28687	Obese	1.0			42.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836882	PRJEB28687	Normal	0.0			20.68	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836883	PRJEB28687	Normal	0.0			21.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836884	PRJEB28687	Normal	0.0			23.21	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836885	PRJEB28687	Normal	0.0			24.04	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836887	PRJEB28687	Obese	1.0			31.55	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836888	PRJEB28687	Normal	0.0			24.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836890	PRJEB28687	Obese	1.0			32.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836892	PRJEB28687	Obese	1.0			32.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836893	PRJEB28687	Normal	0.0			21.87	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836894	PRJEB28687	Overweight	0.0			26.98	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836895	PRJEB28687	Normal	0.0			18.22	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836897	PRJEB28687	Normal	0.0			21.4	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836898	PRJEB28687	Normal	0.0			23.55	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836899	PRJEB28687	Overweight	0.0			26.66	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836900	PRJEB28687	Overweight	0.0			25.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836901	PRJEB28687	Overweight	0.0			27.66	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836902	PRJEB28687	Normal	0.0			23.31	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836904	PRJEB28687	Overweight	0.0			25.93	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836905	PRJEB28687	Normal	0.0			23.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836906	PRJEB28687	Normal	0.0			20.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836907	PRJEB28687	Overweight	0.0			29.67	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836908	PRJEB28687	Normal	0.0			18.71	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836909	PRJEB28687	Overweight	0.0			26.43	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836910	PRJEB28687	Normal	0.0			24.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836911	PRJEB28687	Overweight	0.0			25.28	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836914	PRJEB28687	Normal	0.0			22.98	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836916	PRJEB28687	Normal	0.0			19.94	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836926	PRJEB28687	Overweight	0.0			28.34	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836928	PRJEB28687	Overweight	0.0			27.16	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836929	PRJEB28687	Normal	0.0			21.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836930	PRJEB28687	Normal	0.0			20.66	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836931	PRJEB28687	Normal	0.0			17.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836932	PRJEB28687	Normal	0.0			18.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836933	PRJEB28687	Normal	0.0			21.6	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836934	PRJEB28687	Obese	1.0			32.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836935	PRJEB28687	Normal	0.0			19.35	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836936	PRJEB28687	Normal	0.0			20.0	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836937	PRJEB28687	Normal	0.0			20.82	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836938	PRJEB28687	Normal	0.0			23.47	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836939	PRJEB28687	Normal	0.0			20.11	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836940	PRJEB28687	Normal	0.0			23.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836941	PRJEB28687	Normal	0.0			23.05	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836942	PRJEB28687	Normal	0.0			19.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836944	PRJEB28687	Normal	0.0			22.9	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836945	PRJEB28687	Normal	0.0			23.25	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836946	PRJEB28687	Normal	0.0			19.5	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836947	PRJEB28687	Normal	0.0			22.46	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836948	PRJEB28687	Normal	0.0			19.61	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836949	PRJEB28687	Normal	0.0			19.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836950	PRJEB28687	Normal	0.0			24.06	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836951	PRJEB28687	Overweight	0.0			26.02	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836952	PRJEB28687	Normal	0.0			21.73	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836953	PRJEB28687	Normal	0.0			19.15	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836954	PRJEB28687	Normal	0.0			21.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836955	PRJEB28687	Normal	0.0			22.83	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836956	PRJEB28687	Normal	0.0			20.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836957	PRJEB28687	Overweight	0.0			27.17	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836959	PRJEB28687	Overweight	0.0			27.19	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836960	PRJEB28687	Overweight	0.0			25.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836961	PRJEB28687	Overweight	0.0			26.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836963	PRJEB28687	Normal	0.0			19.75	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836964	PRJEB28687	Overweight	0.0			26.59	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836966	PRJEB28687	Obese	1.0			33.12	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836967	PRJEB28687	Overweight	0.0			26.88	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836969	PRJEB28687	Overweight	0.0			28.53	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836970	PRJEB28687	Overweight	0.0			28.14	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836972	PRJEB28687	Overweight	0.0			27.36	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836976	PRJEB28687	Obese	1.0			34.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836977	PRJEB28687	Normal	0.0			19.7	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836978	PRJEB28687	Overweight	0.0			27.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836979	PRJEB28687	Overweight	0.0			29.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836980	PRJEB28687	Normal	0.0			23.84	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836981	PRJEB28687	Obese	1.0			31.01	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836982	PRJEB28687	Obese	1.0			32.72	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836983	PRJEB28687	Normal	0.0			23.13	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836984	PRJEB28687	Normal	0.0			24.46	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836985	PRJEB28687	Normal	0.0			21.74	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836986	PRJEB28687	Overweight	0.0			29.89	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836987	PRJEB28687	Overweight	0.0			25.91	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836988	PRJEB28687	Overweight	0.0			25.24	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836989	PRJEB28687	Overweight	0.0			25.07	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836990	PRJEB28687	Obese	1.0			30.39	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836991	PRJEB28687	Normal	0.0			23.65	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836993	PRJEB28687	Overweight	0.0			28.83	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836995	PRJEB28687	Overweight	0.0			25.83	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836996	PRJEB28687	Normal	0.0			17.71	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836997	PRJEB28687	Normal	0.0			18.49	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836998	PRJEB28687	Overweight	0.0			26.33	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2836999	PRJEB28687	Normal	0.0			17.51	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2837003	PRJEB28687	Obese	1.0			31.77	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2837005	PRJEB28687	Obese	1.0			34.08	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2837007	PRJEB28687	Normal	0.0			24.81	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2837009	PRJEB28687	Overweight	0.0			26.44	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR2837011	PRJEB28687	Overweight	0.0			28.2	USA			ILLUMINA	Obesity	U.S. immigration westernizes the human gut microbiome	OB			
ERR1678480	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2308520	PRJEB11419	control	0.0		male		Spain				Obesity		OB			
ERR2308543	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2308566	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2308572	PRJEB11419	Obesity	1.0		male		Canada				Obesity		OB			
ERR2308629	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2308708	PRJEB11419	control	0.0		male		Australia				Obesity		OB			
ERR2308711	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2308750	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2308822	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2308823	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2308847	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2308850	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2308861	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2308889	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2308895	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2308896	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2308907	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2308921	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2308931	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2308937	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2309191	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2309363	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2309395	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2309424	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2314031	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2314069	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2314100	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2314110	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2314132	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2314215	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2314223	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2314224	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2314225	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2314228	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2314302	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2314312	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2314355	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2404903	PRJEB11419	control	0.0		female		Canada				Obesity		OB			
ERR2404959	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2404998	PRJEB11419	control	0.0		male		Sweden				Obesity		OB			
ERR2405014	PRJEB11419	Obesity	1.0		male		Ireland				Obesity		OB			
ERR2405069	PRJEB11419	control	0.0		female		Isle of Man				Obesity		OB			
ERR2405072	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2405129	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405130	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405137	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2405138	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2405139	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2405169	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405170	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405171	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405172	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2405220	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405252	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2405257	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405269	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405271	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405273	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405284	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2405364	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1597077	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1597078	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1597092	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1597252	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1597276	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1551653	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1678464	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2032150	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2032156	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2032209	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2032237	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2032262	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032277	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2032351	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032377	PRJEB11419	control	0.0		female		not provided				Obesity		OB			
ERR2032397	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032402	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032438	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032495	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032497	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032540	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2032547	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2032559	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2032561	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032575	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2032576	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2032592	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2032721	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2032848	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2032868	PRJEB11419	control	0.0		female		not provided				Obesity		OB			
ERR2032919	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2032943	PRJEB11419	control	0.0		male		India				Obesity		OB			
ERR2033395	PRJEB11419	control	0.0		female		Ireland				Obesity		OB			
ERR2033534	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2033610	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1841712	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1841731	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1841748	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1841824	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1841828	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1842718	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1842747	PRJEB11419	Obesity	1.0		not provided		United States				Obesity		OB			
ERR1842816	PRJEB11419	Obesity	1.0		male		Switzerland				Obesity		OB			
ERR1844625	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1845795	PRJEB11419	Obesity	1.0		male		Canada				Obesity		OB			
ERR1845803	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1845807	PRJEB11419	Obesity	1.0		male		Australia				Obesity		OB			
ERR1845809	PRJEB11419	control	0.0		male		Australia				Obesity		OB			
ERR1845961	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1845969	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1845976	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1846149	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1846158	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1846215	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2523864	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2523877	PRJEB11419	Obesity	1.0		female		Korea, Republic of				Obesity		OB			
ERR2523909	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2524098	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2524127	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2524165	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2524166	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2524177	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2524189	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2524196	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1854661	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1841524	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1841538	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1844552	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1315996	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1316071	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1316109	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1316169	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1316242	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1316274	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2056760	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2056801	PRJEB11419	Obesity	1.0		male		Serbia				Obesity		OB			
ERR2056818	PRJEB11419	control	0.0		male		Portugal				Obesity		OB			
ERR2056905	PRJEB11419	control	0.0		male		Australia				Obesity		OB			
ERR2056943	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2056954	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2057033	PRJEB11419	control	0.0		male		Canada				Obesity		OB			
ERR2057047	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2057180	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1458743	PRJEB11419	Obesity	1.0		female		Australia				Obesity		OB			
ERR1458744	PRJEB11419	Obesity	1.0		female		Australia				Obesity		OB			
ERR1458795	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1458809	PRJEB11419	control	0.0		male		Belgium				Obesity		OB			
ERR1458838	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1458868	PRJEB11419	control	0.0		female		Canada				Obesity		OB			
ERR1458899	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1458925	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1458941	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1459003	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1459024	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1459045	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1459048	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1459071	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1459072	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1459078	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1459084	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1459120	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1459145	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1459213	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092000	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2092020	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2092030	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2092039	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2092040	PRJEB11419	control	0.0		male		Belgium				Obesity		OB			
ERR2092103	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2092165	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092166	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092178	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092214	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092220	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092243	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092244	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092261	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092264	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092272	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092324	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092338	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092341	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092365	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2092386	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2092465	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2091828	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2091836	PRJEB11419	Obesity	1.0		male		Belgium				Obesity		OB			
ERR2091854	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2091857	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2091869	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2091909	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2091914	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2091917	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2091929	PRJEB11419	control	0.0		male		France				Obesity		OB			
ERR2091930	PRJEB11419	control	0.0		male		France				Obesity		OB			
ERR2091973	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1843438	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1843508	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1843509	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1843512	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR1843522	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1843604	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1843613	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1843628	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1843705	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1843730	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1843748	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1843758	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1843822	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1843845	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1843849	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2318011	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2318133	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2318140	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2318182	PRJEB11419	Obesity	1.0		female		Canada				Obesity		OB			
ERR2318187	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2318196	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2318267	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2318282	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2319269	PRJEB11419	control	0.0		female		Australia				Obesity		OB			
ERR2319278	PRJEB11419	control	0.0		male		Australia				Obesity		OB			
ERR2319380	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2319447	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2319465	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2319500	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2319502	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2319538	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2319549	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2319581	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2306129	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2306197	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2306243	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2306263	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2303816	PRJEB11419	Obesity	1.0		female		Australia				Obesity		OB			
ERR2303846	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2303854	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2303873	PRJEB11419	Obesity	1.0		female		Australia				Obesity		OB			
ERR2303896	PRJEB11419	Obesity	1.0		male		Australia				Obesity		OB			
ERR2303958	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2304010	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2304022	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2304037	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2304052	PRJEB11419	control	0.0		male		Italy				Obesity		OB			
ERR2304065	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2304152	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2304181	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1417426	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1417477	PRJEB11419	control	0.0		female		Sweden				Obesity		OB			
ERR1417538	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1417544	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1417570	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1417572	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1417582	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1417609	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1417610	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1417648	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2579375	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579390	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2579428	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579460	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579470	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2579498	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579564	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2579656	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2579671	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579694	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2579726	PRJEB11419	Obesity	1.0		male		Finland				Obesity		OB			
ERR2579800	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2579810	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2579838	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2579880	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2579913	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2579920	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2579951	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2580102	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR2580107	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1389675	PRJEB11419	control	0.0		female		France				Obesity		OB			
ERR1389706	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1389717	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1389726	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR1389762	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR1389787	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1389826	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1389871	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1389913	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2696468	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696518	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2696574	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2696608	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696825	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2696856	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696907	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2696910	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2696948	PRJEB11419	Obesity	1.0		male		Guernsey				Obesity		OB			
ERR2696961	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2696986	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2696995	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2697003	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1389964	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1389981	PRJEB11419	control	0.0		male		Canada				Obesity		OB			
ERR1390003	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2696457	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2696467	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696569	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696582	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696597	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2696606	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2696612	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2696655	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR2696699	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2696762	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1233449	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1233451	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1841458	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR1841641	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1842695	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1842723	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR1842753	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1842770	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR1842840	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1844518	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR2697596	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2697613	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2697622	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697641	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2697699	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2697702	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR2697716	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697737	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697742	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2697743	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697772	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2697797	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR2697946	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697952	PRJEB11419	Obesity	1.0		male		Netherlands				Obesity		OB			
ERR2697976	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR2697979	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2697985	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2697998	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR2698017	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR2698018	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR1551641	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1551644	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1551652	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR1551655	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR4018905	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR4018906	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR4018992	PRJEB11419	control	0.0		female		Ireland				Obesity		OB			
ERR4019025	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR4019100	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR4019230	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR4019251	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR4019319	PRJEB11419	Obesity	1.0		male		France				Obesity		OB			
ERR4019326	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR4019697	PRJEB11419	Obesity	1.0		male		Philippines				Obesity		OB			
ERR4019700	PRJEB11419	Obesity	1.0		female		Philippines				Obesity		OB			
ERR4020384	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR4020390	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR4020405	PRJEB11419	control	0.0		male		Switzerland				Obesity		OB			
ERR4020447	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR4020456	PRJEB11419	control	0.0		male		Denmark				Obesity		OB			
ERR4020460	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR4020464	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR4020469	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR4020481	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR4020494	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR4020578	PRJEB11419	Obesity	1.0		female		Philippines				Obesity		OB			
ERR4020614	PRJEB11419	Obesity	1.0		female		Philippines				Obesity		OB			
ERR4020643	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR4020644	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR4020662	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR9744032	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR4020715	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR4018914	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR4018946	PRJEB11419	control	0.0		female		India				Obesity		OB			
ERR4019057	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR4019066	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR4019074	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR4019194	PRJEB11419	control	0.0		male		Sweden				Obesity		OB			
ERR9744058	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR9744069	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR9744078	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR9744096	PRJEB11419	Obesity	1.0		male		Mexico				Obesity		OB			
ERR9744108	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9744165	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9744172	PRJEB11419	control	0.0		male		Mexico				Obesity		OB			
ERR9744261	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9744267	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR8477427	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR8477429	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR8477431	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR8477498	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR8477543	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR9734760	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9734761	PRJEB11419	control	0.0		male		Mexico				Obesity		OB			
ERR9734832	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9734841	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9734847	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9734850	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9734875	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9734876	PRJEB11419	Obesity	1.0		male		Mexico				Obesity		OB			
ERR9734891	PRJEB11419	control	0.0		male		Mexico				Obesity		OB			
ERR9734909	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9734915	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9734958	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9734959	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9734974	PRJEB11419	control	0.0		male		Mexico				Obesity		OB			
ERR9734996	PRJEB11419	Obesity	1.0		male		Mexico				Obesity		OB			
ERR9735038	PRJEB11419	control	0.0		female		Mexico				Obesity		OB			
ERR9735039	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9735085	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR9735122	PRJEB11419	Obesity	1.0		male		Mexico				Obesity		OB			
ERR6360868	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6360876	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6360898	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR6360914	PRJEB11419	Obesity	1.0		female		not provided				Obesity		OB			
ERR6360973	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR6361032	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR6361038	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR6361048	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361085	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361111	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR6361117	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361123	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361127	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361129	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361148	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR6361191	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR6361199	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR6361227	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361230	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361237	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361255	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR6361262	PRJEB11419	Obesity	1.0		female		China				Obesity		OB			
ERR6361273	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361304	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361478	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361525	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361530	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361615	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361662	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361705	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERR6361708	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361748	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6361855	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR6361933	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR6362988	PRJEB11419	Obesity	1.0		female		Mexico				Obesity		OB			
ERR6363033	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6363049	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6363160	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR6358233	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR6358286	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR6358288	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERR6358289	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR6358346	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR6358374	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR6358385	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR6358402	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR6358407	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR6358421	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR6358431	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR6358436	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERR7451659	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR7451671	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR7451683	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR7451693	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERR7451701	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR7451721	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR7451750	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERR7451753	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR7458443	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERR7458456	PRJEB11419	Obesity	1.0		female		Isle of Man				Obesity		OB			
ERR7458465	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERR5328198	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERR5328197	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283564	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283565	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283571	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283572	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283574	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283575	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283588	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6283597	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6283598	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6283615	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283616	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283617	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283618	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283620	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283621	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6283649	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283650	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283651	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283652	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283653	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6283655	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283656	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283657	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283658	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283659	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6283680	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6283681	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6283693	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6283696	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6283727	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790624	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5790646	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790651	PRJEB11419	control	0.0		female		Canada				Obesity		OB			
ERS5790673	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5790674	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5790685	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790689	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5790691	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5790696	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5790807	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5790810	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5790811	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5790873	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790877	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790898	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5790931	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5790956	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5790958	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5790967	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5790986	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5790988	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5790992	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5791004	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5791029	PRJEB11419	control	0.0		female		New Zealand				Obesity		OB			
ERS5810049	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5810110	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5810134	PRJEB11419	Obesity	1.0		male		New Zealand				Obesity		OB			
ERS5810160	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5810185	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5810198	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5810205	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5796559	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5796561	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5796708	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5796779	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5801982	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5802025	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5802046	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5802072	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5802076	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5802103	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5802113	PRJEB11419	Obesity	1.0		male		Canada				Obesity		OB			
ERS5802117	PRJEB11419	control	0.0		male		Canada				Obesity		OB			
ERS5802151	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5802176	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5802203	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5802248	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5802273	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5802290	PRJEB11419	Obesity	1.0		female		Canada				Obesity		OB			
ERS5802293	PRJEB11419	control	0.0		male		Canada				Obesity		OB			
ERS5802332	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5802346	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5802368	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5802421	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5802436	PRJEB11419	control	0.0		female		Norway				Obesity		OB			
ERS5802460	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5806610	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5806708	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5806745	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5806769	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5806777	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5806782	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5794089	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5794116	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5794122	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5794134	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5794163	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5794199	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5794202	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5794214	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5794236	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5794266	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5794275	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5794351	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5794390	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5794633	PRJEB11419	control	0.0		male		not provided				Obesity		OB			
ERS5794681	PRJEB11419	Obesity	1.0		male		Australia				Obesity		OB			
ERS5794942	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5794952	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5794994	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5795004	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5795009	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5795019	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5795412	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5795423	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5795510	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5795515	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5796390	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5796451	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5796517	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5796539	PRJEB11419	Obesity	1.0		male		Ireland				Obesity		OB			
ERS5796606	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5796711	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5801558	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5795239	PRJEB11419	Obesity	1.0		male		France				Obesity		OB			
ERS5795266	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5795277	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5795303	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5795351	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5795369	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5795381	PRJEB11419	Obesity	1.0		male		Ireland				Obesity		OB			
ERS5795570	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5795571	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5795578	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5796396	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5796476	PRJEB11419	control	0.0		male		Hungary				Obesity		OB			
ERS5796664	PRJEB11419	Obesity	1.0		female		Canada				Obesity		OB			
ERS5796694	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5801428	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5801449	PRJEB11419	control	0.0		male		Netherlands				Obesity		OB			
ERS5801514	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5801560	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5801566	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS5801575	PRJEB11419	Obesity	1.0		female		China				Obesity		OB			
ERS5801658	PRJEB11419	Obesity	1.0		male		Canada				Obesity		OB			
ERS5801659	PRJEB11419	Obesity	1.0		male		Canada				Obesity		OB			
ERS5801697	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5801730	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS5801731	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS5801748	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5801817	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5801830	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5801846	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS5801852	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5801983	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS5802119	PRJEB11419	control	0.0		male		Canada				Obesity		OB			
ERS5806743	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS7061494	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS7061495	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS7061538	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS7061565	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS7061570	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630020	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630032	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630054	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630058	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630071	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630089	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6630091	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630092	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6630119	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6630120	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630137	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630139	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630179	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630190	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630191	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630193	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630211	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630219	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630235	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630242	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630256	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630278	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630302	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630305	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630316	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS6630332	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630342	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630366	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630380	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630410	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS6630411	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630419	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630535	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS6630575	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS6630610	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630621	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630623	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630625	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630746	PRJEB11419	Obesity	1.0		male		United Kingdom				Obesity		OB			
ERS6630753	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630763	PRJEB11419	control	0.0		female		United Kingdom				Obesity		OB			
ERS6630793	PRJEB11419	Obesity	1.0		female		United States				Obesity		OB			
ERS6630815	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS6630824	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS4851165	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS4851214	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS4851229	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS4851247	PRJEB11419	Obesity	1.0		female		United Kingdom				Obesity		OB			
ERS4851296	PRJEB11419	control	0.0		female		United States				Obesity		OB			
ERS4851309	PRJEB11419	control	0.0		male		United Kingdom				Obesity		OB			
ERS5442580	PRJEB11419	Obesity	1.0		male		United States				Obesity		OB			
ERS5442599	PRJEB11419	control	0.0		male		United States				Obesity		OB			
ERS5442670	PRJEB11419	control	0.0		female		Germany				Obesity		OB			
ERS5442689	PRJEB11419	Obesity	1.0		female		Germany				Obesity		OB			
ERS5442722	PRJEB11419	control	0.0		male		Germany				Obesity		OB			
ERS5442732	PRJEB11419	Obesity	1.0		female		Germany				Obesity		OB			
ERS5442739	PRJEB11419	control	0.0		male		Germany				Obesity		OB			
ERS5442760	PRJEB11419	control	0.0		female		Germany				Obesity		OB			
ERS5442772	PRJEB11419	control	0.0		female		Germany				Obesity		OB			
ERS5442784	PRJEB11419	control	0.0		male		Germany				Obesity		OB			
ERS5442811	PRJEB11419	control	0.0		female		United States				Obesity		OB			
SRR1689253	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689254	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689291	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689362	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689401	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689515	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689535	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689572	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689635	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689692	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689821	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689859	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1689935	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690046	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690153	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690276	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690354	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690429	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690468	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690581	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690640	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690743	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690840	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690896	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1690963	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693198	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693199	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693200	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693202	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693203	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693204	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693205	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693206	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693207	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693208	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693209	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693210	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693211	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693212	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693214	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693215	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693216	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693217	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693218	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693219	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693220	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693221	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693222	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693224	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693225	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693226	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693228	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693229	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693231	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693254	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693255	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693256	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693257	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693258	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693259	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693267	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693268	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693269	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693270	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693276	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693281	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693285	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693293	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693294	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693300	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693305	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693306	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693307	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693308	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693347	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693348	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693349	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693350	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693351	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693352	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693353	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693354	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693355	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693356	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693357	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693358	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693359	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693360	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693361	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1693362	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763554	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763557	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763566	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763569	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763571	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763573	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763574	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763575	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763576	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763577	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763578	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763580	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763589	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763591	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763593	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763594	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763596	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763599	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763600	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763601	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763608	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763610	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763615	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763619	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763620	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763645	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763650	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763661	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763674	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763675	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763678	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763680	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763681	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763684	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763685	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763686	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763687	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763688	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763689	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763690	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763691	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763692	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763693	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763694	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763696	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763697	PRJNA268708	IBS	1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765911	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765912	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765915	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765917	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765919	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765921	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765923	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765926	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765928	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765930	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765931	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765937	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765940	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765941	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765942	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765943	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765944	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765945	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765952	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765954	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765956	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765985	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765990	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765992	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765993	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765994	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765995	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765996	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765997	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765998	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1765999	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766000	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766002	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766003	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766004	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766005	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766006	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766007	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766008	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766009	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766010	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766011	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766012	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766016	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766026	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766027	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766029	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766030	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766034	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766037	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766042	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766044	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766046	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766048	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766050	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766053	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766055	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766057	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766058	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766059	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766060	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766062	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766064	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766066	PRJNA268708	IBS	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766069	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766070	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766071	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766074	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766076	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766078	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766079	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766080	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766081	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766082	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766083	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766084	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766085	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766086	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766087	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766088	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766089	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766090	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766091	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766092	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766093	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1766094	PRJNA268708	healthy	0.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763540	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763560	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763564	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763572	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763582	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763584	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763587	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763604	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763606	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763623	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763634	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763666	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763670	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763672	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763673	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1763695	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687047	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687061	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687067	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687097	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687098	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687172	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687173	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687174	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687427	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687439	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687442	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687444	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687461	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1686980	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1686981	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1686982	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687009	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687039	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687040	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687041	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687042	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687043	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687044	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687045	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687049	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687050	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687052	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687055	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687056	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687058	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687059	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687062	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687063	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687064	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687065	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687066	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687068	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687069	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687094	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687095	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687096	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687100	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687171	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687425	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687430	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687446	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687452	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687456	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687458	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
SRR1687460	PRJNA268708		1.0				Spain	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	irritable bowel syndrome	Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome	IBS			
ERR1678433	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1678446	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1678476	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1678482	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1678487	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2308516	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308606	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2308618	PRJEB11419	IBS	1.0		male		Norway				IBS		IBS			
ERR2308619	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2308643	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2308690	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2308713	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308719	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308735	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2308794	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308803	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308810	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2308862	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2308866	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2308873	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2308874	PRJEB11419	IBS	1.0		male		not provided				IBS		IBS			
ERR2308905	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2308914	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2308943	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2309197	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2309211	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2309221	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2309353	PRJEB11419	control	0.0		male		Switzerland				IBS		IBS			
ERR2309406	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2313944	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2313952	PRJEB11419	IBS	1.0		male		Australia				IBS		IBS			
ERR2314006	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2314049	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2314055	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2314080	PRJEB11419	IBS	1.0		female		Denmark				IBS		IBS			
ERR2314084	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2314094	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2314127	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2314144	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2314180	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2314203	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2314216	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2314219	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2314239	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2314318	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2314324	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2314373	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2404900	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2404915	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2404936	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2404971	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2404986	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2405018	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2405020	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2405036	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2405037	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2405038	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2405048	PRJEB11419	control	0.0		female		Belgium				IBS		IBS			
ERR2405049	PRJEB11419	control	0.0		male		Belgium				IBS		IBS			
ERR2405149	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2405150	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2405152	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2405163	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2405178	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2405182	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2405240	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405241	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405242	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405256	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405272	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405283	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405295	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2405330	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2405372	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2405374	PRJEB11419	IBS	1.0		male		Australia				IBS		IBS			
ERR2405403	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1596982	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1597001	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1597011	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1597014	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1597047	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1597049	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1597050	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1597057	PRJEB11419	control	0.0		female		Switzerland				IBS		IBS			
ERR1597062	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1597084	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1597144	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1597145	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1597146	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1551637	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1551638	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1551647	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1678428	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1678438	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1678458	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1678465	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2032178	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2032206	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032242	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2032279	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032329	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032330	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032381	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032384	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032401	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2032539	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032552	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032569	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2032578	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2032579	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2032728	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2032759	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2032783	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2032862	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2032904	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2032913	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2033486	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1841589	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1841682	PRJEB11419	IBS	1.0		male		Sweden				IBS		IBS			
ERR1841703	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1841727	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1841736	PRJEB11419	control	0.0		male		Brazil				IBS		IBS			
ERR1841782	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1841786	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1841789	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1842693	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842700	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1842721	PRJEB11419	control	0.0		female		Norway				IBS		IBS			
ERR1842727	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1842743	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842745	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842775	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842776	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1842801	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1842802	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1842803	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1842804	PRJEB11419	IBS	1.0		female		not provided				IBS		IBS			
ERR1842809	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1842837	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1842884	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842887	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1842890	PRJEB11419	IBS	1.0		male		Sweden				IBS		IBS			
ERR1842899	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1844570	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1844586	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1844622	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1844626	PRJEB11419	control	0.0		male		Brazil				IBS		IBS			
ERR1844657	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1845729	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1845766	PRJEB11419	control	0.0		female		Australia				IBS		IBS			
ERR1845791	PRJEB11419	IBS	1.0		male		Australia				IBS		IBS			
ERR1845958	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1845967	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1845971	PRJEB11419	IBS	1.0		female		Denmark				IBS		IBS			
ERR1846005	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1846017	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1846020	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1846063	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1846079	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1846091	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1846093	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1846105	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1846129	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1846179	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1846187	PRJEB11419	control	0.0		male		China				IBS		IBS			
ERR1846212	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2523876	PRJEB11419	IBS	1.0		female		Sweden				IBS		IBS			
ERR2523926	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2523928	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2523951	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2523965	PRJEB11419	IBS	1.0		male		Slovakia				IBS		IBS			
ERR2523967	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2523976	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2524105	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2524172	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1854667	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1854676	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1854685	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1854689	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1854696	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1841523	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1841579	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1841614	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1841618	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1841619	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1315804	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1315836	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1316005	PRJEB11419	IBS	1.0		female		Canada				IBS		IBS			
ERR1316046	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1316076	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1316092	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1316116	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1316179	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1316217	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1316253	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2587855	PRJEB11419	control	0.0		male		Argentina				IBS		IBS			
ERR2056787	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2056793	PRJEB11419	control	0.0		male		Netherlands				IBS		IBS			
ERR2056798	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2056812	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2056814	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2056848	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2056850	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2056855	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2056865	PRJEB11419	IBS	1.0		male		France				IBS		IBS			
ERR2056891	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2056893	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2056907	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2057013	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2057022	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2057057	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2057109	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2057129	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2057130	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2057148	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2057149	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2057151	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2057196	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2057198	PRJEB11419	control	0.0		male		Puerto Rico				IBS		IBS			
ERR2057218	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1458702	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1458765	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1458793	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1458851	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1458852	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1458919	PRJEB11419	control	0.0		male		Switzerland				IBS		IBS			
ERR1458936	PRJEB11419	control	0.0		female		Denmark				IBS		IBS			
ERR1458955	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1458982	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1459013	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1459032	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1459046	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1459054	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1459058	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1459067	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1459091	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1459106	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1459144	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1459146	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1459154	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1459166	PRJEB11419	control	0.0		female		Canada				IBS		IBS			
ERR1459181	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1459195	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1459197	PRJEB11419	control	0.0		female		Canada				IBS		IBS			
ERR2091998	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2092010	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092038	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2092060	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2092065	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERR2092066	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2092072	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2092102	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092158	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092160	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092180	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092183	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092215	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092216	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092222	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092223	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092260	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092265	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092266	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092267	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092268	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092273	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092323	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092328	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092330	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092335	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092339	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092346	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092361	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092362	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092363	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092364	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092368	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092379	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092385	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092405	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2092415	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2092427	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1546035	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2091859	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2091893	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2091906	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2091932	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2091934	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2091937	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2091968	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2091972	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843491	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843496	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843507	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1843528	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1843565	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1843575	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1843577	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1843582	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1843590	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1843601	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1843605	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1843606	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1843672	PRJEB11419	IBS	1.0		male		Sweden				IBS		IBS			
ERR1843695	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1843715	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1843726	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843735	PRJEB11419	control	0.0		male		Brazil				IBS		IBS			
ERR1843761	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843787	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1843791	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR1843794	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1843807	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1843820	PRJEB11419	IBS	1.0		male		Ireland				IBS		IBS			
ERR1843828	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1843834	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2318052	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2318128	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2318138	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2318172	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2318180	PRJEB11419	IBS	1.0		female		not provided				IBS		IBS			
ERR2318181	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERR2318246	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319231	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2319242	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319243	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319244	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319245	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319246	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319247	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319248	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319249	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319259	PRJEB11419	control	0.0		male		Australia				IBS		IBS			
ERR2319326	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2319344	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2319372	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2319406	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2319436	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2319479	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2319489	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2319493	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2319494	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2319545	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2319551	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2306108	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2306109	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2306112	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2306147	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2306148	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2306189	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2306233	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2306237	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2303813	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2303851	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2303860	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2303861	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2303876	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2303885	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2303918	PRJEB11419	IBS	1.0		male		Australia				IBS		IBS			
ERR2303933	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2303978	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2304009	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2304046	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2304060	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2304092	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2304156	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2304157	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2304159	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR1079965	PRJEB11419	IBS	1.0		female		not provided				IBS		IBS			
ERR1417433	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1417460	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1417505	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1417517	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1417527	PRJEB11419	control	0.0		male		Austria				IBS		IBS			
ERR1417549	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1417571	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1417592	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1417601	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1417644	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1417645	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579373	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2579393	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579406	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2579419	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2579435	PRJEB11419	IBS	1.0		male		Canada				IBS		IBS			
ERR2579476	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2579487	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2579493	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2579506	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579510	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579550	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579660	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2579670	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579785	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579786	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579893	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2579897	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2579921	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2579932	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2580025	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2580052	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2580100	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2580106	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2579818	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2579821	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1389626	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR1389661	PRJEB11419	IBS	1.0		male		Jersey				IBS		IBS			
ERR1389691	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1389721	PRJEB11419	IBS	1.0		male		Switzerland				IBS		IBS			
ERR1389793	PRJEB11419	IBS	1.0		female		Switzerland				IBS		IBS			
ERR1389803	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1389804	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1389816	PRJEB11419	control	0.0		male		Austria				IBS		IBS			
ERR1389841	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR1389845	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1389896	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR2696510	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2696686	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2696702	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2696704	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2696706	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2696716	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2696764	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2696815	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2696832	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2696857	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696886	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2696897	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696914	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696921	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR2696945	PRJEB11419	IBS	1.0		male		Canada				IBS		IBS			
ERR2696958	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696975	PRJEB11419	IBS	1.0		male		not provided				IBS		IBS			
ERR2696983	PRJEB11419	IBS	1.0		male		Canada				IBS		IBS			
ERR2697054	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2697059	PRJEB11419	IBS	1.0		female		Sri Lanka				IBS		IBS			
ERR1389921	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1389935	PRJEB11419	control	0.0		male		Belgium				IBS		IBS			
ERR1389937	PRJEB11419	IBS	1.0		male		Sweden				IBS		IBS			
ERR1389952	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1390004	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2696445	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERR2696501	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2696502	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696522	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2696525	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2696565	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2696598	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2696618	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2696678	PRJEB11419	control	0.0		female		Canada				IBS		IBS			
ERR2696681	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2696683	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR2696701	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2696714	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2696717	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR1841507	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1841595	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR1842699	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR1842754	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1842810	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR1842832	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697554	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2697611	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697620	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697658	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697710	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697734	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697736	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2697740	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697756	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697789	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697802	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697804	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697809	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697816	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2697838	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697859	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697874	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697876	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2697888	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697902	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697903	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697940	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2697947	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697950	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR2697957	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2697961	PRJEB11419	control	0.0		female		Denmark				IBS		IBS			
ERR2697968	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR2697978	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR2697986	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2698000	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR2698042	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR2698045	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4018881	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR4018947	PRJEB11419	IBS	1.0		male		India				IBS		IBS			
ERR4018956	PRJEB11419	control	0.0		female		Austria				IBS		IBS			
ERR4018957	PRJEB11419	IBS	1.0		male		Austria				IBS		IBS			
ERR4019033	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4019196	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR4019225	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR4019228	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR4019241	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR4019308	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR4019322	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4019323	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4019371	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR4019682	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4019708	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4019730	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4019752	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR4020426	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR4020429	PRJEB11419	control	0.0		male		Australia				IBS		IBS			
ERR4020434	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4020435	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR4020441	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR4020453	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR4020454	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR4020457	PRJEB11419	control	0.0		female		Isle of Man				IBS		IBS			
ERR4020459	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR4020474	PRJEB11419	control	0.0		male		Ireland				IBS		IBS			
ERR4020483	PRJEB11419	control	0.0		male		Spain				IBS		IBS			
ERR4020490	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR4020595	PRJEB11419	control	0.0		male		Philippines				IBS		IBS			
ERR4020622	PRJEB11419	control	0.0		male		Iceland				IBS		IBS			
ERR4020628	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4020633	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4020651	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4020710	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR4018910	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR4019086	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR4019229	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR4019243	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR9744102	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744141	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744175	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744198	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR9744207	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744223	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR9744224	PRJEB11419	control	0.0		male		Mexico				IBS		IBS			
ERR9744236	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744252	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9744258	PRJEB11419	control	0.0		male		Mexico				IBS		IBS			
ERR9744259	PRJEB11419	IBS	1.0		male		Mexico				IBS		IBS			
ERR11274477	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR8477542	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR9734775	PRJEB11419	IBS	1.0		male		Mexico				IBS		IBS			
ERR9734794	PRJEB11419	IBS	1.0		male		Mexico				IBS		IBS			
ERR9734811	PRJEB11419	control	0.0		male		Mexico				IBS		IBS			
ERR9734812	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR9734840	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9734851	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9734896	PRJEB11419	IBS	1.0		not provided		Mexico				IBS		IBS			
ERR9734971	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9734983	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9735017	PRJEB11419	IBS	1.0		female		Mexico				IBS		IBS			
ERR9735020	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR9735021	PRJEB11419	IBS	1.0		male		Mexico				IBS		IBS			
ERR9735022	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR9735095	PRJEB11419	control	0.0		female		Mexico				IBS		IBS			
ERR6360910	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR6361081	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361109	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR10360101	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR6361377	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361392	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361416	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361472	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361556	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361672	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361686	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR6361774	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR6361850	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361888	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6361899	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6363009	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6363010	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR6363147	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6363162	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR6358170	PRJEB11419	IBS	1.0		male		France				IBS		IBS			
ERR6358271	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR6358276	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR6358294	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR6358315	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR6358331	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358335	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358338	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR6358341	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR6358345	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR6358369	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358372	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR6358401	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR6358406	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358411	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358420	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR6358422	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358423	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358426	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR6358428	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR6358442	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERR6358463	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR6358472	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERR7451662	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERR7451673	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR7451730	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERR7451752	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERR7458438	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERR7458444	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERR7458470	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERR5325534	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS6283596	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS6283716	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS6283717	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS6283726	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6283730	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6283731	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6283732	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6283733	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5790622	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5790648	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5790660	PRJEB11419	IBS	1.0		female		Switzerland				IBS		IBS			
ERS5790684	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5790755	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5790791	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5790797	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5790828	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5790834	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5790837	PRJEB11419	IBS	1.0		female		France				IBS		IBS			
ERS5790847	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5790852	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5790874	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5790904	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5790927	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5790937	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5790938	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5790946	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5790978	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5790989	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5791002	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5791003	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5791035	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5810057	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5810092	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5810121	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5810142	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5810154	PRJEB11419	control	0.0		female		New Zealand				IBS		IBS			
ERS5810165	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5810181	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5796506	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5796531	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5796742	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802032	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5802084	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802146	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802177	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5802187	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802211	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5802229	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5802244	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5802256	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802258	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5802305	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802325	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5802353	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5802359	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5802383	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5802397	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5802423	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5802439	PRJEB11419	control	0.0		male		Norway				IBS		IBS			
ERS5802444	PRJEB11419	IBS	1.0		male		Norway				IBS		IBS			
ERS5802474	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5806591	PRJEB11419	control	0.0		female		Canada				IBS		IBS			
ERS5806642	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5806644	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5806681	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERS5806684	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5806690	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5806715	PRJEB11419	IBS	1.0		male		Austria				IBS		IBS			
ERS5806740	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5806754	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5806797	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5794052	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794068	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794074	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794087	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794099	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794106	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5794118	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794130	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794153	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794167	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794168	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794179	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794232	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794237	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794248	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794298	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5794319	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794321	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794330	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794340	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794344	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5794348	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794349	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5794636	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794638	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794640	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794690	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794748	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794780	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794789	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794795	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794796	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794800	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794802	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794811	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794815	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794829	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794833	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794871	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794882	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794901	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794911	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5794921	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5794953	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5794977	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5794981	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794983	PRJEB11419	IBS	1.0		female		Germany				IBS		IBS			
ERS5794995	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5794998	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5795005	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5795013	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5795428	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5795437	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5795498	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5795514	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5795568	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5796320	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5796374	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5796417	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801524	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801692	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801772	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5795192	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5795256	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5795270	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5795312	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5795336	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5795362	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5795363	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5795544	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5795564	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5795643	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5796471	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5796588	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5796611	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5796623	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5796625	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5796638	PRJEB11419	control	0.0		male		New Zealand				IBS		IBS			
ERS5796652	PRJEB11419	IBS	1.0		male		Canada				IBS		IBS			
ERS5796662	PRJEB11419	IBS	1.0		male		Canada				IBS		IBS			
ERS5796741	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5796762	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5801433	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801454	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5801457	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS5801493	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5801499	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801500	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5801517	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5801573	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5801609	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS5801614	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801615	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5801618	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5801622	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801636	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERS5801641	PRJEB11419	IBS	1.0		female		Canada				IBS		IBS			
ERS5801656	PRJEB11419	control	0.0		male		Canada				IBS		IBS			
ERS5801669	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801679	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5801680	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5801703	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5801722	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5801792	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5801826	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5801834	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5801855	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5802020	PRJEB11419	IBS	1.0		female		Ireland				IBS		IBS			
ERS5802039	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5802294	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS5802327	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5802401	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5806659	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS5806660	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5806757	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS5806768	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS7061533	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS7061553	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS7061569	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS7061578	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6630019	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6630046	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS6630049	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6630055	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630066	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630081	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6630107	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630138	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS6630156	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630299	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS6630301	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS6630315	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630496	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630502	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS6630529	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS6630537	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS6630542	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS6630580	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS6630626	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS6630690	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS6630695	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS6630714	PRJEB11419	control	0.0		female		United Kingdom				IBS		IBS			
ERS6630724	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS6630771	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS6630810	PRJEB11419	control	0.0		female		United States				IBS		IBS			
ERS6630836	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS4851172	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS4851188	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS4851200	PRJEB11419	control	0.0		male		United Kingdom				IBS		IBS			
ERS4851230	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS4851253	PRJEB11419	IBS	1.0		male		not provided				IBS		IBS			
ERS4851259	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS4851283	PRJEB11419	control	0.0		male		Austria				IBS		IBS			
ERS4851302	PRJEB11419	IBS	1.0		female		United States				IBS		IBS			
ERS4851319	PRJEB11419	IBS	1.0		male		United Kingdom				IBS		IBS			
ERS4851320	PRJEB11419	IBS	1.0		female		United Kingdom				IBS		IBS			
ERS5442597	PRJEB11419	IBS	1.0		male		United States				IBS		IBS			
ERS5442612	PRJEB11419	control	0.0		male		United States				IBS		IBS			
ERS5442695	PRJEB11419	control	0.0		female		Germany				IBS		IBS			
ERS5442698	PRJEB11419	IBS	1.0		male		Germany				IBS		IBS			
ERS5442748	PRJEB11419	control	0.0		male		Germany				IBS		IBS			
ERS5442753	PRJEB11419	control	0.0		male		Germany				IBS		IBS			
ERS5442768	PRJEB11419	control	0.0		male		Germany				IBS		IBS			
ERS5442769	PRJEB11419	control	0.0		male		Germany				IBS		IBS			
ERS5442780	PRJEB11419	control	0.0		male		Germany				IBS		IBS			
ERS5442805	PRJEB11419	control	0.0		female		United States				IBS		IBS			
CRR024587	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia	Schizophrenia Patients With Prevotella-Enterotype Have a Higher Risk of Obesity	SZ			
CRR024588	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024589	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024590	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024591	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024592	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024593	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024594	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024595	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024596	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024597	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024598	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024599	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024600	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024601	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024602	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024603	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024604	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024605	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024606	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024607	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024608	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024609	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024610	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024611	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024612	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024613	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024614	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024615	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024616	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024617	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024618	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024619	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024620	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024621	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024622	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024623	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024624	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024625	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024626	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024627	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024628	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024629	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024630	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024631	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024632	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024633	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024634	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024635	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024636	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024637	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024638	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024639	PRJCA000673	Healthy	0.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024640	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024641	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024642	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024643	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024644	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024645	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024646	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024647	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024648	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024649	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024650	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024651	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024652	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024653	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024654	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024655	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024656	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024657	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024658	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024659	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024660	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024661	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024662	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024663	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024664	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024665	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024666	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024667	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024668	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024669	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024670	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024671	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024672	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024673	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024674	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024675	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024676	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024677	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024678	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024679	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024680	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024681	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024682	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024683	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024684	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024685	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024686	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024687	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024688	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024689	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024690	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024691	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024692	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024693	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024694	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024695	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024696	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024697	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024698	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024699	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024700	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024701	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024702	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
CRR024703	PRJCA000673	SCZ	1.0				Huludao, China	V3-V4		ILLUMINA	Schizophrenia		SZ			
SRR21566252	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia	A comparative study to determine the association of gut microbiome with schizophrenia in Zhejiang, China	SZ			
SRR21566253	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566254	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566255	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566256	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566257	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566258	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566259	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566260	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566261	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566262	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566263	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566264	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566265	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566266	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566267	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566268	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566269	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566270	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566271	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566272	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566273	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566274	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566275	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566276	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566277	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566278	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566279	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566280	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566281	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566282	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566283	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566284	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566285	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566286	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566287	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566288	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566289	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566290	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566291	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566292	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566293	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566294	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566295	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566296	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566297	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566298	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566299	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566300	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566301	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566302	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566303	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566304	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566305	PRJNA880407	Healthy	0.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566306	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566307	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566308	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566309	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566310	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566311	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566312	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566313	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566314	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566315	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566316	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566317	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566318	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566319	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566320	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566321	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566322	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566323	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566324	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566325	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566326	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566327	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566328	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566329	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566330	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566331	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566332	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566333	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566334	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566335	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566336	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566337	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566338	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566339	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566340	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566341	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566342	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566343	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566344	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566345	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566346	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566347	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566348	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566349	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566350	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR21566351	PRJNA880407	SCZ	1.0				China: Lishui	V3-V4	341f (5??-CCTAYGGGRBGCASCAG-3??) and 806r (5??-GGACTACNNGGGTATCTAAT-3??)	Illumina MiSeq	Schizophrenia		SZ			
SRR22118463	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118464	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118465	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118466	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118467	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118468	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118469	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118470	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118471	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118472	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118473	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118474	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118475	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118476	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118477	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118478	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118479	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118480	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118481	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118482	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118483	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118484	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118485	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118486	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118487	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118488	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118489	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118490	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118491	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118492	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118494	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118495	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118496	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118497	PRJNA896324	Control	0.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118498	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118499	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118500	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118501	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118502	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118503	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118504	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118505	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118506	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118507	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118508	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118509	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118510	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118511	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118512	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118513	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118514	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118515	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118516	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118517	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118518	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118519	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118520	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118521	PRJNA896324	First-episode	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118522	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR22118523	PRJNA896324	Established	1.0				Australia	V3-V4	Forward: 341F: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 805R: 5’-GACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	The Role of the Microbiome in the Metabolic Health of People with Schizophrenia and Related Psychoses: Cross-Sectional and Pre-Post Lifestyle Intervention Analyses	SZ			
SRR18048946	PRJNA807473	SZ031.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048947	PRJNA807473	SZ030.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048948	PRJNA807473	SZ029.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048949	PRJNA807473	SZ028.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048950	PRJNA807473	SZ026.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048951	PRJNA807473	SZ025.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048952	PRJNA807473	SZ024.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048953	PRJNA807473	SZ023.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048954	PRJNA807473	SZ022.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048955	PRJNA807473	SZ021.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048956	PRJNA807473	C12.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048957	PRJNA807473	SZ020.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048958	PRJNA807473	SZ019.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048959	PRJNA807473	SZ018.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048960	PRJNA807473	C71.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048961	PRJNA807473	C64.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048962	PRJNA807473	C63.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048963	PRJNA807473	C62.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048964	PRJNA807473	C08.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048965	PRJNA807473	C61.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048966	PRJNA807473	C60.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048967	PRJNA807473	C59.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048968	PRJNA807473	C58.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048969	PRJNA807473	C57.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048970	PRJNA807473	C55.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048971	PRJNA807473	C54.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048972	PRJNA807473	C52.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048973	PRJNA807473	C51.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048974	PRJNA807473	C50.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048975	PRJNA807473	C07.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048976	PRJNA807473	C49.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048977	PRJNA807473	C46.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048978	PRJNA807473	C44.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048979	PRJNA807473	C43.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048980	PRJNA807473	C42.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048981	PRJNA807473	C40.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048982	PRJNA807473	C39.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048983	PRJNA807473	C36.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048984	PRJNA807473	C35.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048985	PRJNA807473	C34.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048986	PRJNA807473	C05.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048987	PRJNA807473	C33.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048988	PRJNA807473	C32.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048989	PRJNA807473	C31.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048990	PRJNA807473	C30.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048991	PRJNA807473	C29.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048992	PRJNA807473	C28.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048993	PRJNA807473	C27.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048994	PRJNA807473	C26.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048995	PRJNA807473	C25.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048996	PRJNA807473	SZ017.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048997	PRJNA807473	SZ015.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048998	PRJNA807473	SZ014.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18048999	PRJNA807473	SZ013.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049000	PRJNA807473	SZ012.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049001	PRJNA807473	SZ011.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049002	PRJNA807473	SZ010.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049003	PRJNA807473	C11.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049004	PRJNA807473	SZ009.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049005	PRJNA807473	SZ008.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049006	PRJNA807473	SZ007.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049007	PRJNA807473	SZ006.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049008	PRJNA807473	SZ005.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049009	PRJNA807473	SZ004.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049010	PRJNA807473	SZ003.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049011	PRJNA807473	SZ002.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049012	PRJNA807473	SZ001.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049013	PRJNA807473	C88.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049014	PRJNA807473	C10.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049015	PRJNA807473	C87.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049016	PRJNA807473	C86.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049017	PRJNA807473	C85.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049018	PRJNA807473	C84.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049019	PRJNA807473	C83.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049020	PRJNA807473	C82.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049021	PRJNA807473	C81.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049022	PRJNA807473	C80.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049023	PRJNA807473	C79.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049024	PRJNA807473	C78.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049025	PRJNA807473	C09.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049026	PRJNA807473	C77.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049027	PRJNA807473	C76.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049028	PRJNA807473	C75.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049029	PRJNA807473	C74.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049030	PRJNA807473	C73.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049031	PRJNA807473	C72.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049032	PRJNA807473	C24.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049033	PRJNA807473	C03.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049034	PRJNA807473	C23.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049035	PRJNA807473	C22.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049036	PRJNA807473	C21.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049037	PRJNA807473	SZ095.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049038	PRJNA807473	C20.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049039	PRJNA807473	SZ094.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049040	PRJNA807473	SZ093.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049041	PRJNA807473	SZ092.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049042	PRJNA807473	SZ091.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049043	PRJNA807473	SZ090.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049044	PRJNA807473	SZ089.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049045	PRJNA807473	SZ088.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049046	PRJNA807473	SZ087.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049047	PRJNA807473	SZ086.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049048	PRJNA807473	SZ085.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049049	PRJNA807473	C19.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049050	PRJNA807473	SZ084.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049051	PRJNA807473	SZ083.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049052	PRJNA807473	SZ082.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049053	PRJNA807473	SZ079.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049054	PRJNA807473	SZ078.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049055	PRJNA807473	SZ077.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049056	PRJNA807473	SZ076.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049057	PRJNA807473	SZ075.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049058	PRJNA807473	SZ074.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049059	PRJNA807473	SZ073.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049060	PRJNA807473	C18.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049061	PRJNA807473	SZ072.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049062	PRJNA807473	SZ071.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049063	PRJNA807473	SZ070.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049064	PRJNA807473	SZ068.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049065	PRJNA807473	SZ067.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049066	PRJNA807473	SZ066.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049067	PRJNA807473	SZ065.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049068	PRJNA807473	SZ064.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049069	PRJNA807473	SZ063.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049070	PRJNA807473	SZ062.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049071	PRJNA807473	C17.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049072	PRJNA807473	SZ061.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049073	PRJNA807473	SZ060.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049074	PRJNA807473	SZ059.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049075	PRJNA807473	SZ058.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049076	PRJNA807473	SZ057.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049077	PRJNA807473	SZ056.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049078	PRJNA807473	SZ055.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049079	PRJNA807473	SZ054.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049080	PRJNA807473	SZ053.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049081	PRJNA807473	SZ052.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049082	PRJNA807473	C16.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049083	PRJNA807473	SZ051.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049084	PRJNA807473	SZ050.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049085	PRJNA807473	SZ049.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049086	PRJNA807473	SZ048.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049087	PRJNA807473	SZ047.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049088	PRJNA807473	SZ046.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049089	PRJNA807473	SZ045.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049090	PRJNA807473	SZ044.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049091	PRJNA807473	SZ043.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049092	PRJNA807473	SZ042.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049093	PRJNA807473	C15.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049094	PRJNA807473	SZ041.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049095	PRJNA807473	SZ040.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049096	PRJNA807473	SZ039.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049097	PRJNA807473	SZ038.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049098	PRJNA807473	SZ037.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049099	PRJNA807473	SZ036.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049100	PRJNA807473	SZ035.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049101	PRJNA807473	SZ034.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049102	PRJNA807473	SZ033.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049103	PRJNA807473	SZ032.fq	1.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049104	PRJNA807473	C13.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049105	PRJNA807473	C02.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
SRR18049106	PRJNA807473	C01.fq	0.0				China	V3-V4	Forward: 5’-CCTACGGGNGGCWGCAG-3’ Reverse: 5’-ACTACHVGGGTATCTAATCC-3’	ILLUMINA	Schizophrenia	Fecal Dysbiosis and Immune Dysfunction in Chinese Elderly Patients With Schizophrenia: An Observational Study	SZ			
ERR4569889	PRJEB23500	H	0.0				China	V3-V4 	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569890	PRJEB23500	BD	1.0				China	V3-V4 	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569891	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569892	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569893	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569894	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569895	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569896	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569897	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569898	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569899	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569900	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569901	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569902	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569903	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569904	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569905	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569906	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569907	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569908	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569909	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569910	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569911	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569912	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569913	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569914	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569915	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569916	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569917	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569918	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569919	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569920	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569921	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569922	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569923	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569924	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569925	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569926	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569927	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569928	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569929	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569930	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569931	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569932	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569933	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569934	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569935	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569936	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569937	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569938	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569939	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569940	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569941	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569942	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569943	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569944	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569945	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569946	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569947	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569948	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569949	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569950	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569951	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569952	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569953	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569954	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569955	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569956	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569957	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569958	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569959	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569960	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569961	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569962	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569963	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569964	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569965	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569966	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569967	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569968	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569969	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569970	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569971	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569972	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569973	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569974	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569975	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569976	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569977	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569978	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569979	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569980	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569981	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569982	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569983	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569984	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569985	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569986	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569987	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569988	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569989	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569990	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569991	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569992	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569993	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569994	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569995	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569996	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569997	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569998	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4569999	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570000	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570001	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570002	PRJEB23500	H	0.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570003	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570004	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570005	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570006	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
ERR4570007	PRJEB23500	BD	1.0				China	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Bipolar disorder	Gut Microbiota Changes in Patients with Bipolar Depression	BD			
SRR27720404	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720418	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720420	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720421	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720422	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720423	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720424	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720425	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720426	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720427	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720428	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720353	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720354	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720355	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720356	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720357	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720358	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720359	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720360	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720361	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720362	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720363	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720364	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720365	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720366	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720367	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720368	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720369	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720370	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720371	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720372	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720373	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720374	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720375	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720376	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720377	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720378	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720379	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720380	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720381	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720382	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720383	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720384	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720385	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720386	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720387	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720388	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720389	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720390	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720391	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720392	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720393	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720394	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720395	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720396	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720397	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720398	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720399	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720400	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720401	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720402	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720403	PRJNA1068750	HC	0.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720405	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720406	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720407	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720408	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720409	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720410	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720411	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720412	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720413	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720414	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720415	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720416	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720417	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720419	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720429	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720430	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720431	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720432	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720433	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720434	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720435	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720436	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720437	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720438	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720439	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
SRR27720440	PRJNA1068750	BD	1.0				China	V4		ILLUMINA	Bipolar disorder	Disruption of the gut microbiota-inflammation-brain axis in unmedicated bipolar disorder II depression	BD			
ERR2308705	PRJEB11419	Bipolar	1.0		male		United Kingdom				Bipolar		BD			
ERR2314354	PRJEB11419	Bipolar	1.0		female		United States				Bipolar		BD			
ERR2405162	PRJEB11419	control	0.0		female		United States				Bipolar		BD			
ERR1597234	PRJEB11419	control	0.0		female		United Kingdom				Bipolar		BD			
ERR2032263	PRJEB11419	control	0.0		female		United States				Bipolar		BD			
ERR2032586	PRJEB11419	Bipolar	1.0		male		United States				Bipolar		BD			
ERR1841643	PRJEB11419	control	0.0		female		United Kingdom				Bipolar		BD			
ERR2056987	PRJEB11419	control	0.0		male		Ireland				Bipolar		BD			
ERR2057127	PRJEB11419	control	0.0		female		United States				Bipolar		BD			
ERR2091978	PRJEB11419	control	0.0		male		United Kingdom				Bipolar		BD			
ERR1843630	PRJEB11419	control	0.0		female		United Kingdom				Bipolar		BD			
ERR1843754	PRJEB11419	control	0.0		female		United Kingdom				Bipolar		BD			
ERR2303898	PRJEB11419	control	0.0		female		Australia				Bipolar		BD			
ERR2579503	PRJEB11419	control	0.0		male		United States				Bipolar		BD			
ERR2696620	PRJEB11419	Bipolar	1.0		female		United Kingdom				Bipolar		BD			
ERR4019255	PRJEB11419	Bipolar	1.0		male		Canada				Bipolar		BD			
ERR4019692	PRJEB11419	control	0.0		female		Philippines				Bipolar		BD			
ERR4019704	PRJEB11419	control	0.0		male		United States				Bipolar		BD			
ERR6358349	PRJEB11419	Bipolar	1.0		male		United Kingdom				Bipolar		BD			
ERS5790706	PRJEB11419	Bipolar	1.0		female		not provided				Bipolar		BD			
ERS5790730	PRJEB11419	Bipolar	1.0		female		United States				Bipolar		BD			
ERS5790732	PRJEB11419	Bipolar	1.0		male		United States				Bipolar		BD			
ERS5790733	PRJEB11419	Bipolar	1.0		male		United States				Bipolar		BD			
ERS5802040	PRJEB11419	control	0.0		male		United States				Bipolar		BD			
ERS5802379	PRJEB11419	Bipolar	1.0		female		United Kingdom				Bipolar		BD			
ERS5794051	PRJEB11419	Bipolar	1.0		female		United States				Bipolar		BD			
ERS5795007	PRJEB11419	Bipolar	1.0		male		United Kingdom				Bipolar		BD			
ERS5795511	PRJEB11419	Bipolar	1.0		male		United States				Bipolar		BD			
ERS7061523	PRJEB11419	Bipolar	1.0		male		United States				Bipolar		BD			
ERS6630331	PRJEB11419	control	0.0		male		United States				Bipolar		BD			
SRR15495779	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495790	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-14��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495791	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-15��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495792	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-16��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495793	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-17��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495794	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-18��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495795	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-19��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495796	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-20��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495797	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-21��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495798	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-22��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495799	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-23��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495800	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-24��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495801	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-25��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495802	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-26��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495803	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-27��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495804	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-28��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495805	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-29��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495806	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-30��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495807	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-31��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495808	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-32��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495809	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-33��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495810	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-34��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495811	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-35��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495812	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-36��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495813	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-37��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495814	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-38��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495815	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-39��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495816	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-40��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495817	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-41��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495818	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-42��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495819	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-43��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495820	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-44��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495821	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-45��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495822	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-46��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495823	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-47��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495824	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-48��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495825	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-49��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495826	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-50��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495827	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-51��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495828	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-52��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495829	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-53��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495830	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-54��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495831	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-55��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495832	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-56��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495833	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-57��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495834	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-58��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495835	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-59��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495836	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-60��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495837	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-61��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495838	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-62��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495839	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-63��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495840	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-64��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495841	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-65��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495842	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-66��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495843	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-67��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495844	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-68��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495845	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-69��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495846	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-70��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495847	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-71��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495852	SRP332779	AS	1.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-76��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495780	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-4��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495781	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-5��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495782	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-6��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495783	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-7��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495784	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-8��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495785	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-9��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495786	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-10��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495787	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-11��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495788	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-12��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495789	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-13��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495848	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-72��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495849	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-73��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495850	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-74��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495851	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-75��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495853	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-77��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495854	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-78��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495855	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-79��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495856	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-80��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495857	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-81��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495858	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-82��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495859	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-83��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495860	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-84��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495861	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-85��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
SRR15495862	SRP332779	C	0.0				China	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3')R(5��-GGACTACHVGGGTWTCTAAT-86��)	Illumina HiSeq 2500	Ankylosing Spondylitis	Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis	AS			
CRR345298	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-51��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345299	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-52��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345300	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-53��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345301	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-54��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345302	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-55��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345303	PRJCA007396	C	0.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-56��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345304	PRJCA007396	C	0.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-57��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345305	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-58��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345306	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-59��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345307	PRJCA007396	C	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-60��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345308	PRJCA007396	AS	0.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-61��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345250	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-3��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345251	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-4��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345252	PRJCA007396	AS	1.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-5��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345253	PRJCA007396	AS	1.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-6��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345254	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-7��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345255	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-8��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345256	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-9��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345257	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-10��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345258	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-11��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345259	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-12��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345260	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-13��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345261	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-14��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345262	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-15��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345263	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-16��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345264	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-17��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345265	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-18��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345266	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-19��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345267	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-20��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345268	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-21��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345269	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-22��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345270	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-23��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345271	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-24��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345272	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-25��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345273	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-26��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345274	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-27��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345275	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-28��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345276	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-29��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345277	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-30��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345278	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-31��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345279	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-32��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345280	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-33��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345281	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-34��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345282	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-35��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345283	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-36��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345284	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-37��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345285	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-38��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345286	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-39��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345287	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-40��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345288	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-41��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345289	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-42��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345290	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-43��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345291	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-44��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345292	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-45��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345293	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-46��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345294	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-47��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345295	PRJCA007396	AS	1.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-48��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345296	PRJCA007396	AS	1.0		female		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-49��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
CRR345297	PRJCA007396	AS	1.0		male		China	V3�CV4	f(5��-GTGCCAGCMGCCGCGGTAA-3��),r(5��- GGACTACHVGGGTWTCTAAT-50��)	Illumina HiSeq X Ten	Ankylosing Spondylitis	Association of anti-TNF-�� treatment with gut microbiota of patients with ankylosing spondylitis	AS			
SRR8351974	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351975	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351976	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351977	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351978	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351979	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351980	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351981	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351982	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351983	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351984	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351985	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351986	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351987	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351988	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351989	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351990	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351991	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351992	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351993	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351994	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351995	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351996	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351997	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8351998	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352000	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352001	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352002	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352003	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352004	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352005	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352006	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352007	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352008	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352009	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352010	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352011	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352012	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352013	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352014	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352015	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352016	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352017	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352018	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352019	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352020	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352021	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352022	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352023	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352024	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352025	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352026	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352027	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352028	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352029	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352030	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352031	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352032	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352033	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352034	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352035	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352036	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352037	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352038	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352039	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352040	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352041	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352042	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352043	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352044	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352045	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352046	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352047	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352048	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352049	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352050	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352051	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352052	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352053	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352054	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352055	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352056	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352057	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352058	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352059	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352060	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352061	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352062	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352063	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352064	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352065	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352066	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352067	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352068	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352069	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352070	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352071	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352072	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352073	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352074	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352075	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352076	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352077	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352078	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352079	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352080	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352081	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352082	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352083	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352084	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352085	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352086	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352087	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352088	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352089	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352090	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352091	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352092	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352093	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352094	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352095	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352096	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352097	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352098	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352099	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352100	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352101	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352102	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352103	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352104	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352105	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352106	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352107	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352108	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352109	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352110	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352111	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352112	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352113	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352114	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352115	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352116	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352117	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352118	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352119	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352120	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352121	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352122	PRJNA510730	GC	0.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352123	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352124	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR8352125	PRJNA510730	GP	1.0				Italy	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321049	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321050	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321051	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321052	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321053	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321054	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321055	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321056	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321057	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321058	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321059	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321060	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321061	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321062	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321063	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321064	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321065	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321066	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321067	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321068	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321069	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321070	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321071	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321072	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321073	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321074	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321075	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321076	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321077	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321078	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321079	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321080	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321081	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321082	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321083	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321084	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321085	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321086	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321087	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321088	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321089	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321090	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321091	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321092	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321093	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321094	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321095	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321096	PRJNA510730	GC	0.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321097	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
SRR11321098	PRJNA510730	GP	1.0				Italy: Rome	V3-V4		Illumina MiSeq	PD	Dysbiosis of gut microbiota in a selected population of Parkinson's patients	PD			
ERR1513669	PRJEB14674	Control	0.0		female	28.34	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513670	PRJEB14674	Control	0.0		female	33.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513671	PRJEB14674	Control	0.0		female	32.28	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513672	PRJEB14674	Control	0.0		female	24.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513673	PRJEB14674	Control	0.0		male	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513674	PRJEB14674	Control	0.0		male	24.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513675	PRJEB14674	Control	0.0		male	24.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513676	PRJEB14674	Control	0.0		female	31.17	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513677	PRJEB14674	Control	0.0		male	33.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513678	PRJEB14674	Control	0.0		female	25.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513679	PRJEB14674	Control	0.0		male	26.04	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513680	PRJEB14674	Control	0.0		male	26.04	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513681	PRJEB14674	Control	0.0		male	25.4	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513682	PRJEB14674	Case	1.0		female	21.92	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513683	PRJEB14674	Case	1.0		male	32.07	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513684	PRJEB14674	Case	1.0		male	25.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513685	PRJEB14674	Case	1.0		male	34.66	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513686	PRJEB14674	Case	1.0		male	27.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513687	PRJEB14674	Case	1.0		male		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513688	PRJEB14674	Case	1.0		female	19.53	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513689	PRJEB14674	Case	1.0		male	22.87	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513690	PRJEB14674	Case	1.0		male	20.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513691	PRJEB14674	Case	1.0		female	36.84	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513692	PRJEB14674	Case	1.0		male	20.28	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513693	PRJEB14674	Case	1.0		female	25.05	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513694	PRJEB14674	Case	1.0		male	32.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513695	PRJEB14674	Case	1.0		male	29.02	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513696	PRJEB14674	Case	1.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513698	PRJEB14674	Case	1.0		female	20.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513699	PRJEB14674	Case	1.0		male	31.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513700	PRJEB14674	Case	1.0		male	25.54	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513701	PRJEB14674	Case	1.0		male	18.99	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513702	PRJEB14674	Case	1.0		male	23.97	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513703	PRJEB14674	Case	1.0		female	27.92	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513704	PRJEB14674	Case	1.0		male	31.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513705	PRJEB14674	Case	1.0		female	32.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513706	PRJEB14674	Case	1.0		female	21.95	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513707	PRJEB14674	Case	1.0		male	26.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513708	PRJEB14674	Case	1.0		male	26.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513709	PRJEB14674	Case	1.0		male	33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513710	PRJEB14674	Case	1.0		male	29.41	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513711	PRJEB14674	Case	1.0		male	18.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513712	PRJEB14674	Case	1.0		male	25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513713	PRJEB14674	Case	1.0		male	27.98	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513714	PRJEB14674	Case	1.0		male	26.38	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513715	PRJEB14674	Control	0.0		male	24.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513716	PRJEB14674	Control	0.0		male	26.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513717	PRJEB14674	Control	0.0		female	24.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513718	PRJEB14674	Control	0.0		female	37.59	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513719	PRJEB14674	Control	0.0		male	24.21	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513721	PRJEB14674	Control	0.0		female	23.43	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513722	PRJEB14674	Control	0.0		female	25.86	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513723	PRJEB14674	Control	0.0		male	26.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513724	PRJEB14674	Control	0.0		male	26.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513725	PRJEB14674	Control	0.0		male	41.81	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513726	PRJEB14674	Control	0.0		female	32.87	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513727	PRJEB14674	Control	0.0		male	28.69	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513728	PRJEB14674	Control	0.0		male	28.59	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513729	PRJEB14674	Control	0.0		female	25.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513730	PRJEB14674	Control	0.0		female	30.23	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513731	PRJEB14674	Control	0.0		male	43.04	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513732	PRJEB14674	Control	0.0		female	22.14	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513733	PRJEB14674	Control	0.0		female	23.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513734	PRJEB14674	Control	0.0		male	27.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513735	PRJEB14674	Control	0.0		female	23.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513736	PRJEB14674	Control	0.0		male	37.65	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513737	PRJEB14674	Control	0.0		female	18.02	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513738	PRJEB14674	Control	0.0		female	18.95	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513739	PRJEB14674	Control	0.0		male	22.63	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513740	PRJEB14674	Control	0.0		female	40.93	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513741	PRJEB14674	Control	0.0		female	23.76	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513742	PRJEB14674	Control	0.0		female	42.91	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513743	PRJEB14674	Control	0.0		female	26.57	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513744	PRJEB14674	Control	0.0		female	30.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513745	PRJEB14674	Control	0.0		male	34.17	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513746	PRJEB14674	Control	0.0		male	25.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513747	PRJEB14674	Control	0.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513748	PRJEB14674	Control	0.0		male	25.66	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513749	PRJEB14674	Control	0.0		male	35.87	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513750	PRJEB14674	Control	0.0		female	24.27	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513751	PRJEB14674	Control	0.0		female	23.77	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513752	PRJEB14674	Control	0.0		male	35.94	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513753	PRJEB14674	Control	0.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513754	PRJEB14674	Control	0.0		male	27.19	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513755	PRJEB14674	Control	0.0		male	23.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513756	PRJEB14674	Control	0.0		male	27.46	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513757	PRJEB14674	Control	0.0		female	29.95	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513758	PRJEB14674	Control	0.0		female	21.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513759	PRJEB14674	Control	0.0		female	25.74	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513760	PRJEB14674	Control	0.0		female	25.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513761	PRJEB14674	Control	0.0		female	29.62	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513762	PRJEB14674	Control	0.0		male	25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513763	PRJEB14674	Control	0.0		female	32.0	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513764	PRJEB14674	Control	0.0		male	29.41	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513765	PRJEB14674	Control	0.0		female	20.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513766	PRJEB14674	Control	0.0		female	29.26	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513767	PRJEB14674	Control	0.0		female	39.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513768	PRJEB14674	Control	0.0		male	26.62	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513769	PRJEB14674	Control	0.0		female	39.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513770	PRJEB14674	Control	0.0		female	29.18	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513771	PRJEB14674	Control	0.0		male	23.73	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513772	PRJEB14674	Control	0.0		female	20.19	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513773	PRJEB14674	Control	0.0		male	22.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513775	PRJEB14674	Control	0.0		female	21.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513776	PRJEB14674	Control	0.0		female	32.74	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513777	PRJEB14674	Control	0.0		female	22.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513778	PRJEB14674	Case	1.0		male	40.17	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513779	PRJEB14674	Case	1.0		female	22.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513780	PRJEB14674	Case	1.0		female	22.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513781	PRJEB14674	Case	1.0		male	31.01	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513782	PRJEB14674	Case	1.0		female	18.29	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513783	PRJEB14674	Case	1.0		female	24.84	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513784	PRJEB14674	Case	1.0		male	26.57	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513785	PRJEB14674	Case	1.0		male	24.81	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513786	PRJEB14674	Case	1.0		female	26.45	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513787	PRJEB14674	Case	1.0		male	26.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513788	PRJEB14674	Case	1.0		male	25.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513789	PRJEB14674	Case	1.0		male	25.11	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513790	PRJEB14674	Case	1.0		male	22.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513793	PRJEB14674	Case	1.0		male	21.46	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513794	PRJEB14674	Case	1.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513795	PRJEB14674	Case	1.0		male	26.15	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513796	PRJEB14674	Case	1.0		male	23.63	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513797	PRJEB14674	Case	1.0		male	30.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513798	PRJEB14674	Case	1.0		female	18.65	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513799	PRJEB14674	Case	1.0		male	21.23	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513800	PRJEB14674	Case	1.0		female	31.64	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513801	PRJEB14674	Case	1.0		male	23.67	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513802	PRJEB14674	Case	1.0		female	19.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513803	PRJEB14674	Case	1.0		female	14.64	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513804	PRJEB14674	Case	1.0		male	27.25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513805	PRJEB14674	Case	1.0		male	30.51	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513806	PRJEB14674	Case	1.0		female	18.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513807	PRJEB14674	Case	1.0		male	25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513808	PRJEB14674	Case	1.0		male	24.4	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513810	PRJEB14674	Case	1.0		male	27.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513811	PRJEB14674	Case	1.0		male	30.51	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513812	PRJEB14674	Case	1.0		male	37.49	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513813	PRJEB14674	Case	1.0		male	30.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513815	PRJEB14674	Case	1.0		male	30.54	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513816	PRJEB14674	Case	1.0		male	20.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513817	PRJEB14674	Case	1.0		male	24.01	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513819	PRJEB14674	Case	1.0		female	20.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513820	PRJEB14674	Case	1.0		male	30.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513821	PRJEB14674	Case	1.0		male	24.39	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513822	PRJEB14674	Case	1.0		female	19.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513823	PRJEB14674	Case	1.0		female	37.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513825	PRJEB14674	Case	1.0		male	31.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513826	PRJEB14674	Case	1.0		male	19.37	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513827	PRJEB14674	Case	1.0		male	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513828	PRJEB14674	Case	1.0		male	22.59	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513829	PRJEB14674	Case	1.0		male	22.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513830	PRJEB14674	Case	1.0		male	26.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513831	PRJEB14674	Case	1.0		male	28.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513832	PRJEB14674	Case	1.0		female	30.66	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513833	PRJEB14674	Case	1.0		female	22.52	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513834	PRJEB14674	Case	1.0		female	19.76	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513835	PRJEB14674	Case	1.0		female	26.81	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513836	PRJEB14674	Case	1.0		female	28.35	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513837	PRJEB14674	Case	1.0		male	29.53	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513838	PRJEB14674	Case	1.0		female	34.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513839	PRJEB14674	Case	1.0		female	33.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513840	PRJEB14674	Case	1.0		male	30.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513841	PRJEB14674	Case	1.0		female	19.63	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513842	PRJEB14674	Case	1.0		male	40.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513843	PRJEB14674	Case	1.0		male	22.89	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513844	PRJEB14674	Case	1.0		male	27.38	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513845	PRJEB14674	Case	1.0		male	26.25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513846	PRJEB14674	Case	1.0		male	30.57	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513847	PRJEB14674	Case	1.0		male	30.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513849	PRJEB14674	Case	1.0		female	30.18	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513850	PRJEB14674	Case	1.0		female	17.71	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513851	PRJEB14674	Case	1.0		male	23.49	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513853	PRJEB14674	Case	1.0		male	30.51	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513854	PRJEB14674	Case	1.0		male	30.85	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513856	PRJEB14674	Case	1.0		male	28.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513857	PRJEB14674	Case	1.0		male	31.56	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513858	PRJEB14674	Case	1.0		female	20.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513859	PRJEB14674	Case	1.0		female	22.67	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513860	PRJEB14674	Case	1.0		male	30.69	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513861	PRJEB14674	Case	1.0		male	22.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513862	PRJEB14674	Case	1.0		male	23.73	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513863	PRJEB14674	Case	1.0		male	26.63	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513864	PRJEB14674	Case	1.0		male	24.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513865	PRJEB14674	Case	1.0		female	22.81	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513866	PRJEB14674	Case	1.0		female	20.55	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513867	PRJEB14674	Case	1.0		female	23.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513868	PRJEB14674	Case	1.0		female	26.58	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513869	PRJEB14674	Case	1.0		female	18.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513870	PRJEB14674	Case	1.0		male	25.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513871	PRJEB14674	Case	1.0		male	27.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513872	PRJEB14674	Case	1.0		male	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513873	PRJEB14674	Case	1.0		female	27.88	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513874	PRJEB14674	Case	1.0		male	25.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513875	PRJEB14674	Case	1.0		male	24.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513876	PRJEB14674	Case	1.0		female	31.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513877	PRJEB14674	Case	1.0		female	21.79	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513878	PRJEB14674	Case	1.0		male	24.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513879	PRJEB14674	Case	1.0		male	31.87	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513880	PRJEB14674	Case	1.0		female	22.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513881	PRJEB14674	Case	1.0		male	18.46	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513882	PRJEB14674	Case	1.0		female	26.62	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513883	PRJEB14674	Case	1.0		male	25.84	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513884	PRJEB14674	Case	1.0		male	32.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513885	PRJEB14674	Case	1.0		male	31.19	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513886	PRJEB14674	Case	1.0		female	20.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513887	PRJEB14674	Case	1.0		male	26.25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513889	PRJEB14674	Case	1.0		male	30.51	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513890	PRJEB14674	Case	1.0		male	25.42	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513891	PRJEB14674	Case	1.0		female	17.68	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513892	PRJEB14674	Case	1.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513894	PRJEB14674	Case	1.0		male	20.37	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513896	PRJEB14674	Case	1.0		female	34.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513898	PRJEB14674	Case	1.0		female	22.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513899	PRJEB14674	Case	1.0		female	30.18	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513900	PRJEB14674	Case	1.0		male	22.51	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513901	PRJEB14674	Case	1.0		male	26.58	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513902	PRJEB14674	Case	1.0		female	18.02	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513903	PRJEB14674	Case	1.0		female	22.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513904	PRJEB14674	Case	1.0		female	21.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513905	PRJEB14674	Case	1.0		male	31.56	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513906	PRJEB14674	Case	1.0		male	25.09	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513907	PRJEB14674	Case	1.0		male		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513908	PRJEB14674	Case	1.0		female	22.71	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513909	PRJEB14674	Case	1.0		female	20.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513910	PRJEB14674	Case	1.0		male	27.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513911	PRJEB14674	Case	1.0		male	22.24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513912	PRJEB14674	Case	1.0		female	38.57	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513913	PRJEB14674	Case	1.0		female	25.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513914	PRJEB14674	Case	1.0		male	27.88	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513915	PRJEB14674	Case	1.0		female	23.71	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513916	PRJEB14674	Case	1.0		male	24.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513917	PRJEB14674	Case	1.0		male	33.22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513918	PRJEB14674	Case	1.0		male	28.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513919	PRJEB14674	Case	1.0		male	26.54	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513920	PRJEB14674	Case	1.0		male	29.12	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513921	PRJEB14674	Case	1.0		male	33.22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513922	PRJEB14674	Case	1.0		male	31.32	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513923	PRJEB14674	Case	1.0		female	22.14	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513924	PRJEB14674	Case	1.0		female	24.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513925	PRJEB14674	Case	1.0		male	29.53	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513926	PRJEB14674	Case	1.0		male	25.85	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513927	PRJEB14674	Case	1.0		male	18.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513928	PRJEB14674	Case	1.0		male	26.58	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513929	PRJEB14674	Case	1.0		male	23.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513930	PRJEB14674	Case	1.0		female	19.34	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513931	PRJEB14674	Case	1.0		male	27.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513932	PRJEB14674	Case	1.0		male	31.56	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513933	PRJEB14674	Case	1.0		male	24.41	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513934	PRJEB14674	Case	1.0		female	40.97	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513935	PRJEB14674	Case	1.0		male	35.73	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513936	PRJEB14674	Case	1.0		male	21.92	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513939	PRJEB14674	Case	1.0		female	45.64	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513940	PRJEB14674	Case	1.0		male	23.43	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513941	PRJEB14674	Case	1.0		male	30.71	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513942	PRJEB14674	Case	1.0		male	19.52	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513943	PRJEB14674	Case	1.0		male	26.62	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513944	PRJEB14674	Case	1.0		male	24.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513945	PRJEB14674	Case	1.0		male	24.39	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513946	PRJEB14674	Case	1.0		male	24.74	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513947	PRJEB14674	Case	1.0		male	25.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513948	PRJEB14674	Case	1.0		male	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513949	PRJEB14674	Case	1.0		male	27.21	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513950	PRJEB14674	Case	1.0		male	43.18	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513951	PRJEB14674	Case	1.0		male		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513952	PRJEB14674	Case	1.0		female	30.91	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513953	PRJEB14674	Case	1.0		male	25.82	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513954	PRJEB14674	Case	1.0		female	25.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513955	PRJEB14674	Case	1.0		male	25.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513956	PRJEB14674	Case	1.0		male	35.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513957	PRJEB14674	Case	1.0		male	21.41	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513958	PRJEB14674	Control	0.0		female		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513959	PRJEB14674	Control	0.0		female	28.34	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513960	PRJEB14674	Control	0.0		female	24.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513961	PRJEB14674	Control	0.0		female	24.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513963	PRJEB14674	Control	0.0		female	36.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513964	PRJEB14674	Control	0.0		female	33.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513965	PRJEB14674	Control	0.0		female	24.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513966	PRJEB14674	Control	0.0		female	22.31	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513967	PRJEB14674	Control	0.0		male	23.75	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513968	PRJEB14674	Control	0.0		female	27.43	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513969	PRJEB14674	Control	0.0		female	24.22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513970	PRJEB14674	Control	0.0		male	30.34	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513971	PRJEB14674	Control	0.0		female	21.61	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513972	PRJEB14674	Control	0.0		female	24.13	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513973	PRJEB14674	Control	0.0		male	24.36	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513974	PRJEB14674	Control	0.0		male	33.72	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513975	PRJEB14674	Control	0.0		female	28.34	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513976	PRJEB14674	Control	0.0		male	22.8	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513977	PRJEB14674	Control	0.0		male	23.11	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513978	PRJEB14674	Control	0.0		female	34.21	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513979	PRJEB14674	Control	0.0		female	34.57	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513980	PRJEB14674	Control	0.0		female	32.92	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513981	PRJEB14674	Control	0.0		female	21.63	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513982	PRJEB14674	Control	0.0		female	33.67	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513983	PRJEB14674	Control	0.0		female	25.84	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513984	PRJEB14674	Control	0.0		female	17.47	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513985	PRJEB14674	Control	0.0		female	34.33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513986	PRJEB14674	Control	0.0		female	23.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513987	PRJEB14674	Control	0.0		male	24.59	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513988	PRJEB14674	Control	0.0		female	22.31	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513989	PRJEB14674	Control	0.0		male	25.99	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513990	PRJEB14674	Control	0.0		female	32.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513991	PRJEB14674	Control	0.0		male	28.03	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513992	PRJEB14674	Control	0.0		male	30.22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513993	PRJEB14674	Control	0.0		male	24.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513994	PRJEB14674	Control	0.0		male	27.37	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513995	PRJEB14674	Control	0.0		female	23.62	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513996	PRJEB14674	Control	0.0		male	29.99	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513997	PRJEB14674	Control	0.0		male	29.19	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513998	PRJEB14674	Control	0.0		male	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1513999	PRJEB14674	Control	0.0		male		USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514000	PRJEB14674	Control	0.0		male	39.54	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514001	PRJEB14674	Control	0.0		female	33.28	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514002	PRJEB14674	Control	0.0		female	32.77	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514003	PRJEB14674	Control	0.0		male	31.29	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514005	PRJEB14674	Control	0.0		female	33.64	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514006	PRJEB14674	Control	0.0		female	25.06	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514007	PRJEB14674	Control	0.0		male	24.07	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514008	PRJEB14674	Control	0.0		female	44.99	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514009	PRJEB14674	Control	0.0		female	36.49	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514010	PRJEB14674	Control	0.0		female	24.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514011	PRJEB14674	Control	0.0		male	30.81	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514012	PRJEB14674	Control	0.0		female	41.96	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514013	PRJEB14674	Control	0.0		female	34.44	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514014	PRJEB14674	Control	0.0		female	27.48	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
ERR1514015	PRJEB14674	Control	0.0		female	29.18	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq	Parkinsons	Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome	PD			
SRR15012442	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012444	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012445	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012446	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012447	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012449	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012450	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012451	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012452	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012453	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012454	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012455	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012456	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012457	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012458	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012460	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012461	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012462	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012463	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012464	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012465	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012466	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012467	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012500	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012501	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012503	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012504	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012505	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012506	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012507	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012508	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012509	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012510	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012511	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012512	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012514	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012515	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012516	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012517	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012518	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012519	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012520	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012521	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012522	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012523	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012525	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012526	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012527	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012528	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012529	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012530	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012531	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012532	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012533	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012534	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012537	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012538	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012539	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012540	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012541	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012542	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012543	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012544	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012545	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012546	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012548	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012549	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012550	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012551	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012552	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012553	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012554	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012555	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012556	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012557	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012559	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012560	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012561	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012562	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012563	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012568	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012569	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012570	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012571	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012572	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012574	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012575	PRJNA742875	Parkinson’s disease	1.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012576	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012577	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012578	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012579	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012580	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012581	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012582	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012583	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012585	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012586	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012587	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012588	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012589	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012590	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012591	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012592	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012593	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012594	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012596	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012597	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012598	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012599	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012600	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012601	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012602	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012603	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012604	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012605	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012607	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012608	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012609	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012610	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012611	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012612	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012613	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012614	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012615	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012616	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012618	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012619	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012620	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012621	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012622	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012623	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012624	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012625	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012626	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012627	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012629	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012630	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012631	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012632	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012633	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012634	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012635	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012636	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012637	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012638	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012640	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012641	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012642	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012643	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012644	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012645	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012646	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012647	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012648	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012649	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012652	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012653	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012654	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012655	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012656	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012657	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012658	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012659	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012660	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012661	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012663	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012664	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012665	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012666	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012667	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR15012668	PRJNA742875	healthy	0.0				Korea	V3-V4	F: CCTACGGGNGGCWGCAG; R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Oral and gut dysbiosis leads to functional alterations in Parkinson's disease	PD			
SRR10604964	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604965	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604966	PRJNA594156	Parkinsons	1.0		male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604967	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604968	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604969	PRJNA594156	Control	0.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604970	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604971	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604972	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604973	PRJNA594156	Control	0.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604975	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604976	PRJNA594156	Control	0.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604977	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604978	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604979	PRJNA594156	Control	0.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604980	PRJNA594156	Control	0.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604981	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604982	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604983	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604984	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604985	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604986	PRJNA594156	Control	0.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604987	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604988	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604990	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604991	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604992	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604995	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604996	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604997	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604998	PRJNA594156	Control	0.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10604999	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605000	PRJNA594156	Parkinsons	1.0	20.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605001	PRJNA594156	Parkinsons	1.0	22.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605002	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605003	PRJNA594156	Parkinsons	1.0	21.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605004	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605005	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605006	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605008	PRJNA594156	Parkinsons	1.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605009	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605010	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605011	PRJNA594156	Parkinsons	1.0	20.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605012	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605013	PRJNA594156	Parkinsons	1.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605014	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605015	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605016	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605017	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605018	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605019	PRJNA594156	Parkinsons	1.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605020	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605021	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605022	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605023	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605024	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605025	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605026	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605027	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605028	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605029	PRJNA594156	Control	0.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605030	PRJNA594156	Control	0.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605031	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605032	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605033	PRJNA594156	Control	0.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605034	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605035	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605036	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605037	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605038	PRJNA594156	Control	0.0	22.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605039	PRJNA594156	Control	0.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605040	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605041	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605042	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605043	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605044	PRJNA594156	Control	0.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605045	PRJNA594156	Control	0.0	21.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605046	PRJNA594156	Control	0.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605047	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605049	PRJNA594156	Control	0.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605050	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605051	PRJNA594156	Parkinsons	1.0	17.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605052	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605053	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605054	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605055	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605056	PRJNA594156	Parkinsons	1.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605057	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605058	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605059	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605060	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605061	PRJNA594156	Parkinsons	1.0	21.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605062	PRJNA594156	Parkinsons	1.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605063	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605064	PRJNA594156	Parkinsons	1.0	17.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605065	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605066	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605067	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605068	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605070	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605071	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605072	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605073	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605074	PRJNA594156	Control	0.0	19.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605075	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605076	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605077	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605078	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605080	PRJNA594156	Parkinsons	1.0	22.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605081	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605082	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605083	PRJNA594156	Parkinsons	1.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605084	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605085	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605086	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605087	PRJNA594156	Parkinsons	1.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605088	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605089	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605090	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605091	PRJNA594156	Parkinsons	1.0	22.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605092	PRJNA594156	Parkinsons	1.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605093	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605094	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605095	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605096	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605097	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605098	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605099	PRJNA594156	Control	0.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605100	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605101	PRJNA594156	Parkinsons	1.0	20.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605102	PRJNA594156	Parkinsons	1.0	22.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605103	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605104	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605105	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605106	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605107	PRJNA594156	Parkinsons	1.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605108	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605109	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605110	PRJNA594156	Parkinsons	1.0	23.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605111	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605112	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605113	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605114	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605115	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605116	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605117	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605118	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605119	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605120	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605121	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605122	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605123	PRJNA594156	Parkinsons	1.0	23.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605124	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605125	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605126	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605127	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605128	PRJNA594156	Parkinsons	1.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605129	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605130	PRJNA594156	Parkinsons	1.0	22.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605131	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605132	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605133	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605134	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605136	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605137	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605138	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605139	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605140	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605141	PRJNA594156	Parkinsons	1.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605142	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605143	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605144	PRJNA594156	Parkinsons	1.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605145	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605146	PRJNA594156	Parkinsons	1.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605147	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605148	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605149	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605150	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605151	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605152	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605153	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605154	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605155	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605156	PRJNA594156	Parkinsons	1.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605157	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605158	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605159	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605160	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605161	PRJNA594156	Parkinsons	1.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605162	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605163	PRJNA594156	Control	0.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605164	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605165	PRJNA594156	Parkinsons	1.0	21.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605166	PRJNA594156	Control	0.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605167	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605168	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605169	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605170	PRJNA594156	Control	0.0	30.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605172	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605173	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605174	PRJNA594156	Control	0.0	19.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605175	PRJNA594156	Parkinsons	1.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605176	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605177	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605178	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605179	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605180	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605181	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605182	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605183	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605184	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605186	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605187	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605188	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605189	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605190	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605191	PRJNA594156	Parkinsons	1.0	31.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605192	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605194	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605195	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605196	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605197	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605198	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605199	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605200	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605201	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605202	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605203	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605204	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605205	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605206	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605207	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605208	PRJNA594156	Control	0.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605209	PRJNA594156	Control	0.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605210	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605211	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605212	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605213	PRJNA594156	Control	0.0	24.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605214	PRJNA594156	Control	0.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605215	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605216	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605217	PRJNA594156	Control	0.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605218	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605219	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605220	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605221	PRJNA594156	Control	0.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605222	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605223	PRJNA594156	Control	0.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605224	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605225	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605226	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605227	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605228	PRJNA594156	Control	0.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605229	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605230	PRJNA594156	Control	0.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605231	PRJNA594156	Control	0.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605232	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605233	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605234	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605235	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605236	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605237	PRJNA594156	Parkinsons	1.0	15.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605238	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605239	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605240	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605241	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605242	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605243	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605244	PRJNA594156	Control	0.0	23.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605245	PRJNA594156	Parkinsons	1.0	29.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605246	PRJNA594156	Parkinsons	1.0	25.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605247	PRJNA594156	Parkinsons	1.0	26.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605248	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605249	PRJNA594156	Control	0.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605250	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605251	PRJNA594156	Parkinsons	1.0	21.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605252	PRJNA594156	Parkinsons	1.0	26.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605253	PRJNA594156	Parkinsons	1.0	27.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605254	PRJNA594156	Parkinsons	1.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605255	PRJNA594156	Parkinsons	1.0	28.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605256	PRJNA594156	Parkinsons	1.0	24.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605257	PRJNA594156	Parkinsons	1.0	28.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605258	PRJNA594156	Parkinsons	1.0	30.0	female		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605259	PRJNA594156	Control	0.0	27.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605260	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605261	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605262	PRJNA594156	Parkinsons	1.0	25.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
SRR10605263	PRJNA594156	Parkinsons	1.0	29.0	male		Canada	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVHHHTWTCTAAT	ILLUMINA	Parkinson's patients	Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease	PD			
ERR3046385	PRJEB30615	Parkinson's disease	1.0	50.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046388	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046393	PRJEB30615	Parkinson's disease	1.0	68.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046395	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046398	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046399	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046401	PRJEB30615	Parkinson's disease	1.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046403	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046422	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046427	PRJEB30615	healthy control	0.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046429	PRJEB30615	healthy control	0.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046430	PRJEB30615	healthy control	0.0	65.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046432	PRJEB30615	healthy control	0.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046433	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046434	PRJEB30615	healthy control	0.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046439	PRJEB30615	healthy control	0.0	56.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046440	PRJEB30615	healthy control	0.0	56.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046444	PRJEB30615	healthy control	0.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046449	PRJEB30615	Parkinson's disease	1.0	50.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046450	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046452	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046455	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046458	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046459	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046462	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046466	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046467	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046470	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046473	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046475	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046478	PRJEB30615	Parkinson's disease	1.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046481	PRJEB30615	Parkinson's disease	1.0	62.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046491	PRJEB30615	healthy control	0.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046493	PRJEB30615	healthy control	0.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046494	PRJEB30615	healthy control	0.0	65.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046495	PRJEB30615	healthy control	0.0	64.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046497	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046498	PRJEB30615	healthy control	0.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046499	PRJEB30615	healthy control	0.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046500	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046501	PRJEB30615	healthy control	0.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046502	PRJEB30615	healthy control	0.0	57.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046505	PRJEB30615	healthy control	0.0	55.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046510	PRJEB30615	healthy control	0.0	70.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046513	PRJEB30615	Parkinson's disease	1.0	50.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046517	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046523	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046526	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046528	PRJEB30615	Parkinson's disease	1.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046531	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046537	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046548	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046551	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046556	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046561	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046562	PRJEB30615	healthy control	0.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046568	PRJEB30615	healthy control	0.0	56.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046573	PRJEB30615	healthy control	0.0	66.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046583	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046587	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046588	PRJEB30615	Parkinson's disease	1.0	78.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046589	PRJEB30615	Parkinson's disease	1.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046590	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046594	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046596	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046601	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046605	PRJEB30615	Parkinson's disease	1.0	62.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046614	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046617	PRJEB30615	healthy control	0.0	61.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046620	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046621	PRJEB30615	healthy control	0.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046623	PRJEB30615	healthy control	0.0	64.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046625	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046632	PRJEB30615	healthy control	0.0	56.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046634	PRJEB30615	healthy control	0.0	76.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046636	PRJEB30615	healthy control	0.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046637	PRJEB30615	healthy control	0.0	66.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046638	PRJEB30615	healthy control	0.0	70.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046386	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046387	PRJEB30615	Parkinson's disease	1.0	65.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046389	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046390	PRJEB30615	Parkinson's disease	1.0	47.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046391	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046392	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046394	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046396	PRJEB30615	Parkinson's disease	1.0	78.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046397	PRJEB30615	Parkinson's disease	1.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046400	PRJEB30615	Parkinson's disease	1.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046402	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046404	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046405	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046406	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046407	PRJEB30615	Parkinson's disease	1.0	81.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046408	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046409	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046410	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046411	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046412	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046413	PRJEB30615	Parkinson's disease	1.0	62.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046414	PRJEB30615	Parkinson's disease	1.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046415	PRJEB30615	Parkinson's disease	1.0	74.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046416	PRJEB30615	Parkinson's disease	1.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046417	PRJEB30615	Parkinson's disease	1.0	62.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046418	PRJEB30615	Parkinson's disease	1.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046419	PRJEB30615	Parkinson's disease	1.0	77.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046421	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046423	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046424	PRJEB30615	healthy control	0.0	58.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046425	PRJEB30615	healthy control	0.0	61.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046426	PRJEB30615	healthy control	0.0	55.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046428	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046431	PRJEB30615	healthy control	0.0	64.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046435	PRJEB30615	healthy control	0.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046436	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046437	PRJEB30615	healthy control	0.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046438	PRJEB30615	healthy control	0.0	57.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046441	PRJEB30615	healthy control	0.0	55.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046442	PRJEB30615	healthy control	0.0	76.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046443	PRJEB30615	healthy control	0.0	71.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046445	PRJEB30615	healthy control	0.0	66.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046446	PRJEB30615	healthy control	0.0	70.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046447	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046448	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046451	PRJEB30615	Parkinson's disease	1.0	65.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046453	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046454	PRJEB30615	Parkinson's disease	1.0	47.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046456	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046457	PRJEB30615	Parkinson's disease	1.0	68.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046460	PRJEB30615	Parkinson's disease	1.0	78.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046461	PRJEB30615	Parkinson's disease	1.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046463	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046464	PRJEB30615	Parkinson's disease	1.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046465	PRJEB30615	Parkinson's disease	1.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046468	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046469	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046471	PRJEB30615	Parkinson's disease	1.0	81.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046472	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046474	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046476	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046477	PRJEB30615	Parkinson's disease	1.0	62.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046479	PRJEB30615	Parkinson's disease	1.0	74.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046480	PRJEB30615	Parkinson's disease	1.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046482	PRJEB30615	Parkinson's disease	1.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046483	PRJEB30615	Parkinson's disease	1.0	77.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046484	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046485	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046486	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046487	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046488	PRJEB30615	healthy control	0.0	58.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046489	PRJEB30615	healthy control	0.0	61.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046490	PRJEB30615	healthy control	0.0	55.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046492	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046496	PRJEB30615	healthy control	0.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046503	PRJEB30615	healthy control	0.0	56.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046504	PRJEB30615	healthy control	0.0	56.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046506	PRJEB30615	healthy control	0.0	76.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046507	PRJEB30615	healthy control	0.0	71.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046508	PRJEB30615	healthy control	0.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046509	PRJEB30615	healthy control	0.0	66.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046511	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046512	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046514	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046515	PRJEB30615	Parkinson's disease	1.0	65.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046516	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046518	PRJEB30615	Parkinson's disease	1.0	47.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046519	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046520	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046521	PRJEB30615	Parkinson's disease	1.0	68.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046522	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046524	PRJEB30615	Parkinson's disease	1.0	78.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046525	PRJEB30615	Parkinson's disease	1.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046527	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046529	PRJEB30615	Parkinson's disease	1.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046530	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046532	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046533	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046534	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046535	PRJEB30615	Parkinson's disease	1.0	81.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046536	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046538	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046539	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046540	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046541	PRJEB30615	Parkinson's disease	1.0	62.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046542	PRJEB30615	Parkinson's disease	1.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046543	PRJEB30615	Parkinson's disease	1.0	74.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046544	PRJEB30615	Parkinson's disease	1.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046545	PRJEB30615	Parkinson's disease	1.0	62.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046546	PRJEB30615	Parkinson's disease	1.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046547	PRJEB30615	Parkinson's disease	1.0	77.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046549	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046550	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046552	PRJEB30615	healthy control	0.0	58.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046553	PRJEB30615	healthy control	0.0	61.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046554	PRJEB30615	healthy control	0.0	55.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046555	PRJEB30615	healthy control	0.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046557	PRJEB30615	healthy control	0.0	66.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046558	PRJEB30615	healthy control	0.0	65.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046559	PRJEB30615	healthy control	0.0	64.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046560	PRJEB30615	healthy control	0.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046563	PRJEB30615	healthy control	0.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046564	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046565	PRJEB30615	healthy control	0.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046566	PRJEB30615	healthy control	0.0	57.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046567	PRJEB30615	healthy control	0.0	56.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046569	PRJEB30615	healthy control	0.0	55.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046570	PRJEB30615	healthy control	0.0	76.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046571	PRJEB30615	healthy control	0.0	71.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046572	PRJEB30615	healthy control	0.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046574	PRJEB30615	healthy control	0.0	70.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046575	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046576	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046577	PRJEB30615	Parkinson's disease	1.0	50.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046578	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046579	PRJEB30615	Parkinson's disease	1.0	65.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046580	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046581	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046582	PRJEB30615	Parkinson's disease	1.0	47.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046584	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046585	PRJEB30615	Parkinson's disease	1.0	68.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046586	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046591	PRJEB30615	Parkinson's disease	1.0	75.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046592	PRJEB30615	Parkinson's disease	1.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046593	PRJEB30615	Parkinson's disease	1.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046595	PRJEB30615	Parkinson's disease	1.0	60.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046597	PRJEB30615	Parkinson's disease	1.0	78.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046598	PRJEB30615	Parkinson's disease	1.0	67.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046599	PRJEB30615	Parkinson's disease	1.0	81.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046600	PRJEB30615	Parkinson's disease	1.0	74.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046602	PRJEB30615	Parkinson's disease	1.0	69.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046603	PRJEB30615	Parkinson's disease	1.0	53.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046604	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046606	PRJEB30615	Parkinson's disease	1.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046607	PRJEB30615	Parkinson's disease	1.0	74.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046608	PRJEB30615	Parkinson's disease	1.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046609	PRJEB30615	Parkinson's disease	1.0	62.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046610	PRJEB30615	Parkinson's disease	1.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046611	PRJEB30615	Parkinson's disease	1.0	77.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046612	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046613	PRJEB30615	Parkinson's disease	1.0	77.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046615	PRJEB30615	Parkinson's disease	1.0	0.0			Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046616	PRJEB30615	healthy control	0.0	58.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046618	PRJEB30615	healthy control	0.0	55.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046619	PRJEB30615	healthy control	0.0	61.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046622	PRJEB30615	healthy control	0.0	65.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046624	PRJEB30615	healthy control	0.0	67.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046626	PRJEB30615	healthy control	0.0	72.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046627	PRJEB30615	healthy control	0.0	70.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046628	PRJEB30615	healthy control	0.0	63.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046629	PRJEB30615	healthy control	0.0	59.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046630	PRJEB30615	healthy control	0.0	57.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046631	PRJEB30615	healthy control	0.0	56.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046633	PRJEB30615	healthy control	0.0	55.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046635	PRJEB30615	healthy control	0.0	71.0	male		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046639	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR3046640	PRJEB30615	healthy control	0.0	64.0	female		Germany	V4-V5	F: AYTGGGYDTAAAGNG; R: CCGTCAATTCMTTTRAGTTT	ILLUMINA	Parkinson's patients	Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota	PD			
ERR2730148	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730149	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730150	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730151	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730152	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730153	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730154	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730155	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730156	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730157	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730158	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730159	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730160	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730161	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730162	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730163	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730164	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730165	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730166	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730167	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730168	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730169	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730170	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730171	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730172	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730173	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730174	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730175	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730176	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730177	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730178	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730179	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730180	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730181	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730182	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730183	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730184	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730185	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730186	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730187	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730188	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730189	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730190	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730191	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730192	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730193	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730194	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730195	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730196	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730197	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730198	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730199	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730201	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730202	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730203	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730204	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730205	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730206	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730207	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730208	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730209	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730210	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730211	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730212	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730213	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730214	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730215	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730216	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730217	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730218	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730219	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730220	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730221	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730222	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730223	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730224	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730225	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730226	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730227	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730229	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730231	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730232	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730233	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730234	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730235	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730236	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730237	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730238	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730239	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730241	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730242	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730243	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730244	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730245	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730246	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730247	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730248	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730249	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730250	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730251	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730252	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730253	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730254	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730255	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730256	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730257	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730258	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730259	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730260	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730261	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730262	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730264	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730265	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730266	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730267	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730268	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730269	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730270	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730272	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730273	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730274	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730275	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730276	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730277	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730278	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730279	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730280	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730281	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730282	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730283	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730284	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730285	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730286	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730287	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730288	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730289	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730290	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730291	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730292	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730293	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730294	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730295	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730296	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730298	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730299	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730300	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730301	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730302	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730304	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730305	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730306	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730307	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730308	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730309	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730310	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730311	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730312	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730313	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730314	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730315	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730316	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730317	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730318	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730319	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730320	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730321	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730323	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730324	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730325	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730326	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730327	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730328	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730329	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730330	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730331	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730332	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730333	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730334	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730335	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730336	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730337	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730338	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730339	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730340	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730341	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730342	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730343	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730344	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730345	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730346	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730347	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730348	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730350	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730351	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730352	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730353	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730354	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730355	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730356	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730357	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730358	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730359	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730360	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730361	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730362	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730363	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730364	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730365	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730366	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730367	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730368	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730369	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730370	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730371	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730372	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730373	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730374	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730375	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730376	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730377	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730378	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730379	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730380	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730381	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730382	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730383	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730384	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730385	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730386	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730387	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730388	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730389	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730390	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730391	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730393	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730394	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730395	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730396	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730397	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730398	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730399	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730400	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730401	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730402	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR2730403	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040009	PRJEB27564	control	0.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040012	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040013	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040014	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040015	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040016	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040017	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
ERR3040018	PRJEB27564	Parkinson’s disease	1.0				Finland	V3-V4	F: CCTACGGGNGGCWGCAG;  R: GACTACHVGGGTATCTAATCC	ILLUMINA	Parkinson's patients	Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression	PD			
SRR13592997	PRJNA695309	Graves disease	1.0	43.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13592998	PRJNA695309	Graves disease	1.0	65.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13592999	PRJNA695309	Graves disease	1.0	57.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593000	PRJNA695309	Graves disease	1.0	55.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593009	PRJNA695309	Graves disease	1.0	36.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593010	PRJNA695309	Graves disease	1.0	40.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593011	PRJNA695309	Graves disease	1.0	66.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593012	PRJNA695309	Graves disease	1.0	28.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593013	PRJNA695309	Graves disease	1.0	45.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593014	PRJNA695309	Graves disease	1.0	38.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593015	PRJNA695309	Graves disease	1.0	67.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593016	PRJNA695309	Graves disease	1.0	33.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593038	PRJNA695309	Graves disease	1.0	23.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593039	PRJNA695309	Graves disease	1.0	33.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593041	PRJNA695309	Graves disease	1.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593042	PRJNA695309	Graves disease	1.0	41.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593043	PRJNA695309	Graves disease	1.0	54.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593044	PRJNA695309	Graves disease	1.0	45.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593052	PRJNA695309	Graves disease	1.0	40.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593053	PRJNA695309	Graves disease	1.0	49.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593001	PRJNA695309	Graves disease	1.0	45.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593002	PRJNA695309	Graves disease	1.0	60.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593003	PRJNA695309	Graves disease	1.0	48.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593004	PRJNA695309	Graves disease	1.0	57.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593005	PRJNA695309	Graves disease	1.0	52.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593006	PRJNA695309	Graves disease	1.0	42.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593008	PRJNA695309	Graves disease	1.0	47.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593017	PRJNA695309	Graves disease	1.0	25.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593019	PRJNA695309	Graves disease	1.0	41.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593020	PRJNA695309	Graves disease	1.0	41.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593021	PRJNA695309	Graves disease	1.0	61.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593022	PRJNA695309	Graves disease	1.0	37.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593023	PRJNA695309	Graves disease	1.0	63.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593024	PRJNA695309	Graves disease	1.0	44.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593025	PRJNA695309	Graves disease	1.0	38.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593026	PRJNA695309	Graves disease	1.0	53.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593027	PRJNA695309	Graves disease	1.0	22.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593028	PRJNA695309	Graves disease	1.0	40.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593030	PRJNA695309	Graves disease	1.0	42.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593031	PRJNA695309	Graves disease	1.0	55.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593032	PRJNA695309	Graves disease	1.0	49.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593033	PRJNA695309	Graves disease	1.0	48.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593034	PRJNA695309	Graves disease	1.0	32.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593035	PRJNA695309	Graves disease	1.0	25.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593036	PRJNA695309	Graves disease	1.0	42.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593037	PRJNA695309	Graves disease	1.0	59.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593045	PRJNA695309	Graves disease	1.0	27.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593046	PRJNA695309	Graves disease	1.0	72.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593047	PRJNA695309	Graves disease	1.0	35.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593048	PRJNA695309	Graves disease	1.0	45.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593049	PRJNA695309	Graves disease	1.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593050	PRJNA695309	Graves disease	1.0	53.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593094	PRJNA695309	Graves disease	1.0	61.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593095	PRJNA695309	Graves disease	1.0	55.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593096	PRJNA695309	Graves disease	1.0	38.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593040	PRJNA695309	Healthy control	0.0	30.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593051	PRJNA695309	Healthy control	0.0	45.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593054	PRJNA695309	Healthy control	0.0	37.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593055	PRJNA695309	Healthy control	0.0	38.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593056	PRJNA695309	Healthy control	0.0	48.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593066	PRJNA695309	Healthy control	0.0	39.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593067	PRJNA695309	Healthy control	0.0	29.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593068	PRJNA695309	Healthy control	0.0	43.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593069	PRJNA695309	Healthy control	0.0	33.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593070	PRJNA695309	Healthy control	0.0	47.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593071	PRJNA695309	Healthy control	0.0	48.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593072	PRJNA695309	Healthy control	0.0	46.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593073	PRJNA695309	Healthy control	0.0	31.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593078	PRJNA695309	Healthy control	0.0	45.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593079	PRJNA695309	Healthy control	0.0	40.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593080	PRJNA695309	Healthy control	0.0	48.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593081	PRJNA695309	Healthy control	0.0	53.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593082	PRJNA695309	Healthy control	0.0	58.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593083	PRJNA695309	Healthy control	0.0	27.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593084	PRJNA695309	Healthy control	0.0	35.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593085	PRJNA695309	Healthy control	0.0	42.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593086	PRJNA695309	Healthy control	0.0	49.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593087	PRJNA695309	Healthy control	0.0	55.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593088	PRJNA695309	Healthy control	0.0	56.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593089	PRJNA695309	Healthy control	0.0	41.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593090	PRJNA695309	Healthy control	0.0	31.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593091	PRJNA695309	Healthy control	0.0	53.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593092	PRJNA695309	Healthy control	0.0	49.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593007	PRJNA695309	Healthy control	0.0	57.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593018	PRJNA695309	Healthy control	0.0	52.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593029	PRJNA695309	Healthy control	0.0	57.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593057	PRJNA695309	Healthy control	0.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593058	PRJNA695309	Healthy control	0.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593059	PRJNA695309	Healthy control	0.0	43.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593060	PRJNA695309	Healthy control	0.0	41.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593061	PRJNA695309	Healthy control	0.0	31.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593062	PRJNA695309	Healthy control	0.0	52.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593063	PRJNA695309	Healthy control	0.0	33.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593064	PRJNA695309	Healthy control	0.0	62.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593065	PRJNA695309	Healthy control	0.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593074	PRJNA695309	Healthy control	0.0	62.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593075	PRJNA695309	Healthy control	0.0	34.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593076	PRJNA695309	Healthy control	0.0	26.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593077	PRJNA695309	Healthy control	0.0	44.0	male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593093	PRJNA695309	Healthy control	0.0	46.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593097	PRJNA695309	Healthy control	0.0	40.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593098	PRJNA695309	Healthy control	0.0	27.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR13593099	PRJNA695309	Healthy control	0.0	40.0	female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Alterations of Gut Microbiota in Patients With Graves�� Disease	GD			
SRR19749385	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749386	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749387	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749388	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749389	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749390	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749391	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749392	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749394	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749395	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749396	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749397	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749398	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749399	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749400	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749401	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749402	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749403	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749405	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749406	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749407	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749408	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749409	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749410	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749411	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749412	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749413	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749414	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749416	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749417	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749418	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749419	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749420	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749421	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749422	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749423	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749450	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749451	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749452	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749453	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749454	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749455	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749456	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749457	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749459	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749460	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749461	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749462	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749463	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749464	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749465	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749466	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749467	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749468	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749470	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749471	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749472	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749473	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749474	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749475	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749476	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749477	PRJNA850658	Graves disease	1.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749478	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749479	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749481	PRJNA850658	Graves disease	1.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749393	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749404	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749415	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749424	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749425	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749426	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749427	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749428	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749429	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749430	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749431	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749432	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749433	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749434	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749435	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749436	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749437	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749438	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749439	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749440	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749441	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749442	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749443	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749444	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749458	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749469	PRJNA850658	Healthy control	0.0		male		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749480	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749482	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749493	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749504	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749515	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749516	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
SRR19749517	PRJNA850658	Healthy control	0.0		female		China	V3-V4	FWD:CCTACGGGNGGCWGCAG;REV:GACTACHVGGGTATCTAATCC	Illumina MiSeq	Graves disease	Correlation between gut microbiota and the development of Graves�� disease: A prospective study	GD			
ERR2168235	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168240	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168242	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168246	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168247	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168248	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168249	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168250	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168251	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168252	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168253	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168254	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168255	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168258	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168259	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168260	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168261	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168265	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168266	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168267	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168273	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168276	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168277	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168280	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168282	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168283	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168284	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168286	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168287	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168290	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168293	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168294	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168296	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168297	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168300	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168301	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168302	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168308	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168310	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168311	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168315	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168316	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168317	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168318	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168322	PRJEB22977	MS PPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168323	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168324	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168327	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168328	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168329	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168332	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168333	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168335	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168337	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168340	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168341	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168342	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168343	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168344	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168345	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168346	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168347	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168348	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168349	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168350	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168351	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168352	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168353	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168354	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168355	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168356	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168357	PRJEB22977	MS SPMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168358	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168359	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168360	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168361	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168362	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168363	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168365	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168366	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168367	PRJEB22977	MS RRMS	1.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168368	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168369	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168370	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168371	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168372	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2168373	PRJEB22977	HC	0.0				Germany	V1-V3	Forward: 5'-AGAGTTTGATCCTGGCTCAG-3' Reverse: 5'-ATTACCGCGGCTGCTGG-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167319	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167320	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167321	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167322	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167323	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167324	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167325	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167326	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167327	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167328	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167329	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167330	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167331	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167332	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167333	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167334	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167335	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167336	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167337	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167338	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167339	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167340	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167341	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167342	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167343	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167344	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167345	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167346	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167347	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167348	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167349	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167350	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167351	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167352	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167353	PRJEB22970	Healthy control	0.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167354	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167355	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167356	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167357	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167358	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167359	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167360	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167361	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167362	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167363	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167364	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167365	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167366	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167367	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167368	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167369	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167370	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167371	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167372	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167373	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167374	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167375	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167376	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167377	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167378	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167379	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167380	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167381	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167382	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167383	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167384	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167385	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167386	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167387	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167388	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167389	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167390	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167391	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167392	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167393	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167394	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167395	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167396	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167397	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167398	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167399	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167400	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167401	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167402	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167403	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167404	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167405	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167406	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167407	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167408	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167409	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167410	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167411	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167412	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167413	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167414	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167415	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167416	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167417	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167418	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167419	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167420	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167421	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167422	PRJEB22970	Multiple Sclerosis - RRMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167423	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167424	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167425	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167426	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167427	PRJEB22970	Multiple Sclerosis - PPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR2167428	PRJEB22970	Multiple Sclerosis - SPMS	1.0				Germany	V3-V4	Forward: 5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3' Reverse: 5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3'	ILLUMINA	multiple sclerosis	Integrated Microbiome and Host Transcriptome Profiles Link Parkinson��s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain	MS			
ERR4682180	PRJEB32763	RRMS_Remission	1.0	61.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682181	PRJEB32763	RRMS_Remission	1.0	61.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682182	PRJEB32763	RRMS_Remission	1.0	42.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682183	PRJEB32763	RRMS_Remission	1.0	42.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682184	PRJEB32763	RRMS_Remission	1.0	42.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682185	PRJEB32763	RRMS_Remission	1.0	42.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682186	PRJEB32763	RRMS_Remission	1.0	47.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682187	PRJEB32763	RRMS_Remission	1.0	47.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682188	PRJEB32763	HC	0.0	62.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682189	PRJEB32763	HC	0.0	62.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682190	PRJEB32763	HC	0.0	39.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682191	PRJEB32763	HC	0.0	39.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682192	PRJEB32763	HC	0.0	63.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682193	PRJEB32763	HC	0.0	63.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682194	PRJEB32763	HC	0.0	45.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682195	PRJEB32763	HC	0.0	45.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682196	PRJEB32763	HC	0.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682197	PRJEB32763	HC	0.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682198	PRJEB32763	HC	0.0	34.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682199	PRJEB32763	HC	0.0	34.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682200	PRJEB32763	HC	0.0	64.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682201	PRJEB32763	HC	0.0	64.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682202	PRJEB32763	HC	0.0	59.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682203	PRJEB32763	HC	0.0	59.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682204	PRJEB32763	HC	0.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682205	PRJEB32763	HC	0.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682206	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682207	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682208	PRJEB32763	RRMS_Remission	1.0	51.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682209	PRJEB32763	RRMS_Remission	1.0	51.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682210	PRJEB32763	RRMS_Remission	1.0	36.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682211	PRJEB32763	RRMS_Remission	1.0	36.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682212	PRJEB32763	RRMS_Remission	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682213	PRJEB32763	RRMS_Remission	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682214	PRJEB32763	RRMS_Remission	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682215	PRJEB32763	RRMS_Remission	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682216	PRJEB32763	RRMS_Remission	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682217	PRJEB32763	RRMS_Remission	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682218	PRJEB32763	RRMS_Relapse	1.0	55.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682219	PRJEB32763	RRMS_Relapse	1.0	55.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682220	PRJEB32763	RRMS_Remission	1.0	32.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682221	PRJEB32763	RRMS_Remission	1.0	32.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682222	PRJEB32763	RRMS_Remission	1.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682223	PRJEB32763	RRMS_Remission	1.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682224	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682225	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682226	PRJEB32763	RRMS_Relapse	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682227	PRJEB32763	RRMS_Relapse	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682228	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682229	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682230	PRJEB32763	RRMS_Relapse	1.0	35.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682231	PRJEB32763	RRMS_Relapse	1.0	35.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682232	PRJEB32763	RRMS_Relapse	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682233	PRJEB32763	RRMS_Relapse	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682234	PRJEB32763	RRMS_Relapse	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682235	PRJEB32763	RRMS_Relapse	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682236	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682237	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682238	PRJEB32763	RRMS_Remission	1.0	19.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682239	PRJEB32763	RRMS_Remission	1.0	19.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682240	PRJEB32763	RRMS_Relapse	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682241	PRJEB32763	RRMS_Relapse	1.0	41.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682242	PRJEB32763	RRMS_Relapse	1.0	48.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682243	PRJEB32763	RRMS_Relapse	1.0	48.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682244	PRJEB32763	RRMS_Relapse	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682245	PRJEB32763	RRMS_Relapse	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682246	PRJEB32763	HC	0.0	36.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682247	PRJEB32763	HC	0.0	36.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682248	PRJEB32763	HC	0.0	31.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682249	PRJEB32763	HC	0.0	31.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682250	PRJEB32763	HC	0.0	30.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682251	PRJEB32763	HC	0.0	30.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682252	PRJEB32763	HC	0.0	24.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682253	PRJEB32763	HC	0.0	24.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682254	PRJEB32763	HC	0.0	34.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682255	PRJEB32763	HC	0.0	34.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682256	PRJEB32763	HC	0.0	22.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682257	PRJEB32763	HC	0.0	22.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682258	PRJEB32763	HC	0.0	33.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682259	PRJEB32763	HC	0.0	33.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682260	PRJEB32763	HC	0.0	29.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682261	PRJEB32763	HC	0.0	29.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682262	PRJEB32763	RRMS_Remission	1.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682263	PRJEB32763	RRMS_Remission	1.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682264	PRJEB32763	HC	0.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682265	PRJEB32763	HC	0.0	38.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682266	PRJEB32763	HC	0.0	47.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682267	PRJEB32763	HC	0.0	47.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682268	PRJEB32763	RRMS_Remission	1.0	64.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682269	PRJEB32763	RRMS_Remission	1.0	64.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682270	PRJEB32763	RRMS_Remission	1.0	59.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682271	PRJEB32763	RRMS_Remission	1.0	59.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682272	PRJEB32763	HC	0.0	58.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682273	PRJEB32763	HC	0.0	58.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682274	PRJEB32763	HC	0.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682275	PRJEB32763	HC	0.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682276	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682277	PRJEB32763	RRMS_Relapse	1.0	38.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682278	PRJEB32763	RRMS_Remission	1.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682279	PRJEB32763	RRMS_Remission	1.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682280	PRJEB32763	HC	0.0	56.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682281	PRJEB32763	HC	0.0	56.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682282	PRJEB32763	RRMS_Remission	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682283	PRJEB32763	RRMS_Remission	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682284	PRJEB32763	HC	0.0	37.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682285	PRJEB32763	HC	0.0	37.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682286	PRJEB32763	HC	0.0	44.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682287	PRJEB32763	HC	0.0	44.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682288	PRJEB32763	RRMS_Remission	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682289	PRJEB32763	RRMS_Remission	1.0	39.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682290	PRJEB32763	HC	0.0	45.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682291	PRJEB32763	HC	0.0	45.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682292	PRJEB32763	RRMS_Remission	1.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682293	PRJEB32763	RRMS_Remission	1.0	61.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682294	PRJEB32763	HC	0.0	63.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682295	PRJEB32763	HC	0.0	63.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682296	PRJEB32763	HC	0.0	62.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682297	PRJEB32763	HC	0.0	62.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682298	PRJEB32763	HC	0.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682299	PRJEB32763	HC	0.0	43.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682300	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682301	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682302	PRJEB32763	HC	0.0	32.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682303	PRJEB32763	HC	0.0	32.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682304	PRJEB32763	HC	0.0	51.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682305	PRJEB32763	HC	0.0	51.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682306	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682307	PRJEB32763	RRMS_Remission	1.0	31.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682308	PRJEB32763	RRMS_Remission	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682309	PRJEB32763	RRMS_Remission	1.0	21.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682310	PRJEB32763	HC	0.0	64.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682311	PRJEB32763	HC	0.0	64.0	male		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682312	PRJEB32763	RRMS_Remission	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
ERR4682313	PRJEB32763	RRMS_Remission	1.0	37.0	female		USA	V4	Forward: F515(5'-GTGCCAGCMGCCGCGGTAA-3') Reverse: R806(5'-GGACTACHVGGGTWTCTAAT-3')	ILLUMINA	multiple sclerosis	Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis	MS			
SRR12213521	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213522	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213523	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213533	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213544	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213554	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213555	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213556	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213557	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213558	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213559	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213560	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213561	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213562	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213563	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213564	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213565	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213566	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213567	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213568	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213569	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213570	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213571	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213572	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213573	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213574	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213575	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213576	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213577	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213578	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213579	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213580	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	1.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213581	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213582	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213583	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213584	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213585	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213586	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213587	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213588	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
SRR12213589	PRJNA646010	T2DM: Type 2 Diabetes Mellitus	0.0				India	V3�CV4	F(5��-CCTACGGGNGGCWGCAG-3��) and R(5��-GACTACHVGGGTATCTAATCC-3��)	Illumina HiSeq	T2DM: Type 2 Diabetes Mellitus	Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy	T2DM			
ERR10891756	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	34.0	female	35.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891757	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	48.0	female	21.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891758	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	22.0	male	23.0	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891759	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	40.0	male	25.7	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891760	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	31.0	female	22.7	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891761	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	21.0	female	18.0	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891762	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	27.0	female	25.4	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891763	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	20.0	female	19.1	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891764	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	32.0	female	26.1	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891765	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	29.0	female	20.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891766	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	29.0	female	18.4	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891767	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	20.0	female	23.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891768	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	20.0	female	22.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891769	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	30.0	female	26.1	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891770	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	29.0	female	24.7	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891771	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	26.0	female	24.6	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891772	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	22.0	female	24.6	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891773	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	21.0	female	24.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891774	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	20.0	female	22.9	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891775	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	0.0	21.0	female	39.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891776	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	62.0	female	23.6	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891777	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	48.0	male	28.4	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891778	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	67.0	female	34.9	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891779	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	64.0	female	41.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891780	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	67.0	female	20.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891781	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	38.0	male	47.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891782	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	69.0	female	28.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891783	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	70.0	female	27.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891784	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	49.0	female	24.9	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891785	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	62.0	female	38.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891786	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	66.0	female	34.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891787	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	64.0	male	27.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891788	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	46.0	female	31.2	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891789	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	57.0	male	30.4	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891790	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	42.0	male	32.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891791	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	54.0	female	27.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891792	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	65.0	female	36.3	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891794	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	79.0	female	19.8	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891795	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	65.0	female	27.0	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
ERR10891796	PRJEB59916	T2DM: Type 2 Diabetes Mellitus	1.0	76.0	male	34.7	The United Arab Emirates	V4	F(5��-GTGCCAGCMGCCGCGGTAA-3��) and R(5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiSeq	T2DM: Type 2 Diabetes Mellitus	Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers: a multi-omics analysis	T2DM			
SRR25476961	PRJNA1000711	HC-10	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476962	PRJNA1000711	HC-9	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476963	PRJNA1000711	HC-8	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476964	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476965	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476966	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476967	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476968	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476969	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476970	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476971	PRJNA1000711	HC-7	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476972	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476973	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476974	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476975	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476976	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476977	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476978	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476979	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476980	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476981	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476982	PRJNA1000711	HC-6	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476983	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476984	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476985	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476986	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476987	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476988	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476989	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476990	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476991	PRJNA1000711	T2DM patients with microalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476992	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476993	PRJNA1000711	HC-5	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476994	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476995	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476996	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476997	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476998	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25476999	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477000	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477001	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477002	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477003	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477004	PRJNA1000711	HC-4	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477005	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477006	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477007	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477008	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477009	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477010	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477011	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477012	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477013	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477014	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477015	PRJNA1000711	HC-3	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477016	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477017	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477018	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477019	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477020	PRJNA1000711	T2DM patients with normoalbuminuria	1.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477021	PRJNA1000711	HC-15	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477022	PRJNA1000711	HC-14	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477023	PRJNA1000711	HC-13	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477024	PRJNA1000711	HC-12	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477025	PRJNA1000711	HC-11	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477026	PRJNA1000711	HC-2	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR25477027	PRJNA1000711	HC-1	0.0				China	V3-V4	F: ACTCCTACGGGAGGCAGCA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin	T2DM			
SRR24823706	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823707	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823708	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823709	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823710	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823711	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823712	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823713	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823715	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823716	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823717	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823718	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823719	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823720	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823721	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823722	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823774	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823776	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR24823777	PRJNA978958	T2DM	1.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638307	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638308	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638309	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638310	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638311	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638312	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638313	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638314	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638315	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR25638316	PRJNA978958	healthy	0.0				China	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus	T2DM			
SRR18461313	PRJNA819279	healthy	0.0	10.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461314	PRJNA819279	healthy	0.0	9.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461315	PRJNA819279	healthy	0.0	11.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461316	PRJNA819279	healthy	0.0	15.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461317	PRJNA819279	healthy	0.0	9.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461318	PRJNA819279	healthy	0.0	12.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461320	PRJNA819279	healthy	0.0	10.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461321	PRJNA819279	healthy	0.0	11.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461322	PRJNA819279	healthy	0.0	8.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461323	PRJNA819279	healthy	0.0	9.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461324	PRJNA819279	healthy	0.0	8.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461325	PRJNA819279	healthy	0.0	15.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461326	PRJNA819279	healthy	0.0	13.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461327	PRJNA819279	healthy	0.0	7.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461328	PRJNA819279	healthy	0.0	14.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461329	PRJNA819279	healthy	0.0	12.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461331	PRJNA819279	healthy	0.0	16.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461332	PRJNA819279	healthy	0.0	7.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461333	PRJNA819279	healthy	0.0	13.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461334	PRJNA819279	healthy	0.0	10.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461335	PRJNA819279	T2DM	0.0	13.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461336	PRJNA819279	T2DM	1.0	13.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461337	PRJNA819279	T2DM	1.0	17.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461338	PRJNA819279	T2DM	1.0	13.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461339	PRJNA819279	T2DM	1.0	12.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461340	PRJNA819279	T2DM	1.0	15.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461342	PRJNA819279	T2DM	1.0	17.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461343	PRJNA819279	T2DM	1.0	14.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461344	PRJNA819279	T2DM	1.0	15.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461345	PRJNA819279	T2DM	1.0	14.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461346	PRJNA819279	T2DM	1.0	11.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461347	PRJNA819279	T2DM	1.0	15.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461348	PRJNA819279	T2DM	1.0	13.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461349	PRJNA819279	T2DM	1.0	15.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461350	PRJNA819279	T2DM	1.0	14.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461351	PRJNA819279	T2DM	1.0	15.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461353	PRJNA819279	T2DM	1.0	14.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461354	PRJNA819279	T2DM	1.0	14.0	male		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461355	PRJNA819279	T2DM	1.0	14.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461356	PRJNA819279	T2DM	1.0	12.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR18461357	PRJNA819279	T2DM	1.0	16.0	female		Mexico	V3-V4		ILLUMINA	Type 2 Diabetes Mellitus	Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects	T2DM			
SRR16112628	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus	T2DM			
SRR16112650	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 3 Diabetes Mellitus	T2DM			
SRR16112672	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 4 Diabetes Mellitus	T2DM			
SRR16112673	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 5 Diabetes Mellitus	T2DM			
SRR16112685	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 6 Diabetes Mellitus	T2DM			
SRR16112689	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 7 Diabetes Mellitus	T2DM			
SRR16112705	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 8 Diabetes Mellitus	T2DM			
SRR16112709	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 9 Diabetes Mellitus	T2DM			
SRR16112713	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 10 Diabetes Mellitus	T2DM			
SRR16112715	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 11 Diabetes Mellitus	T2DM			
SRR16112717	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 12 Diabetes Mellitus	T2DM			
SRR16112718	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 13 Diabetes Mellitus	T2DM			
SRR16112722	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 14 Diabetes Mellitus	T2DM			
SRR16112730	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 15 Diabetes Mellitus	T2DM			
SRR16112731	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 16 Diabetes Mellitus	T2DM			
SRR16112732	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 17 Diabetes Mellitus	T2DM			
SRR16112733	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 18 Diabetes Mellitus	T2DM			
SRR16112736	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 19 Diabetes Mellitus	T2DM			
SRR16112737	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 20 Diabetes Mellitus	T2DM			
SRR16112738	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 21 Diabetes Mellitus	T2DM			
SRR16112739	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 22 Diabetes Mellitus	T2DM			
SRR16112740	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 23 Diabetes Mellitus	T2DM			
SRR16112742	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 24 Diabetes Mellitus	T2DM			
SRR16112743	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 25 Diabetes Mellitus	T2DM			
SRR16112779	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 26 Diabetes Mellitus	T2DM			
SRR16112783	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 27 Diabetes Mellitus	T2DM			
SRR16112793	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 28 Diabetes Mellitus	T2DM			
SRR16112809	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 29 Diabetes Mellitus	T2DM			
SRR16112811	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 30 Diabetes Mellitus	T2DM			
SRR16112812	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 31 Diabetes Mellitus	T2DM			
SRR16112813	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 32 Diabetes Mellitus	T2DM			
SRR16112814	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 33 Diabetes Mellitus	T2DM			
SRR16112815	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 34 Diabetes Mellitus	T2DM			
SRR16112816	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 35 Diabetes Mellitus	T2DM			
SRR16112817	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 36 Diabetes Mellitus	T2DM			
SRR16112818	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 37 Diabetes Mellitus	T2DM			
SRR16112819	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 38 Diabetes Mellitus	T2DM			
SRR16112820	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 39 Diabetes Mellitus	T2DM			
SRR16112822	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 40 Diabetes Mellitus	T2DM			
SRR16112823	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 41 Diabetes Mellitus	T2DM			
SRR16112825	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 42 Diabetes Mellitus	T2DM			
SRR16112826	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 43 Diabetes Mellitus	T2DM			
SRR16112827	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 44 Diabetes Mellitus	T2DM			
SRR16112828	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 45 Diabetes Mellitus	T2DM			
SRR16112829	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 46 Diabetes Mellitus	T2DM			
SRR16112830	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 47 Diabetes Mellitus	T2DM			
SRR16112900	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 48 Diabetes Mellitus	T2DM			
SRR16112903	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 49 Diabetes Mellitus	T2DM			
SRR16112905	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 50 Diabetes Mellitus	T2DM			
SRR16112906	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 51 Diabetes Mellitus	T2DM			
SRR16112907	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 52 Diabetes Mellitus	T2DM			
SRR16112908	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 53 Diabetes Mellitus	T2DM			
SRR16112909	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 54 Diabetes Mellitus	T2DM			
SRR16112910	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 55 Diabetes Mellitus	T2DM			
SRR16112912	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 56 Diabetes Mellitus	T2DM			
SRR16112913	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 57 Diabetes Mellitus	T2DM			
SRR16112914	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 58 Diabetes Mellitus	T2DM			
SRR16112916	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 59 Diabetes Mellitus	T2DM			
SRR16112917	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 60 Diabetes Mellitus	T2DM			
SRR16112918	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 61 Diabetes Mellitus	T2DM			
SRR16112919	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 62 Diabetes Mellitus	T2DM			
SRR16112920	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 63 Diabetes Mellitus	T2DM			
SRR16112921	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 64 Diabetes Mellitus	T2DM			
SRR16112922	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 65 Diabetes Mellitus	T2DM			
SRR16112923	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 66 Diabetes Mellitus	T2DM			
SRR16112924	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 67 Diabetes Mellitus	T2DM			
SRR16112925	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 68 Diabetes Mellitus	T2DM			
SRR16112927	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 69 Diabetes Mellitus	T2DM			
SRR16112928	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 70 Diabetes Mellitus	T2DM			
SRR16112935	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 71 Diabetes Mellitus	T2DM			
SRR16112946	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 72 Diabetes Mellitus	T2DM			
SRR16112977	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 73 Diabetes Mellitus	T2DM			
SRR16112978	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 74 Diabetes Mellitus	T2DM			
SRR16112979	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 75 Diabetes Mellitus	T2DM			
SRR16112980	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 76 Diabetes Mellitus	T2DM			
SRR16112981	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 77 Diabetes Mellitus	T2DM			
SRR16112982	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 78 Diabetes Mellitus	T2DM			
SRR16112983	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 79 Diabetes Mellitus	T2DM			
SRR16112984	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 80 Diabetes Mellitus	T2DM			
SRR16112986	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 81 Diabetes Mellitus	T2DM			
SRR16112987	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 82 Diabetes Mellitus	T2DM			
SRR16112989	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 83 Diabetes Mellitus	T2DM			
SRR16112990	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 84 Diabetes Mellitus	T2DM			
SRR16112991	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 85 Diabetes Mellitus	T2DM			
SRR16113001	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 86 Diabetes Mellitus	T2DM			
SRR16113013	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 87 Diabetes Mellitus	T2DM			
SRR16113059	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 88 Diabetes Mellitus	T2DM			
SRR16113060	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 89 Diabetes Mellitus	T2DM			
SRR16113062	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 90 Diabetes Mellitus	T2DM			
SRR16113064	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 91 Diabetes Mellitus	T2DM			
SRR16113065	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 92 Diabetes Mellitus	T2DM			
SRR16113066	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 93 Diabetes Mellitus	T2DM			
SRR16113068	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 94 Diabetes Mellitus	T2DM			
SRR16113069	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 95 Diabetes Mellitus	T2DM			
SRR16113070	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 96 Diabetes Mellitus	T2DM			
SRR16113071	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 97 Diabetes Mellitus	T2DM			
SRR16113075	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 98 Diabetes Mellitus	T2DM			
SRR16113076	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 99 Diabetes Mellitus	T2DM			
SRR16113077	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 100 Diabetes Mellitus	T2DM			
SRR16113079	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 101 Diabetes Mellitus	T2DM			
SRR16113080	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 102 Diabetes Mellitus	T2DM			
SRR16113081	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 103 Diabetes Mellitus	T2DM			
SRR16113082	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 104 Diabetes Mellitus	T2DM			
SRR16113083	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 105 Diabetes Mellitus	T2DM			
SRR16113085	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 106 Diabetes Mellitus	T2DM			
SRR16113086	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 107 Diabetes Mellitus	T2DM			
SRR16113087	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 108 Diabetes Mellitus	T2DM			
SRR16113088	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 109 Diabetes Mellitus	T2DM			
SRR16113090	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 110 Diabetes Mellitus	T2DM			
SRR16113095	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 111 Diabetes Mellitus	T2DM			
SRR16113103	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 112 Diabetes Mellitus	T2DM			
SRR16113119	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 113 Diabetes Mellitus	T2DM			
SRR16113120	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 114 Diabetes Mellitus	T2DM			
SRR16072588	PRJNA766337	healthy	0.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 115 Diabetes Mellitus	T2DM			
SRR16112626	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 116 Diabetes Mellitus	T2DM			
SRR16112627	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 117 Diabetes Mellitus	T2DM			
SRR16112629	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 118 Diabetes Mellitus	T2DM			
SRR16112630	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 119 Diabetes Mellitus	T2DM			
SRR16112631	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 120 Diabetes Mellitus	T2DM			
SRR16112632	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 121 Diabetes Mellitus	T2DM			
SRR16112633	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 122 Diabetes Mellitus	T2DM			
SRR16112634	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 123 Diabetes Mellitus	T2DM			
SRR16112635	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 124 Diabetes Mellitus	T2DM			
SRR16112636	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 125 Diabetes Mellitus	T2DM			
SRR16112637	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 126 Diabetes Mellitus	T2DM			
SRR16112638	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 127 Diabetes Mellitus	T2DM			
SRR16112639	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 128 Diabetes Mellitus	T2DM			
SRR16112640	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 129 Diabetes Mellitus	T2DM			
SRR16112641	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 130 Diabetes Mellitus	T2DM			
SRR16112642	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 131 Diabetes Mellitus	T2DM			
SRR16112643	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 132 Diabetes Mellitus	T2DM			
SRR16112644	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 133 Diabetes Mellitus	T2DM			
SRR16112645	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 134 Diabetes Mellitus	T2DM			
SRR16112646	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 135 Diabetes Mellitus	T2DM			
SRR16112647	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 136 Diabetes Mellitus	T2DM			
SRR16112648	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 137 Diabetes Mellitus	T2DM			
SRR16112649	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 138 Diabetes Mellitus	T2DM			
SRR16112651	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 139 Diabetes Mellitus	T2DM			
SRR16112652	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 140 Diabetes Mellitus	T2DM			
SRR16112653	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 141 Diabetes Mellitus	T2DM			
SRR16112654	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 142 Diabetes Mellitus	T2DM			
SRR16112655	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 143 Diabetes Mellitus	T2DM			
SRR16112656	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 144 Diabetes Mellitus	T2DM			
SRR16112657	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 145 Diabetes Mellitus	T2DM			
SRR16112658	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 146 Diabetes Mellitus	T2DM			
SRR16112659	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 147 Diabetes Mellitus	T2DM			
SRR16112660	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 148 Diabetes Mellitus	T2DM			
SRR16112661	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 149 Diabetes Mellitus	T2DM			
SRR16112662	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 150 Diabetes Mellitus	T2DM			
SRR16112663	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 151 Diabetes Mellitus	T2DM			
SRR16112664	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 152 Diabetes Mellitus	T2DM			
SRR16112665	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 153 Diabetes Mellitus	T2DM			
SRR16112666	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 154 Diabetes Mellitus	T2DM			
SRR16112667	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 155 Diabetes Mellitus	T2DM			
SRR16112668	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 156 Diabetes Mellitus	T2DM			
SRR16112669	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 157 Diabetes Mellitus	T2DM			
SRR16112670	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 158 Diabetes Mellitus	T2DM			
SRR16112671	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 159 Diabetes Mellitus	T2DM			
SRR16112674	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 160 Diabetes Mellitus	T2DM			
SRR16112675	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 161 Diabetes Mellitus	T2DM			
SRR16112676	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 162 Diabetes Mellitus	T2DM			
SRR16112677	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 163 Diabetes Mellitus	T2DM			
SRR16112678	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 164 Diabetes Mellitus	T2DM			
SRR16112679	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 165 Diabetes Mellitus	T2DM			
SRR16112680	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 166 Diabetes Mellitus	T2DM			
SRR16112681	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 167 Diabetes Mellitus	T2DM			
SRR16112682	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 168 Diabetes Mellitus	T2DM			
SRR16112683	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 169 Diabetes Mellitus	T2DM			
SRR16112684	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 170 Diabetes Mellitus	T2DM			
SRR16112686	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 171 Diabetes Mellitus	T2DM			
SRR16112687	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 172 Diabetes Mellitus	T2DM			
SRR16112688	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 173 Diabetes Mellitus	T2DM			
SRR16112690	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 174 Diabetes Mellitus	T2DM			
SRR16112691	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 175 Diabetes Mellitus	T2DM			
SRR16112692	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 176 Diabetes Mellitus	T2DM			
SRR16112693	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 177 Diabetes Mellitus	T2DM			
SRR16112694	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 178 Diabetes Mellitus	T2DM			
SRR16112695	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 179 Diabetes Mellitus	T2DM			
SRR16112696	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 180 Diabetes Mellitus	T2DM			
SRR16112697	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 181 Diabetes Mellitus	T2DM			
SRR16112698	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 182 Diabetes Mellitus	T2DM			
SRR16112699	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 183 Diabetes Mellitus	T2DM			
SRR16112700	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 184 Diabetes Mellitus	T2DM			
SRR16112701	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 185 Diabetes Mellitus	T2DM			
SRR16112702	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 186 Diabetes Mellitus	T2DM			
SRR16112703	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 187 Diabetes Mellitus	T2DM			
SRR16112704	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 188 Diabetes Mellitus	T2DM			
SRR16112706	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 189 Diabetes Mellitus	T2DM			
SRR16112707	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 190 Diabetes Mellitus	T2DM			
SRR16112708	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 191 Diabetes Mellitus	T2DM			
SRR16112710	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 192 Diabetes Mellitus	T2DM			
SRR16112711	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 193 Diabetes Mellitus	T2DM			
SRR16112712	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 194 Diabetes Mellitus	T2DM			
SRR16112714	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 195 Diabetes Mellitus	T2DM			
SRR16112716	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 196 Diabetes Mellitus	T2DM			
SRR16112719	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 197 Diabetes Mellitus	T2DM			
SRR16112720	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 198 Diabetes Mellitus	T2DM			
SRR16112721	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 199 Diabetes Mellitus	T2DM			
SRR16112723	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 200 Diabetes Mellitus	T2DM			
SRR16112724	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 201 Diabetes Mellitus	T2DM			
SRR16112725	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 202 Diabetes Mellitus	T2DM			
SRR16112726	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 203 Diabetes Mellitus	T2DM			
SRR16112727	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 204 Diabetes Mellitus	T2DM			
SRR16112728	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 205 Diabetes Mellitus	T2DM			
SRR16112729	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 206 Diabetes Mellitus	T2DM			
SRR16112734	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 207 Diabetes Mellitus	T2DM			
SRR16112735	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 208 Diabetes Mellitus	T2DM			
SRR16112741	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 209 Diabetes Mellitus	T2DM			
SRR16112744	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 210 Diabetes Mellitus	T2DM			
SRR16112745	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 211 Diabetes Mellitus	T2DM			
SRR16112746	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 212 Diabetes Mellitus	T2DM			
SRR16112747	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 213 Diabetes Mellitus	T2DM			
SRR16112748	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 214 Diabetes Mellitus	T2DM			
SRR16112749	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 215 Diabetes Mellitus	T2DM			
SRR16112750	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 216 Diabetes Mellitus	T2DM			
SRR16112751	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 217 Diabetes Mellitus	T2DM			
SRR16112752	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 218 Diabetes Mellitus	T2DM			
SRR16112753	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 219 Diabetes Mellitus	T2DM			
SRR16112754	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 220 Diabetes Mellitus	T2DM			
SRR16112755	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 221 Diabetes Mellitus	T2DM			
SRR16112756	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 222 Diabetes Mellitus	T2DM			
SRR16112757	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 223 Diabetes Mellitus	T2DM			
SRR16112758	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 224 Diabetes Mellitus	T2DM			
SRR16112759	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 225 Diabetes Mellitus	T2DM			
SRR16112760	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 226 Diabetes Mellitus	T2DM			
SRR16112761	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 227 Diabetes Mellitus	T2DM			
SRR16112762	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 228 Diabetes Mellitus	T2DM			
SRR16112763	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 229 Diabetes Mellitus	T2DM			
SRR16112764	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 230 Diabetes Mellitus	T2DM			
SRR16112765	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 231 Diabetes Mellitus	T2DM			
SRR16112766	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 232 Diabetes Mellitus	T2DM			
SRR16112767	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 233 Diabetes Mellitus	T2DM			
SRR16112768	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 234 Diabetes Mellitus	T2DM			
SRR16112769	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 235 Diabetes Mellitus	T2DM			
SRR16112770	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 236 Diabetes Mellitus	T2DM			
SRR16112771	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 237 Diabetes Mellitus	T2DM			
SRR16112772	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 238 Diabetes Mellitus	T2DM			
SRR16112773	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 239 Diabetes Mellitus	T2DM			
SRR16112774	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 240 Diabetes Mellitus	T2DM			
SRR16112775	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 241 Diabetes Mellitus	T2DM			
SRR16112776	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 242 Diabetes Mellitus	T2DM			
SRR16112777	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 243 Diabetes Mellitus	T2DM			
SRR16112778	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 244 Diabetes Mellitus	T2DM			
SRR16112780	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 245 Diabetes Mellitus	T2DM			
SRR16112781	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 246 Diabetes Mellitus	T2DM			
SRR16112782	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 247 Diabetes Mellitus	T2DM			
SRR16112784	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 248 Diabetes Mellitus	T2DM			
SRR16112785	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 249 Diabetes Mellitus	T2DM			
SRR16112786	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 250 Diabetes Mellitus	T2DM			
SRR16112787	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 251 Diabetes Mellitus	T2DM			
SRR16112788	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 252 Diabetes Mellitus	T2DM			
SRR16112789	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 253 Diabetes Mellitus	T2DM			
SRR16112790	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 254 Diabetes Mellitus	T2DM			
SRR16112791	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 255 Diabetes Mellitus	T2DM			
SRR16112792	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 256 Diabetes Mellitus	T2DM			
SRR16112794	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 257 Diabetes Mellitus	T2DM			
SRR16112795	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 258 Diabetes Mellitus	T2DM			
SRR16112796	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 259 Diabetes Mellitus	T2DM			
SRR16112797	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 260 Diabetes Mellitus	T2DM			
SRR16112798	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 261 Diabetes Mellitus	T2DM			
SRR16112799	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 262 Diabetes Mellitus	T2DM			
SRR16112800	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 263 Diabetes Mellitus	T2DM			
SRR16112801	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 264 Diabetes Mellitus	T2DM			
SRR16112802	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 265 Diabetes Mellitus	T2DM			
SRR16112803	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 266 Diabetes Mellitus	T2DM			
SRR16112804	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 267 Diabetes Mellitus	T2DM			
SRR16112805	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 268 Diabetes Mellitus	T2DM			
SRR16112806	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 269 Diabetes Mellitus	T2DM			
SRR16112807	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 270 Diabetes Mellitus	T2DM			
SRR16112808	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 271 Diabetes Mellitus	T2DM			
SRR16112810	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 272 Diabetes Mellitus	T2DM			
SRR16112821	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 273 Diabetes Mellitus	T2DM			
SRR16112824	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 274 Diabetes Mellitus	T2DM			
SRR16112832	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 275 Diabetes Mellitus	T2DM			
SRR16112833	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 276 Diabetes Mellitus	T2DM			
SRR16112834	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 277 Diabetes Mellitus	T2DM			
SRR16112835	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 278 Diabetes Mellitus	T2DM			
SRR16112836	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 279 Diabetes Mellitus	T2DM			
SRR16112837	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 280 Diabetes Mellitus	T2DM			
SRR16112838	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 281 Diabetes Mellitus	T2DM			
SRR16112839	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 282 Diabetes Mellitus	T2DM			
SRR16112840	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 283 Diabetes Mellitus	T2DM			
SRR16112841	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 284 Diabetes Mellitus	T2DM			
SRR16112842	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 285 Diabetes Mellitus	T2DM			
SRR16112843	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 286 Diabetes Mellitus	T2DM			
SRR16112844	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 287 Diabetes Mellitus	T2DM			
SRR16112845	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 288 Diabetes Mellitus	T2DM			
SRR16112846	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 289 Diabetes Mellitus	T2DM			
SRR16112847	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 290 Diabetes Mellitus	T2DM			
SRR16112848	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 291 Diabetes Mellitus	T2DM			
SRR16112849	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 292 Diabetes Mellitus	T2DM			
SRR16112850	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 293 Diabetes Mellitus	T2DM			
SRR16112851	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 294 Diabetes Mellitus	T2DM			
SRR16112852	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 295 Diabetes Mellitus	T2DM			
SRR16112853	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 296 Diabetes Mellitus	T2DM			
SRR16112854	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 297 Diabetes Mellitus	T2DM			
SRR16112855	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 298 Diabetes Mellitus	T2DM			
SRR16112856	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 299 Diabetes Mellitus	T2DM			
SRR16112857	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 300 Diabetes Mellitus	T2DM			
SRR16112858	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 301 Diabetes Mellitus	T2DM			
SRR16112859	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 302 Diabetes Mellitus	T2DM			
SRR16112860	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 303 Diabetes Mellitus	T2DM			
SRR16112861	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 304 Diabetes Mellitus	T2DM			
SRR16112862	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 305 Diabetes Mellitus	T2DM			
SRR16112863	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 306 Diabetes Mellitus	T2DM			
SRR16112864	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 307 Diabetes Mellitus	T2DM			
SRR16112865	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 308 Diabetes Mellitus	T2DM			
SRR16112866	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 309 Diabetes Mellitus	T2DM			
SRR16112867	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 310 Diabetes Mellitus	T2DM			
SRR16112868	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 311 Diabetes Mellitus	T2DM			
SRR16112869	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 312 Diabetes Mellitus	T2DM			
SRR16112870	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 313 Diabetes Mellitus	T2DM			
SRR16112871	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 314 Diabetes Mellitus	T2DM			
SRR16112872	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 315 Diabetes Mellitus	T2DM			
SRR16112873	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 316 Diabetes Mellitus	T2DM			
SRR16112874	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 317 Diabetes Mellitus	T2DM			
SRR16112875	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 318 Diabetes Mellitus	T2DM			
SRR16112876	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 319 Diabetes Mellitus	T2DM			
SRR16112877	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 320 Diabetes Mellitus	T2DM			
SRR16112878	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 321 Diabetes Mellitus	T2DM			
SRR16112879	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 322 Diabetes Mellitus	T2DM			
SRR16112880	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 323 Diabetes Mellitus	T2DM			
SRR16112881	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 324 Diabetes Mellitus	T2DM			
SRR16112882	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 325 Diabetes Mellitus	T2DM			
SRR16112883	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 326 Diabetes Mellitus	T2DM			
SRR16112884	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 327 Diabetes Mellitus	T2DM			
SRR16112885	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 328 Diabetes Mellitus	T2DM			
SRR16112886	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 329 Diabetes Mellitus	T2DM			
SRR16112887	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 330 Diabetes Mellitus	T2DM			
SRR16112888	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 331 Diabetes Mellitus	T2DM			
SRR16112889	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 332 Diabetes Mellitus	T2DM			
SRR16112890	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 333 Diabetes Mellitus	T2DM			
SRR16112891	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 334 Diabetes Mellitus	T2DM			
SRR16112892	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 335 Diabetes Mellitus	T2DM			
SRR16112893	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 336 Diabetes Mellitus	T2DM			
SRR16112894	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 337 Diabetes Mellitus	T2DM			
SRR16112895	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 338 Diabetes Mellitus	T2DM			
SRR16112896	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 339 Diabetes Mellitus	T2DM			
SRR16112897	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 340 Diabetes Mellitus	T2DM			
SRR16112898	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 341 Diabetes Mellitus	T2DM			
SRR16112899	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 342 Diabetes Mellitus	T2DM			
SRR16112901	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 343 Diabetes Mellitus	T2DM			
SRR16112902	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 344 Diabetes Mellitus	T2DM			
SRR16112904	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 345 Diabetes Mellitus	T2DM			
SRR16112911	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 346 Diabetes Mellitus	T2DM			
SRR16112915	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 347 Diabetes Mellitus	T2DM			
SRR16112926	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 348 Diabetes Mellitus	T2DM			
SRR16112929	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 349 Diabetes Mellitus	T2DM			
SRR16112930	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 350 Diabetes Mellitus	T2DM			
SRR16112931	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 351 Diabetes Mellitus	T2DM			
SRR16112932	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 352 Diabetes Mellitus	T2DM			
SRR16112933	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 353 Diabetes Mellitus	T2DM			
SRR16112934	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 354 Diabetes Mellitus	T2DM			
SRR16112936	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 355 Diabetes Mellitus	T2DM			
SRR16112937	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 356 Diabetes Mellitus	T2DM			
SRR16112938	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 357 Diabetes Mellitus	T2DM			
SRR16112939	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 358 Diabetes Mellitus	T2DM			
SRR16112940	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 359 Diabetes Mellitus	T2DM			
SRR16112941	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 360 Diabetes Mellitus	T2DM			
SRR16112942	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 361 Diabetes Mellitus	T2DM			
SRR16112943	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 362 Diabetes Mellitus	T2DM			
SRR16112944	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 363 Diabetes Mellitus	T2DM			
SRR16112945	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 364 Diabetes Mellitus	T2DM			
SRR16112947	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 365 Diabetes Mellitus	T2DM			
SRR16112948	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 366 Diabetes Mellitus	T2DM			
SRR16112949	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 367 Diabetes Mellitus	T2DM			
SRR16112950	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 368 Diabetes Mellitus	T2DM			
SRR16112951	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 369 Diabetes Mellitus	T2DM			
SRR16112952	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 370 Diabetes Mellitus	T2DM			
SRR16112953	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 371 Diabetes Mellitus	T2DM			
SRR16112954	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 372 Diabetes Mellitus	T2DM			
SRR16112955	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 373 Diabetes Mellitus	T2DM			
SRR16112956	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 374 Diabetes Mellitus	T2DM			
SRR16112957	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 375 Diabetes Mellitus	T2DM			
SRR16112958	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 376 Diabetes Mellitus	T2DM			
SRR16112959	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 377 Diabetes Mellitus	T2DM			
SRR16112960	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 378 Diabetes Mellitus	T2DM			
SRR16112961	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 379 Diabetes Mellitus	T2DM			
SRR16112962	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 380 Diabetes Mellitus	T2DM			
SRR16112963	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 381 Diabetes Mellitus	T2DM			
SRR16112964	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 382 Diabetes Mellitus	T2DM			
SRR16112965	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 383 Diabetes Mellitus	T2DM			
SRR16112966	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 384 Diabetes Mellitus	T2DM			
SRR16112967	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 385 Diabetes Mellitus	T2DM			
SRR16112968	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 386 Diabetes Mellitus	T2DM			
SRR16112969	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 387 Diabetes Mellitus	T2DM			
SRR16112970	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 388 Diabetes Mellitus	T2DM			
SRR16112971	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 389 Diabetes Mellitus	T2DM			
SRR16112972	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 390 Diabetes Mellitus	T2DM			
SRR16112973	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 391 Diabetes Mellitus	T2DM			
SRR16112974	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 392 Diabetes Mellitus	T2DM			
SRR16112975	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 393 Diabetes Mellitus	T2DM			
SRR16112976	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 394 Diabetes Mellitus	T2DM			
SRR16112985	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 395 Diabetes Mellitus	T2DM			
SRR16112988	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 396 Diabetes Mellitus	T2DM			
SRR16112992	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 397 Diabetes Mellitus	T2DM			
SRR16112993	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 398 Diabetes Mellitus	T2DM			
SRR16112994	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 399 Diabetes Mellitus	T2DM			
SRR16112995	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 400 Diabetes Mellitus	T2DM			
SRR16112996	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 401 Diabetes Mellitus	T2DM			
SRR16112997	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 402 Diabetes Mellitus	T2DM			
SRR16112998	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 403 Diabetes Mellitus	T2DM			
SRR16112999	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 404 Diabetes Mellitus	T2DM			
SRR16113000	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 405 Diabetes Mellitus	T2DM			
SRR16113002	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 406 Diabetes Mellitus	T2DM			
SRR16113003	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 407 Diabetes Mellitus	T2DM			
SRR16113004	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 408 Diabetes Mellitus	T2DM			
SRR16113005	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 409 Diabetes Mellitus	T2DM			
SRR16113006	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 410 Diabetes Mellitus	T2DM			
SRR16113007	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 411 Diabetes Mellitus	T2DM			
SRR16113008	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 412 Diabetes Mellitus	T2DM			
SRR16113009	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 413 Diabetes Mellitus	T2DM			
SRR16113010	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 414 Diabetes Mellitus	T2DM			
SRR16113011	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 415 Diabetes Mellitus	T2DM			
SRR16113012	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 416 Diabetes Mellitus	T2DM			
SRR16113014	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 417 Diabetes Mellitus	T2DM			
SRR16113015	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 418 Diabetes Mellitus	T2DM			
SRR16113016	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 419 Diabetes Mellitus	T2DM			
SRR16113017	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 420 Diabetes Mellitus	T2DM			
SRR16113018	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 421 Diabetes Mellitus	T2DM			
SRR16113019	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 422 Diabetes Mellitus	T2DM			
SRR16113020	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 423 Diabetes Mellitus	T2DM			
SRR16113021	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 424 Diabetes Mellitus	T2DM			
SRR16113022	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 425 Diabetes Mellitus	T2DM			
SRR16113023	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 426 Diabetes Mellitus	T2DM			
SRR16113024	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 427 Diabetes Mellitus	T2DM			
SRR16113025	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 428 Diabetes Mellitus	T2DM			
SRR16113026	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 429 Diabetes Mellitus	T2DM			
SRR16113027	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 430 Diabetes Mellitus	T2DM			
SRR16113028	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 431 Diabetes Mellitus	T2DM			
SRR16113029	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 432 Diabetes Mellitus	T2DM			
SRR16113030	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 433 Diabetes Mellitus	T2DM			
SRR16113031	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 434 Diabetes Mellitus	T2DM			
SRR16113032	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 435 Diabetes Mellitus	T2DM			
SRR16113033	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 436 Diabetes Mellitus	T2DM			
SRR16113034	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 437 Diabetes Mellitus	T2DM			
SRR16113035	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 438 Diabetes Mellitus	T2DM			
SRR16113036	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 439 Diabetes Mellitus	T2DM			
SRR16113037	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 440 Diabetes Mellitus	T2DM			
SRR16113038	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 441 Diabetes Mellitus	T2DM			
SRR16113039	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 442 Diabetes Mellitus	T2DM			
SRR16113040	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 443 Diabetes Mellitus	T2DM			
SRR16113041	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 444 Diabetes Mellitus	T2DM			
SRR16113042	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 445 Diabetes Mellitus	T2DM			
SRR16113043	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 446 Diabetes Mellitus	T2DM			
SRR16113044	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 447 Diabetes Mellitus	T2DM			
SRR16113045	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 448 Diabetes Mellitus	T2DM			
SRR16113046	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 449 Diabetes Mellitus	T2DM			
SRR16113047	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 450 Diabetes Mellitus	T2DM			
SRR16113048	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 451 Diabetes Mellitus	T2DM			
SRR16113049	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 452 Diabetes Mellitus	T2DM			
SRR16113050	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 453 Diabetes Mellitus	T2DM			
SRR16113051	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 454 Diabetes Mellitus	T2DM			
SRR16113052	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 455 Diabetes Mellitus	T2DM			
SRR16113053	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 456 Diabetes Mellitus	T2DM			
SRR16113054	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 457 Diabetes Mellitus	T2DM			
SRR16113055	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 458 Diabetes Mellitus	T2DM			
SRR16113056	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 459 Diabetes Mellitus	T2DM			
SRR16113057	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 460 Diabetes Mellitus	T2DM			
SRR16113058	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 461 Diabetes Mellitus	T2DM			
SRR16113061	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 462 Diabetes Mellitus	T2DM			
SRR16113063	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 463 Diabetes Mellitus	T2DM			
SRR16113067	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 464 Diabetes Mellitus	T2DM			
SRR16113072	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 465 Diabetes Mellitus	T2DM			
SRR16113073	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 466 Diabetes Mellitus	T2DM			
SRR16113074	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 467 Diabetes Mellitus	T2DM			
SRR16113078	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 468 Diabetes Mellitus	T2DM			
SRR16113084	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 469 Diabetes Mellitus	T2DM			
SRR16113089	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 470 Diabetes Mellitus	T2DM			
SRR16113091	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 471 Diabetes Mellitus	T2DM			
SRR16113092	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 472 Diabetes Mellitus	T2DM			
SRR16113093	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 473 Diabetes Mellitus	T2DM			
SRR16113094	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 474 Diabetes Mellitus	T2DM			
SRR16113096	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 475 Diabetes Mellitus	T2DM			
SRR16113097	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 476 Diabetes Mellitus	T2DM			
SRR16113098	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 477 Diabetes Mellitus	T2DM			
SRR16113099	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 478 Diabetes Mellitus	T2DM			
SRR16113100	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 479 Diabetes Mellitus	T2DM			
SRR16113101	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 480 Diabetes Mellitus	T2DM			
SRR16113102	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 481 Diabetes Mellitus	T2DM			
SRR16113104	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 482 Diabetes Mellitus	T2DM			
SRR16113105	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 483 Diabetes Mellitus	T2DM			
SRR16113106	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 484 Diabetes Mellitus	T2DM			
SRR16113107	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 485 Diabetes Mellitus	T2DM			
SRR16113108	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 486 Diabetes Mellitus	T2DM			
SRR16113109	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 487 Diabetes Mellitus	T2DM			
SRR16113110	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 488 Diabetes Mellitus	T2DM			
SRR16113111	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 489 Diabetes Mellitus	T2DM			
SRR16113112	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 490 Diabetes Mellitus	T2DM			
SRR16113113	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 491 Diabetes Mellitus	T2DM			
SRR16113114	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 492 Diabetes Mellitus	T2DM			
SRR16113115	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 493 Diabetes Mellitus	T2DM			
SRR16113116	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 494 Diabetes Mellitus	T2DM			
SRR16113117	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 495 Diabetes Mellitus	T2DM			
SRR16113118	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 496 Diabetes Mellitus	T2DM			
SRR16113121	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 497 Diabetes Mellitus	T2DM			
SRR16113122	PRJNA766337	T2DM	1.0				Japan			ILLUMINA	Type 2 Diabetes Mellitus	Effects of Smoking on the Gut Microbiota in Individuals with Type 497 Diabetes Mellitus	T2DM			
SRR21530562	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530563	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530564	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530565	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530566	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530567	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530568	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530569	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530570	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530571	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530572	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530573	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530574	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530575	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530576	PRJNA879337	T2DM and other TCM syndromes	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530577	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530578	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530579	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530580	PRJNA879337	T2DM who had a longer course	1.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530581	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR21530582	PRJNA879337	healthy	0.0				China	V4	F: GTGCCAGCMGCCGCGGTAA; R: GGACTACHVGGGTWTCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	A study on the association between gut microbiota, inflammation, and type 2 diabetes	T2DM			
SRR17211493	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211494	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 3 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211503	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 4 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211514	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 5 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211525	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 6 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211536	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 7 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211547	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 8 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211552	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 9 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211553	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 10 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211554	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 11 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211555	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 12 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211556	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 13 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211557	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 14 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211558	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 15 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211559	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 16 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211560	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 17 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211561	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 18 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211562	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 19 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211563	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 20 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211564	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 21 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211565	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 22 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211566	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 23 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211567	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 24 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211568	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 25 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211569	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 26 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211570	PRJNA788301	healthy	0.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 27 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211524	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 28 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211526	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 29 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211527	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 30 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211528	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 31 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211529	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 32 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211530	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 33 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211531	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 34 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211532	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 35 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211533	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 36 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211534	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 37 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211535	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 38 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211537	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 39 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211538	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 40 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211539	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 41 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211540	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 42 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211541	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 43 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211542	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 44 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211543	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 45 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211544	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 46 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211545	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 47 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211546	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 48 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211548	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 49 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211549	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 50 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211550	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 51 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR17211551	PRJNA788301	T2DM	1.0				China	 V3-V4	F：5'-CCTACGGGNGGCWGCAG-3'，R：5'-GACTACHVGGGTATCTAATCC-3	ILLUMINA	Type 2 Diabetes Mellitus	Intermittent hypoxia is involved in gut microbial dysbiosis in type 52 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome	T2DM			
SRR12929831	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929832	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929833	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929834	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929835	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929836	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929837	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929838	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929839	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929840	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929841	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929842	PRJNA668251	non diabetic controls	0.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929843	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR12929844	PRJNA668251	T2DM	1.0		female		uncalculated	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ILLUMINA	Type 2 Diabetes Mellitus	Metagenomic 16S rDNA amplicon data of microbial diversity of guts in Vietnamese humans with type 2 diabetes and nondiabetic adults	T2DM			
SRR14715295	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715296	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715299	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715300	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715304	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715305	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715306	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715307	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715315	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715316	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715318	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715319	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715321	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715322	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715324	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715328	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715332	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715333	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715335	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715336	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715337	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715339	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715340	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715341	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715342	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715347	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715349	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715352	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715353	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715354	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715355	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715363	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715364	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715365	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715366	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715370	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715371	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715372	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715373	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715374	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715375	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715377	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715378	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715382	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715383	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715384	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715385	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715386	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715389	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715392	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715393	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715394	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715395	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715396	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715397	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715398	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715399	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715400	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715403	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715404	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715406	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715407	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715408	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715409	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715410	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715411	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715413	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715415	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715416	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715418	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715420	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715421	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715422	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715424	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715425	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715426	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715427	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715431	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715432	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715433	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715438	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715440	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715441	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715442	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715443	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715444	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715446	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715447	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715448	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715449	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715452	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715453	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715454	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715455	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715460	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715461	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715462	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715463	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715465	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715469	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715470	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715471	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715472	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715475	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715478	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715480	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715481	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715482	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715484	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715485	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715486	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715487	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715489	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715492	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715493	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715496	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715497	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715498	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715499	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715500	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715502	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715503	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715504	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715505	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715506	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715507	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715511	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715513	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715514	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715515	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715516	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715517	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715519	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715521	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715524	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715525	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715526	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715527	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715528	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715529	PRJNA734860	Non-diabetic	0.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715530	PRJNA734860	Non-diabetic	0.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715292	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715293	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715294	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715297	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715298	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715302	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715303	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715308	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715309	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715310	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715311	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715313	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715314	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715317	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715320	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715325	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715326	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715327	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715329	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715330	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715331	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715338	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715343	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715344	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715346	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715348	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715350	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715351	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715358	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715359	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715360	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715362	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715367	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715369	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715376	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715380	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715381	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715387	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715388	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715391	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715402	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715405	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715414	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715417	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715419	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715428	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715429	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715430	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715435	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715436	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715437	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715439	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715450	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715451	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715457	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715458	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715459	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715464	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715466	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715473	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715474	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715476	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715477	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715483	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715488	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715491	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715494	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715495	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715508	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715509	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715510	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715518	PRJNA734860	T2DM	1.0		female		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715520	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715522	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR14715531	PRJNA734860	T2DM	1.0		male		USA	V4	F:5'-AATGATACGGCGACCACCGAGATCTACACGCTXXXXXXXXXXXXTATGGTAATTGTGTGYCAGCMGCCGCGGTAA-3'，其中 XXXXXXXXXXXX 是多重文库的索引序列;R:5'-CAAGCAGAAGACGGCATACGAGATAGTCAGCCAGCCGGACTACNVGGGTWTCTAAT-3'	ILLUMINA	Type 2 Diabetes Mellitus	Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas	T2DM			
SRR18047729	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047730	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047731	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047732	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047733	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047734	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047735	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047736	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047737	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047738	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047739	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047740	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047741	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047742	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047743	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047744	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047745	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047746	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047747	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047748	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047749	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047750	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047751	PRJNA807457	without T2DM	0.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047752	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047753	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047754	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047755	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047756	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047757	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047758	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047759	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047760	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047761	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047762	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047763	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047764	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047765	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047766	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047767	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR18047768	PRJNA807457	T2DM	1.0				Mexico	V4–V5		ILLUMINA	Type 2 Diabetes Mellitus	Changes in the Composition and Diversity of the Intestinal Microbiota Associated with Carbohydrate Consumption in Type 2 Diabetes Mellitus Patients	T2DM			
SRR10420132	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420133	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420134	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420135	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420136	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420137	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420138	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420139	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420140	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420141	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420142	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420143	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420144	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420145	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420146	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420147	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420148	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420149	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420150	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420151	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420152	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420153	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420154	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420155	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420156	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420157	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420158	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420159	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420160	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420161	PRJNA588353	healthy	0.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420162	PRJNA588353	healthy	0.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420163	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420164	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420165	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420166	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420167	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420168	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420169	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420170	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420171	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420172	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420173	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420174	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420175	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420176	PRJNA588353	T2DM	1.0		male		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420177	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420178	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
SRR10420179	PRJNA588353	T2DM	1.0		female		Sudan	V3-V4	F: CCTAYGGGRBGCASCAG; R: GGACTACNNGGGTATCTAAT	ION_TORRENT	Type 2 Diabetes Mellitus	Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents	T2DM			
ERR2308804	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2308906	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERR2308908	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2308938	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR2309216	PRJEB11419	control	0.0		male		Sweden				Diabetes_T2		T2DM			
ERR2313995	PRJEB11419	control	0.0		female		Ireland				Diabetes_T2		T2DM			
ERR2314096	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2314234	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERR2314313	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2314340	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2405211	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR2405212	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR1597129	PRJEB11419	control	0.0		female		United Kingdom				Diabetes_T2		T2DM			
ERR2032211	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR2032264	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2032562	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR2032593	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERR2032859	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR2033213	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR1845825	PRJEB11419	control	0.0		male		Australia				Diabetes_T2		T2DM			
ERR1841598	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR1316239	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR1458821	PRJEB11419	control	0.0		female		United Kingdom				Diabetes_T2		T2DM			
ERR1458896	PRJEB11419	Diabetes T2	1.0		female		United Kingdom				Diabetes_T2		T2DM			
ERR1459097	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2092026	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2092071	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERR2092078	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2092209	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2092414	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2092416	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2091935	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR1843585	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2319297	PRJEB11419	control	0.0		female		Canada				Diabetes_T2		T2DM			
ERR2319343	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2303959	PRJEB11419	control	0.0		female		Germany				Diabetes_T2		T2DM			
ERR1417591	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2580098	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR2587858	PRJEB11419	control	0.0		male		Argentina				Diabetes_T2		T2DM			
ERR1389830	PRJEB11419	Diabetes T2	1.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2696967	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERR1389999	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERR2696718	PRJEB11419	Diabetes T2	1.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR1842854	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2697883	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR2698048	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR4020510	PRJEB11419	control	0.0		female		United Kingdom				Diabetes_T2		T2DM			
ERR4020512	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERR4020592	PRJEB11419	Diabetes T2	1.0		male		Philippines				Diabetes_T2		T2DM			
ERR9744104	PRJEB11419	control	0.0		female		Mexico				Diabetes_T2		T2DM			
ERR9744113	PRJEB11419	Diabetes T2	1.0		female		Mexico				Diabetes_T2		T2DM			
ERR9744274	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR11274496	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR9735046	PRJEB11419	control	0.0		female		Mexico				Diabetes_T2		T2DM			
ERR9735092	PRJEB11419	control	0.0		male		Mexico				Diabetes_T2		T2DM			
ERR9735112	PRJEB11419	Diabetes T2	1.0		male		Mexico				Diabetes_T2		T2DM			
ERR6363061	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERR6363101	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR6358235	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERR6358437	PRJEB11419	Diabetes T2	1.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5790693	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERS5790757	PRJEB11419	Diabetes T2	1.0		male		United Kingdom				Diabetes_T2		T2DM			
ERS5810208	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERS5796505	PRJEB11419	control	0.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5802206	PRJEB11419	control	0.0		male		Switzerland				Diabetes_T2		T2DM			
ERS5802284	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERS5802331	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERS5806720	PRJEB11419	control	0.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5794196	PRJEB11419	control	0.0		male		United Kingdom				Diabetes_T2		T2DM			
ERS5794660	PRJEB11419	Diabetes T2	1.0		male		Australia				Diabetes_T2		T2DM			
ERS5794818	PRJEB11419	Diabetes T2	1.0		male		United Kingdom				Diabetes_T2		T2DM			
ERS5795298	PRJEB11419	Diabetes T2	1.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5796312	PRJEB11419	Diabetes T2	1.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5796412	PRJEB11419	Diabetes T2	1.0		male		United Kingdom				Diabetes_T2		T2DM			
ERS5801505	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERS5801642	PRJEB11419	control	0.0		male		Canada				Diabetes_T2		T2DM			
ERS5801664	PRJEB11419	Diabetes T2	1.0		male		United States				Diabetes_T2		T2DM			
ERS5802297	PRJEB11419	control	0.0		female		United States				Diabetes_T2		T2DM			
ERS5806582	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERS6630261	PRJEB11419	Diabetes T2	1.0		female		United States				Diabetes_T2		T2DM			
ERS6630405	PRJEB11419	control	0.0		male		United States				Diabetes_T2		T2DM			
ERS4851191	PRJEB11419	Diabetes T2	1.0		male		Finland				Diabetes_T2		T2DM			
ERS4851287	PRJEB11419	Diabetes T2	1.0		female		United Kingdom				Diabetes_T2		T2DM			
ERS5442778	PRJEB11419	control	0.0		male		Germany				Diabetes_T2		T2DM			
ERR3928932	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928933	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928938	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928939	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928940	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928941	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928942	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928943	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928944	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928945	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928950	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928951	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928952	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928953	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928956	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928961	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928965	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928967	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928969	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928970	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928973	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928976	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928977	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928979	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928983	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928984	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928985	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928987	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928988	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928989	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928990	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928991	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928992	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928993	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928994	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928995	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928996	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928997	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928998	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3928999	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929000	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929003	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929006	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929007	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929009	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929011	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929013	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929015	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929017	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929018	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929019	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929021	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929024	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929026	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929028	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929029	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929030	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929031	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929032	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929033	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929035	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929036	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929037	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929038	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929040	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929041	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929042	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929043	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929044	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929045	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929046	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929047	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929048	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929049	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929052	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929053	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929058	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929059	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929061	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929062	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929064	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929066	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929068	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929070	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929072	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929074	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929076	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929078	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929080	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929081	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929082	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929083	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929084	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3928934	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928935	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928937	PRJEB36789	crc	1.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928946	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928947	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928948	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928949	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928954	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928955	PRJEB36789	healthy	0.0				Argentina	V4			Colorectal Cancer		CRC			
ERR3928957	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928958	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928959	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928960	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928962	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928963	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928964	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928966	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928968	PRJEB36789	crc	1.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928971	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928972	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928974	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928975	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928978	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928980	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928981	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928982	PRJEB36789	healthy	0.0				Chile	V4			Colorectal Cancer		CRC			
ERR3928986	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929001	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929002	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929004	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929005	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929008	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929010	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929012	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929014	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929016	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929020	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929022	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929023	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929025	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929027	PRJEB36789	healthy	0.0				UK	V4			Colorectal Cancer		CRC			
ERR3929034	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929039	PRJEB36789	crc	1.0				India	V4			Colorectal Cancer		CRC			
ERR3929050	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929051	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929054	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929055	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929056	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929057	PRJEB36789	healthy	0.0				India	V4			Colorectal Cancer		CRC			
ERR3929060	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929063	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929065	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929067	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929069	PRJEB36789	crc	1.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929071	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929073	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929075	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929077	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929079	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
ERR3929085	PRJEB36789	healthy	0.0				Vietnam	V4			Colorectal Cancer		CRC			
SRR18656057	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656058	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656059	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656060	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656061	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656062	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656063	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656064	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656065	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656066	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656067	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656068	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656069	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656070	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656071	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656072	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656073	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656074	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656075	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656076	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656077	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656078	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656079	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656080	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656081	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656082	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656083	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656084	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656085	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656086	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656087	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656088	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656089	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656090	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656091	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656092	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656093	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656094	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656095	PRJNA824020	healthy	0.0				China	V4			Colorectal Cancer		CRC			
SRR18656096	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656097	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656098	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656099	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656100	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656101	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656102	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656103	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656104	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656105	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656106	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656107	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656108	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656109	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656110	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656111	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656112	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656113	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656114	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
SRR18656115	PRJNA824020	crc	1.0				China	V4			Colorectal Cancer		CRC			
DRR305656	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305657	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305658	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305659	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305660	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305661	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305662	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305663	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305664	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305665	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305666	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305667	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305668	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305669	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305670	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305671	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305672	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305673	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305674	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305675	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305676	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305677	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305678	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305679	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305680	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305681	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305682	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305683	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305684	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305685	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305686	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305687	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305688	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305689	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305690	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305691	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305692	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305693	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305694	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305695	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305696	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305697	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305698	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305699	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305700	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305701	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305702	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305703	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305704	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305705	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305706	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305707	PRJDB11845	crc	1.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305708	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305709	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305710	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305711	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305712	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305713	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305714	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305715	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305716	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305717	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305718	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305719	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305720	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305721	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305722	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305723	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305724	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305725	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305726	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305727	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305728	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305729	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305730	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305731	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305732	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305733	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305734	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305735	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305736	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305737	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305738	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305739	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305740	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305741	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305742	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305743	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305744	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305745	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305746	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305747	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305748	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305749	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305750	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305751	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305752	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305753	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305754	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305755	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305757	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
DRR305758	PRJDB11845	healthy	0.0				Japan	V1-V2			Colorectal Cancer		CRC			
ERR475482	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475493	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475501	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475509	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475515	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475516	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475520	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475521	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475527	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475529	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475531	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475533	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475539	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475540	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475547	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475555	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475557	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475560	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475568	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475569	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475573	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475577	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475578	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475579	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475580	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475581	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475582	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475586	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475588	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475589	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475591	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475592	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475594	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475500	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475513	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475532	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475541	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475548	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475553	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475576	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475585	PRJEB6070	CRC	1.0				France	V4			Colorectal Cancer		CRC			
ERR475469	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475470	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475471	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475473	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475474	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475476	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475477	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475478	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475480	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475481	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475483	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475484	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475485	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475486	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475487	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475491	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475492	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475494	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475495	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475497	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475508	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475512	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475514	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475517	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475522	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475523	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475525	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475526	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475534	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475545	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475550	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475562	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475564	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475565	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475566	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475567	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475570	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475571	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475572	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475575	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475468	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475488	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475499	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475503	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475519	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475524	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475563	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475574	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475504	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
ERR475549	PRJEB6070	Normal	0.0				France	V4			Colorectal Cancer		CRC			
SRR2143527	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143533	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143534	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143557	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143560	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143580	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143586	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143588	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143591	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143602	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143606	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143621	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143633	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143635	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143638	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143644	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143649	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143652	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143654	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143662	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143665	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143667	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143668	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143675	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143676	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143677	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143681	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143683	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143684	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143694	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143705	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143707	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143709	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143722	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143724	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143732	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143745	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143746	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143759	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143760	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143761	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143762	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143767	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143768	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143776	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143798	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143824	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143835	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143838	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143840	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143886	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143889	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143890	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143900	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143901	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143902	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143906	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143910	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143934	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143935	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143937	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143943	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143966	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143979	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143982	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143985	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143998	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144020	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144021	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144024	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144027	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144032	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144033	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144034	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144035	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144043	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144073	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144091	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144092	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144093	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144105	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144115	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144126	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143524	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143552	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143555	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143562	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143587	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143613	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143637	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143663	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143669	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143672	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143674	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143682	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143697	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143699	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143708	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143712	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143716	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143717	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143718	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143719	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143734	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143735	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143743	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143748	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143749	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143750	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143758	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143769	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143770	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143777	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143784	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143786	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143788	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143827	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143828	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143836	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143837	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143841	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143842	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143845	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143857	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143858	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143865	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143885	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143888	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143891	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143894	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143895	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143898	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143899	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143903	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143905	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143907	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143909	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143925	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143931	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143942	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143963	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143964	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143965	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143968	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143978	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143986	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143988	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143996	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144001	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144003	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144005	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144006	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144008	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144012	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144016	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144019	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144029	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144039	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144070	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144096	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144101	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144106	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144108	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144110	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144119	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144120	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144121	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144131	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143521	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143526	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143537	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143558	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143559	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143577	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143578	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143590	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143593	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143599	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143609	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143627	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143631	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143634	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143659	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143693	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143696	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143698	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143721	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143723	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143725	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143727	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143733	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143736	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143744	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143747	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143763	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143764	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143766	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143778	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143779	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143780	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143785	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143789	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143792	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143793	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143796	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143805	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143807	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143808	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143813	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143814	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143830	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143832	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143839	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143856	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143878	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143883	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143893	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143897	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143908	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143911	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143922	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143924	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143926	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143928	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143936	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143950	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143951	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143959	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143960	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143967	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143981	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143984	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143987	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2143989	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2143999	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144002	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144004	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144007	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144009	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144011	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144015	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144017	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144031	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144040	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144071	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144090	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144094	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144098	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144103	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144107	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144109	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144111	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144117	PRJNA290926	Cancer	1.0				USA	V4			Colorectal Cancer		CRC			
SRR2144127	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRR2144129	PRJNA290926	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390121	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390717	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386977	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387079	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387027	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390134	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390119	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390692	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390110	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390685	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386895	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386972	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390722	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390130	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390100	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387104	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387061	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390719	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390040	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390724	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390667	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386904	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387107	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387026	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390727	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390720	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386922	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387088	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387064	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390093	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387073	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387080	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390680	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387092	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386889	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387095	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386899	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387106	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390698	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387025	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387071	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387097	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387068	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390687	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387113	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386896	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390092	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386893	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390108	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390057	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390697	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387082	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387041	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390702	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387091	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390076	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390032	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390136	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387034	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390740	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386915	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387103	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390077	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390728	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387101	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387083	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387063	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387065	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390138	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387042	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390046	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390672	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387096	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390714	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390104	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387053	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387039	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387059	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387032	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387023	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390044	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387060	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390113	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390075	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387066	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390060	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390106	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390132	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387057	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390699	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390678	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390091	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390118	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390068	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1390124	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387069	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387051	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1387043	PRJNA318004	CRC	1.0				USA	V4			Colorectal Cancer		CRC			
SRS1386911	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386934	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390133	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387029	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386932	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387114	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390066	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390059	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390103	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390067	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386979	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390675	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390693	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390665	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390731	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390704	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386933	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387112	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390730	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390669	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386976	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390031	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387021	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390683	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390741	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390048	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390671	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387089	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386956	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390712	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386892	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386917	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390038	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386951	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390070	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387018	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390062	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386983	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390676	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390051	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390054	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390063	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390055	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390655	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386969	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386929	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390061	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390071	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390043	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390074	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390664	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390657	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387110	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390674	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386954	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386953	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390084	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386930	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387044	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390700	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387076	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390721	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390715	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387019	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387030	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390065	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390706	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390101	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390083	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390710	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390688	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390739	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387102	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390072	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386971	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390079	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387099	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390053	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390723	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390729	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390734	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387028	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390713	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390659	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386928	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390064	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390102	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386958	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390058	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387033	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390045	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386898	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386884	PRJNA318004	healthy	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386960	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386961	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390056	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387109	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390708	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390052	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386975	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390746	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386919	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390738	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387108	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386978	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386887	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386968	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390650	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386957	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386931	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386916	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386936	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390716	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390116	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386959	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386901	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386939	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390686	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386923	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386903	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1387105	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390668	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386947	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390660	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386955	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386943	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1390663	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386921	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386894	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS1386963	PRJNA318004	Normal	0.0				USA	V4			Colorectal Cancer		CRC			
SRS2855688	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855687	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855683	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855686	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855685	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855684	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855681	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855682	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855690	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855692	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855616	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855618	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855622	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855614	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855615	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859542	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855617	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855610	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855773	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855774	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855770	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855769	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855701	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855561	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859541	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855557	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855556	PRJNA430990	CRC	1.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855555	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855558	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855564	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855565	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855699	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855697	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855689	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855696	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855694	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855693	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855695	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855691	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859554	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855702	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855730	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859560	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855731	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859564	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855732	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859567	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859565	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855733	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855734	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855735	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855648	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859544	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855650	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855649	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859546	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859548	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855652	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855651	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855646	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855645	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855666	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855669	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855665	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855667	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859550	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855672	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855668	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855671	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855664	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855591	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855595	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855594	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855647	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855593	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855600	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855597	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855598	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855596	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855625	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855589	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855624	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855626	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855586	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855581	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855620	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855621	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855623	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855609	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855588	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855590	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855765	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859566	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855767	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855766	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855763	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855761	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855764	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2861655	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859563	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855759	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855728	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855729	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2861568	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855725	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855724	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855726	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855723	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855727	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855722	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2859559	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855579	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855580	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855577	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855578	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855576	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2861563	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855575	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855572	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855583	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855582	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855551	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855545	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855547	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855548	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855550	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855552	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855553	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855554	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855539	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855540	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855633	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855635	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855636	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855637	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855639	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855638	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855641	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855640	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855643	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855642	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855602	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855603	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855599	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855601	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRS2855605	PRJNA430990	healthy	0.0				China	V3-V4			Colorectal Cancer		CRC			
SRR23368042	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder	Altered Gut Microbiota and Short-chain Fatty Acids in Chinese Children with Constipated Autism Spectrum Disorder	ASD			
SRR23368043	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368044	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368045	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368046	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368047	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368048	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368049	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368050	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368051	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368052	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368053	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368054	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368055	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368056	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368057	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368058	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368059	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368060	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368061	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368062	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368063	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368064	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368065	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368066	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368067	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368068	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368069	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368070	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368071	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368072	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368073	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368074	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368075	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368076	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368077	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368078	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368079	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368080	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368081	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368082	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368083	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368084	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368085	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368086	PRJNA932561	Healthy	0.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368087	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368088	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368089	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368090	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368091	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368092	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368093	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368094	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368095	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368096	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368097	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368098	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368099	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368100	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368101	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368102	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368103	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368104	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368105	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368106	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368107	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368108	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368109	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368110	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368111	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368112	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368113	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368114	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368115	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368116	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368117	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368118	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368119	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368120	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR23368121	PRJNA932561	ASD	1.0				China:Xiamen	V3-V4	(338?F: 5��-ACTCCTACGGGAGGCAGCAG-3�� and 806?R: 5��-GGACTACHVGGGTWTCTAAT-3��)	Illumina MiniSeq	Autism Spectrum Disorder		ASD			
SRR28782240	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder	Comprehensive Analysis of Gut Microbiota Composition and Functional Metabolism in Children with Autism Spectrum Disorder and Neurotypical Children: Implications for Sex-Based Differences and Metabolic Dysregulation	ASD			
SRR28782241	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782242	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782243	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782244	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782245	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782246	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782247	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782248	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782249	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782250	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782251	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782252	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782253	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782254	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782255	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782256	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782257	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782198	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782199	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782200	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782201	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782202	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782203	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782204	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782205	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782206	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782207	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782208	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782209	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782210	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782211	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782212	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782213	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782214	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782215	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782216	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782217	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782218	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782219	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782220	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782221	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782222	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782223	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782224	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782225	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782226	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782227	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782228	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782229	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782230	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782231	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782232	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782233	PRJNA1103839	ASD	1.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782234	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782235	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782236	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782237	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782238	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782239	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR28782258	PRJNA1103839	Healthy	0.0				Mexico: Mexico City	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305328	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305329	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305330	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305331	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305332	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305333	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305334	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305335	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305336	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305337	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305338	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305339	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305340	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305341	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305342	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305343	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305344	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305345	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305346	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305347	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305348	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305349	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305350	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305351	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305352	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305353	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305354	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305355	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305356	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305357	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305358	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305359	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305360	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305361	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305362	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305363	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305364	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305365	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305366	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305367	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305368	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305369	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305370	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305371	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305372	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305373	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305374	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305375	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305376	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305377	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305378	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305379	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305380	PRJNA578223	ASD	1.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305381	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305382	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305383	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305384	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305385	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305386	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305387	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305388	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305389	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305390	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305391	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305392	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305393	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305394	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305395	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305396	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305397	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305398	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305399	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305400	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305401	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305402	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305403	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305404	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305405	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305406	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305407	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305408	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305409	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305410	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305411	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305412	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305413	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305414	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305415	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305416	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305417	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305418	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305419	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305420	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305421	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305422	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
SRR10305423	PRJNA578223	Healthy	0.0				China:Shanghai	V3-V4		Illumina MiSeq	Autism Spectrum Disorder		ASD			
ERR1368879	RISK_PRISM_f	CD	1.0	19.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368880	RISK_PRISM_f	CD	1.0	26.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368881	RISK_PRISM_f	UC	1.0	55.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368882	RISK_PRISM_f	CD	1.0	57.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368883	RISK_PRISM_f	IC	1.0	46.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368884	RISK_PRISM_f	IC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368885	RISK_PRISM_f	CD	1.0	61.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368886	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368887	RISK_PRISM_f	UC	1.0	50.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368888	RISK_PRISM_f	UC	1.0	46.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368889	RISK_PRISM_f	UC	1.0	36.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368890	RISK_PRISM_f	CD	1.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368891	RISK_PRISM_f	CD	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368892	RISK_PRISM_f	CD	1.0	60.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368893	RISK_PRISM_f	IC	1.0	12.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368894	RISK_PRISM_f	CD	1.0	20.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368895	RISK_PRISM_f	IC	1.0	33.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368896	RISK_PRISM_f	UC	1.0	12.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368897	RISK_PRISM_f	UC	1.0	43.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368898	RISK_PRISM_f	CD	1.0	18.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368899	RISK_PRISM_f	CD	1.0	54.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368900	RISK_PRISM_f	CD	1.0	19.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368901	RISK_PRISM_f	CD	1.0	15.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368902	RISK_PRISM_f	IC	1.0	31.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368903	RISK_PRISM_f	UC	1.0	74.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368904	RISK_PRISM_f	CD	1.0	37.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368905	RISK_PRISM_f	CD	1.0	34.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368906	RISK_PRISM_f	UC	1.0	80.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368907	RISK_PRISM_f	CD	1.0	8.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368908	RISK_PRISM_f	CD	1.0	29.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368909	RISK_PRISM_f	UC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368910	RISK_PRISM_f	IC	1.0	13.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368911	RISK_PRISM_f	CD	1.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368912	RISK_PRISM_f	CD	1.0	62.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368913	RISK_PRISM_f	UC	1.0	41.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368914	RISK_PRISM_f	UC	1.0	18.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368915	RISK_PRISM_f	UC	1.0	83.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368916	RISK_PRISM_f	CD	1.0	53.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368917	RISK_PRISM_f	CD	1.0	58.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368918	RISK_PRISM_f	CD	1.0	62.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368919	RISK_PRISM_f	UC	1.0	44.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368920	RISK_PRISM_f	CD	1.0	55.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368921	RISK_PRISM_f	UC	1.0	26.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368922	RISK_PRISM_f	CD	1.0	12.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368923	RISK_PRISM_f	UC	1.0	48.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368924	RISK_PRISM_f	CD	1.0	15.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368925	RISK_PRISM_f	UC	1.0	33.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368926	RISK_PRISM_f	IC	1.0	8.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368927	RISK_PRISM_f	CD	1.0	47.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368928	RISK_PRISM_f	CD	1.0	48.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368929	RISK_PRISM_f	CD	1.0	53.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368930	RISK_PRISM_f	UC	1.0	36.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368931	RISK_PRISM_f	CD	1.0	20.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368932	RISK_PRISM_f	CD	1.0	26.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368933	RISK_PRISM_f	UC	1.0	39.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368934	RISK_PRISM_f	CD	1.0	51.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368935	RISK_PRISM_f	UC	1.0	50.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368936	RISK_PRISM_f	UC	1.0	67.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368937	RISK_PRISM_f	UC	1.0	69.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368938	RISK_PRISM_f	UC	1.0	24.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368939	RISK_PRISM_f	CD	1.0	15.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368940	RISK_PRISM_f	UC	1.0	53.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368941	RISK_PRISM_f	CD	1.0	9.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368942	RISK_PRISM_f	CD	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368943	RISK_PRISM_f	CD	1.0	47.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368944	RISK_PRISM_f	CD	1.0	65.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368945	RISK_PRISM_f	IC	1.0	51.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368946	RISK_PRISM_f	CD	1.0	7.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368947	RISK_PRISM_f	CD	1.0	40.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368948	RISK_PRISM_f	CD	1.0	35.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368949	RISK_PRISM_f	CD	1.0	29.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368950	RISK_PRISM_f	UC	1.0	18.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368951	RISK_PRISM_f	CD	1.0	16.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368952	RISK_PRISM_f	UC	1.0	53.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368953	RISK_PRISM_f	CD	1.0	15.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368954	RISK_PRISM_f	CD	1.0	11.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368955	RISK_PRISM_f	UC	1.0	61.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368956	RISK_PRISM_f	UC	1.0	74.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368957	RISK_PRISM_f	CD	1.0	66.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368958	RISK_PRISM_f	UC	1.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368959	RISK_PRISM_f	UC	1.0	60.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368960	RISK_PRISM_f	CD	1.0	20.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368961	RISK_PRISM_f	UC	1.0	50.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368962	RISK_PRISM_f	UC	1.0	27.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368964	RISK_PRISM_f	CD	1.0	27.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368965	RISK_PRISM_f	CD	1.0	62.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368966	RISK_PRISM_f	UC	1.0	51.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368967	RISK_PRISM_f	UC	1.0	35.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368968	RISK_PRISM_f	UC	1.0	19.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368969	RISK_PRISM_f	CD	1.0	7.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368970	RISK_PRISM_f	no	0.0	22.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368971	RISK_PRISM_f	no	0.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368972	RISK_PRISM_f	no	0.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368973	RISK_PRISM_f	no	0.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368974	RISK_PRISM_f	CD	1.0	65.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368976	RISK_PRISM_f	cCD	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368977	RISK_PRISM_f	iCD	1.0	26.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368978	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368979	RISK_PRISM_f	iCD	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368980	RISK_PRISM_f	UC	1.0	68.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368981	RISK_PRISM_f	iCD	1.0	25.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368982	RISK_PRISM_f	IC	1.0	30.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368983	RISK_PRISM_f	IC	1.0	37.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368984	RISK_PRISM_f	iCD	1.0	65.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368986	RISK_PRISM_f	UC	1.0	34.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368987	RISK_PRISM_f	UC	1.0	48.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368988	RISK_PRISM_f	cCD	1.0	68.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368989	RISK_PRISM_f	iCD	1.0	30.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368990	RISK_PRISM_f	cCD	1.0	38.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368991	RISK_PRISM_f	iCD	1.0	53.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368992	RISK_PRISM_f	UC	1.0	20.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368993	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368994	RISK_PRISM_f	UC	1.0	34.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368995	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368996	RISK_PRISM_f	UC	1.0	27.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368997	RISK_PRISM_f	iCD	1.0	36.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1368999	RISK_PRISM_f	UC	1.0	63.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369000	RISK_PRISM_f	cCD	1.0	45.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369001	RISK_PRISM_f	cCD	1.0	57.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369002	RISK_PRISM_f	cCD	1.0	30.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369003	RISK_PRISM_f	iCD	1.0	34.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369004	RISK_PRISM_f	iCD	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369005	RISK_PRISM_f	cCD	1.0	38.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369006	RISK_PRISM_f	iCD	1.0	25.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369007	RISK_PRISM_f	iCD	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369008	RISK_PRISM_f	iCD	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369009	RISK_PRISM_f	UC	1.0	27.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369010	RISK_PRISM_f	IC	1.0	55.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369011	RISK_PRISM_f	cCD	1.0	25.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369012	RISK_PRISM_f	iCD	1.0	51.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369013	RISK_PRISM_f	UC	1.0	64.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369014	RISK_PRISM_f	iCD	1.0	66.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369015	RISK_PRISM_f	iCD	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369016	RISK_PRISM_f	iCD	1.0	43.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369017	RISK_PRISM_f	iCD	1.0	31.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369018	RISK_PRISM_f	iCD	1.0	19.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369019	RISK_PRISM_f	iCD	1.0	34.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369020	RISK_PRISM_f	iCD	1.0	57.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369021	RISK_PRISM_f	iCD	1.0	60.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369022	RISK_PRISM_f	cCD	1.0	68.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369023	RISK_PRISM_f	UC	1.0	65.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369025	RISK_PRISM_f	UC	1.0	47.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369026	RISK_PRISM_f	UC	1.0	46.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369027	RISK_PRISM_f	UC	1.0	72.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369028	RISK_PRISM_f	iCD	1.0	24.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369029	RISK_PRISM_f	UC	1.0	49.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369030	RISK_PRISM_f	cCD	1.0	44.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369031	RISK_PRISM_f	iCD	1.0	42.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369032	RISK_PRISM_f	cCD	1.0		male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369033	RISK_PRISM_f	iCD	1.0	58.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369034	RISK_PRISM_f	cCD	1.0	34.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369035	RISK_PRISM_f	iCD	1.0	70.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369036	RISK_PRISM_f	cCD	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369037	RISK_PRISM_f	iCD	1.0	20.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369038	RISK_PRISM_f	no	0.0	57.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369039	RISK_PRISM_f	IC	1.0	26.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369040	RISK_PRISM_f	IC	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369041	RISK_PRISM_f	cCD	1.0	53.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369042	RISK_PRISM_f	iCD	1.0	42.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369043	RISK_PRISM_f	CD	1.0	37.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369044	RISK_PRISM_f	cCD	1.0	60.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369045	RISK_PRISM_f	UC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369046	RISK_PRISM_f	UC	1.0	26.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369048	RISK_PRISM_f	iCD	1.0	45.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369049	RISK_PRISM_f	iCD	1.0	62.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369050	RISK_PRISM_f	IC	1.0	38.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369051	RISK_PRISM_f	iCD	1.0	31.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369052	RISK_PRISM_f	IC	1.0	46.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369053	RISK_PRISM_f	iCD	1.0	60.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369054	RISK_PRISM_f	iCD	1.0	54.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369056	RISK_PRISM_f	cCD	1.0	57.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369057	RISK_PRISM_f	cCD	1.0	28.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369058	RISK_PRISM_f	iCD	1.0	28.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369059	RISK_PRISM_f	cCD	1.0	22.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369060	RISK_PRISM_f	CD	1.0	34.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369061	RISK_PRISM_f	iCD	1.0	57.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369062	RISK_PRISM_f	iCD	1.0	63.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369063	RISK_PRISM_f	iCD	1.0	36.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369064	RISK_PRISM_f	UC	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369065	RISK_PRISM_f	CD	1.0	62.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369066	RISK_PRISM_f	iCD	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369067	RISK_PRISM_f	UC	1.0	64.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369068	RISK_PRISM_f	UC	1.0	36.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369069	RISK_PRISM_f	iCD	1.0	35.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369070	RISK_PRISM_f	iCD	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369071	RISK_PRISM_f	iCD	1.0	37.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369072	RISK_PRISM_f	cCD	1.0	67.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369073	RISK_PRISM_f	iCD	1.0	34.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369074	RISK_PRISM_f	UC	1.0	71.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369075	RISK_PRISM_f	cCD	1.0	28.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369077	RISK_PRISM_f	UC	1.0	39.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369078	RISK_PRISM_f	iCD	1.0	39.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369079	RISK_PRISM_f	iCD	1.0	36.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369080	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369081	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369082	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369083	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369084	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369085	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369086	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369087	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369088	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369089	RISK_PRISM_f	UC	1.0	31.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369090	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369091	RISK_PRISM_f	cCD	1.0	77.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369092	RISK_PRISM_f	IC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369093	RISK_PRISM_f	UC	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369094	RISK_PRISM_f	UC	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369095	RISK_PRISM_f	UC	1.0	24.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369096	RISK_PRISM_f	UC	1.0	48.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369097	RISK_PRISM_f	UC	1.0	48.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369098	RISK_PRISM_f	IC	1.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369099	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369100	RISK_PRISM_f	UC	1.0	23.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369101	RISK_PRISM_f	UC	1.0	41.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369102	RISK_PRISM_f	iCD	1.0	30.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369103	RISK_PRISM_f	iCD	1.0	30.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369104	RISK_PRISM_f	UC	1.0	23.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369105	RISK_PRISM_f	cCD	1.0	60.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369107	RISK_PRISM_f	IC	1.0	31.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369108	RISK_PRISM_f	no	0.0	82.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369109	RISK_PRISM_f	no	0.0	82.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369110	RISK_PRISM_f	CD	1.0	41.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369111	RISK_PRISM_f	cCD	1.0	38.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369112	RISK_PRISM_f	IC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369113	RISK_PRISM_f	UC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369114	RISK_PRISM_f	UC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369115	RISK_PRISM_f	IC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369116	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369117	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369118	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369119	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369120	RISK_PRISM_f	cCD	1.0	38.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369122	RISK_PRISM_f	UC	1.0	67.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369123	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369124	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369125	RISK_PRISM_f	cCD	1.0	38.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369126	RISK_PRISM_f	iCD	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369127	RISK_PRISM_f	iCD	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369128	RISK_PRISM_f	UC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369129	RISK_PRISM_f	UC	1.0	22.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369130	RISK_PRISM_f	iCD	1.0	20.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369131	RISK_PRISM_f	UC	1.0	23.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369132	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369133	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369134	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369135	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369136	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369137	RISK_PRISM_f	cCD	1.0	38.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369138	RISK_PRISM_f	iCD	1.0	23.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369139	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369140	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369141	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369142	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369143	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369144	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369145	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369146	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369147	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369148	RISK_PRISM_f	iCD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369149	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369150	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369151	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369152	RISK_PRISM_f	CD	1.0	30.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369153	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369154	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369155	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369156	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369157	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369158	RISK_PRISM_f	iCD	1.0	21.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369159	RISK_PRISM_f	UC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369160	RISK_PRISM_f	UC	1.0	21.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369161	RISK_PRISM_f	UC	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1369162	RISK_PRISM_f	UC	1.0	29.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370255	RISK_PRISM_f	iCD	1.0	13.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370256	RISK_PRISM_f	iCD	1.0	14.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370257	RISK_PRISM_f	iCD	1.0	9.25	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370258	RISK_PRISM_f	iCD	1.0	13.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370259	RISK_PRISM_f	iCD	1.0	12.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370260	RISK_PRISM_f	iCD	1.0	16.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370261	RISK_PRISM_f	iCD	1.0	12.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370262	RISK_PRISM_f	iCD	1.0	11.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370263	RISK_PRISM_f	iCD	1.0	13.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370264	RISK_PRISM_f	iCD	1.0	10.16666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370265	RISK_PRISM_f	UC	1.0	15.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370266	RISK_PRISM_f	iCD	1.0	16.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370267	RISK_PRISM_f	UC	1.0	14.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370268	RISK_PRISM_f	cCD	1.0	16.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370269	RISK_PRISM_f	iCD	1.0	10.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370270	RISK_PRISM_f	cCD	1.0	15.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370271	RISK_PRISM_f	iCD	1.0	10.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370272	RISK_PRISM_f	cCD	1.0	7.666666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370273	RISK_PRISM_f	iCD	1.0	9.083333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370274	RISK_PRISM_f	iCD	1.0	10.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370275	RISK_PRISM_f	iCD	1.0	13.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370276	RISK_PRISM_f	iCD	1.0	11.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370277	RISK_PRISM_f	UC	1.0	17.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370278	RISK_PRISM_f	cCD	1.0	14.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370279	RISK_PRISM_f	iCD	1.0	14.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370280	RISK_PRISM_f	iCD	1.0	13.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370282	RISK_PRISM_f	cCD	1.0	9.166666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370283	RISK_PRISM_f	UC	1.0	14.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370284	RISK_PRISM_f	iCD	1.0	13.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370285	RISK_PRISM_f	iCD	1.0	7.666666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370286	RISK_PRISM_f	iCD	1.0	11.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370287	RISK_PRISM_f	iCD	1.0	11.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370288	RISK_PRISM_f	iCD	1.0	8.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370289	RISK_PRISM_f	iCD	1.0	11.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370290	RISK_PRISM_f	cCD	1.0	12.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370291	RISK_PRISM_f	no	0.0	15.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370292	RISK_PRISM_f	no	0.0	12.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370293	RISK_PRISM_f	UC	1.0	15.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370294	RISK_PRISM_f	iCD	1.0	10.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370295	RISK_PRISM_f	iCD	1.0	12.16666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370296	RISK_PRISM_f	no	0.0	11.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370297	RISK_PRISM_f	CD	1.0	15.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370298	RISK_PRISM_f	iCD	1.0	7.333333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370299	RISK_PRISM_f	no	0.0	8.333333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370300	RISK_PRISM_f	iCD	1.0	9.666666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370301	RISK_PRISM_f	iCD	1.0	15.25	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370302	RISK_PRISM_f	cCD	1.0	16.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370303	RISK_PRISM_f	no	0.0	12.66666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370304	RISK_PRISM_f	iCD	1.0	13.66666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370305	RISK_PRISM_f	iCD	1.0	11.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370306	RISK_PRISM_f	no	0.0	11.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370307	RISK_PRISM_f	iCD	1.0	15.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370308	RISK_PRISM_f	iCD	1.0	7.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370309	RISK_PRISM_f	UC	1.0	8.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370310	RISK_PRISM_f	iCD	1.0	12.25	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370311	RISK_PRISM_f	IC	1.0	11.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370312	RISK_PRISM_f	iCD	1.0	10.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370313	RISK_PRISM_f	UC	1.0	10.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370314	RISK_PRISM_f	iCD	1.0	6.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370315	RISK_PRISM_f	iCD	1.0	9.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370316	RISK_PRISM_f	iCD	1.0	10.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370317	RISK_PRISM_f	iCD	1.0	12.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370318	RISK_PRISM_f	cCD	1.0	13.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370319	RISK_PRISM_f	iCD	1.0	14.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370320	RISK_PRISM_f	iCD	1.0	9.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370321	RISK_PRISM_f	CD	1.0	10.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370322	RISK_PRISM_f	iCD	1.0	12.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370323	RISK_PRISM_f	no	0.0	9.833333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370324	RISK_PRISM_f	cCD	1.0	16.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370325	RISK_PRISM_f	iCD	1.0	11.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370326	RISK_PRISM_f	no	0.0		male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370327	RISK_PRISM_f	iCD	1.0	8.916666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370328	RISK_PRISM_f	IC	1.0	13.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370329	RISK_PRISM_f	iCD	1.0	11.66666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370330	RISK_PRISM_f	cCD	1.0	10.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370331	RISK_PRISM_f	cCD	1.0	6.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370332	RISK_PRISM_f	iCD	1.0	11.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370333	RISK_PRISM_f	iCD	1.0	16.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370334	RISK_PRISM_f	iCD	1.0	13.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370335	RISK_PRISM_f	IC	1.0	7.916666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370336	RISK_PRISM_f	no	0.0		male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370337	RISK_PRISM_f	iCD	1.0	15.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370338	RISK_PRISM_f	no	0.0	3.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370339	RISK_PRISM_f	no	0.0	7.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370340	RISK_PRISM_f	iCD	1.0	10.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370341	RISK_PRISM_f	iCD	1.0	11.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370342	RISK_PRISM_f	no	0.0	12.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370343	RISK_PRISM_f	iCD	1.0	14.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370344	RISK_PRISM_f	UC	1.0	13.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370345	RISK_PRISM_f	iCD	1.0	7.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370346	RISK_PRISM_f	iCD	1.0	8.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370347	RISK_PRISM_f	iCD	1.0	8.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370348	RISK_PRISM_f	cCD	1.0	13.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370349	RISK_PRISM_f	cCD	1.0	5.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370350	RISK_PRISM_f	iCD	1.0	16.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370351	RISK_PRISM_f	iCD	1.0	14.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370352	RISK_PRISM_f	iCD	1.0	11.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370353	RISK_PRISM_f	no	0.0	12.33333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370354	RISK_PRISM_f	iCD	1.0	12.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370355	RISK_PRISM_f	iCD	1.0	9.416666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370356	RISK_PRISM_f	iCD	1.0	10.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370357	RISK_PRISM_f	UC	1.0	10.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370358	RISK_PRISM_f	CD	1.0	9.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370359	RISK_PRISM_f	UC	1.0	6.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370360	RISK_PRISM_f	cCD	1.0	15.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370361	RISK_PRISM_f	no	0.0	12.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370362	RISK_PRISM_f	no	0.0		male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370363	RISK_PRISM_f	no	0.0		male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370364	RISK_PRISM_f	cCD	1.0	16.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370365	RISK_PRISM_f	IC	1.0	12.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370366	RISK_PRISM_f	cCD	1.0	14.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370367	RISK_PRISM_f	cCD	1.0	7.25	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370368	RISK_PRISM_f	iCD	1.0	14.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370369	RISK_PRISM_f	iCD	1.0	12.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370370	RISK_PRISM_f	iCD	1.0	9.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370371	RISK_PRISM_f	cCD	1.0	12.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370372	RISK_PRISM_f	UC	1.0	12.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370373	RISK_PRISM_f	no	0.0	15.66666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370374	RISK_PRISM_f	iCD	1.0	9.666666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370375	RISK_PRISM_f	cCD	1.0	8.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370376	RISK_PRISM_f	iCD	1.0	15.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370377	RISK_PRISM_f	UC	1.0	6.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370378	RISK_PRISM_f	iCD	1.0	15.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370379	RISK_PRISM_f	UC	1.0	11.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370380	RISK_PRISM_f	cCD	1.0	10.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370381	RISK_PRISM_f	no	0.0	14.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370382	RISK_PRISM_f	no	0.0	15.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370383	RISK_PRISM_f	iCD	1.0	13.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370384	RISK_PRISM_f	iCD	1.0	10.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370385	RISK_PRISM_f	no	0.0	12.66666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370386	RISK_PRISM_f	UC	1.0	11.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370387	RISK_PRISM_f	iCD	1.0	16.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370388	RISK_PRISM_f	iCD	1.0	13.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370389	RISK_PRISM_f	UC	1.0	14.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370390	RISK_PRISM_f	iCD	1.0	14.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370391	RISK_PRISM_f	cCD	1.0	14.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370392	RISK_PRISM_f	CD	1.0	9.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370393	RISK_PRISM_f	IC	1.0	9.083333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370394	RISK_PRISM_f	iCD	1.0	13.66666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370395	RISK_PRISM_f	iCD	1.0	13.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370396	RISK_PRISM_f	iCD	1.0	11.08333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370397	RISK_PRISM_f	iCD	1.0	15.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370398	RISK_PRISM_f	iCD	1.0	15.16666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370399	RISK_PRISM_f	iCD	1.0	10.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370400	RISK_PRISM_f	iCD	1.0	14.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370401	RISK_PRISM_f	cCD	1.0	12.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370402	RISK_PRISM_f	cCD	1.0	6.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370403	RISK_PRISM_f	iCD	1.0	15.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370404	RISK_PRISM_f	iCD	1.0	10.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370405	RISK_PRISM_f	cCD	1.0	9.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370406	RISK_PRISM_f	iCD	1.0	16.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370407	RISK_PRISM_f	iCD	1.0	10.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370408	RISK_PRISM_f	iCD	1.0	10.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370410	RISK_PRISM_f	iCD	1.0	15.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370411	RISK_PRISM_f	iCD	1.0	10.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370412	RISK_PRISM_f	iCD	1.0	15.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370413	RISK_PRISM_f	iCD	1.0	9.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370415	RISK_PRISM_f	iCD	1.0	5.416666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370416	RISK_PRISM_f	cCD	1.0	8.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370417	RISK_PRISM_f	CD	1.0	5.333333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370418	RISK_PRISM_f	iCD	1.0	12.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370419	RISK_PRISM_f	iCD	1.0	8.416666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370420	RISK_PRISM_f	iCD	1.0	11.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370421	RISK_PRISM_f	iCD	1.0	12.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370422	RISK_PRISM_f	iCD	1.0	5.833333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370423	RISK_PRISM_f	iCD	1.0	9.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370424	RISK_PRISM_f	iCD	1.0	14.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370425	RISK_PRISM_f	iCD	1.0	10.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370426	RISK_PRISM_f	iCD	1.0	14.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370427	RISK_PRISM_f	iCD	1.0	12.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370428	RISK_PRISM_f	iCD	1.0	16.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370429	RISK_PRISM_f	iCD	1.0	8.166666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370430	RISK_PRISM_f	iCD	1.0	5.166666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370431	RISK_PRISM_f	cCD	1.0	7.916666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370432	RISK_PRISM_f	cCD	1.0	13.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370433	RISK_PRISM_f	iCD	1.0	15.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370434	RISK_PRISM_f	iCD	1.0	16.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370435	RISK_PRISM_f	UC	1.0	7.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370436	RISK_PRISM_f	iCD	1.0	14.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370437	RISK_PRISM_f	cCD	1.0	16.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370438	RISK_PRISM_f	iCD	1.0	13.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370439	RISK_PRISM_f	no	0.0	5.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370440	RISK_PRISM_f	UC	1.0	7.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370441	RISK_PRISM_f	no	0.0	15.66666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370442	RISK_PRISM_f	IC	1.0	5.333333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370443	RISK_PRISM_f	iCD	1.0	14.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370445	RISK_PRISM_f	cCD	1.0	14.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370446	RISK_PRISM_f	cCD	1.0	8.833333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370447	RISK_PRISM_f	IC	1.0	16.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370448	RISK_PRISM_f	iCD	1.0	14.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370449	RISK_PRISM_f	no	0.0	10.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370450	RISK_PRISM_f	iCD	1.0	7.583333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370451	RISK_PRISM_f	iCD	1.0	15.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370452	RISK_PRISM_f	cCD	1.0	13.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370453	RISK_PRISM_f	iCD	1.0	11.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370454	RISK_PRISM_f	iCD	1.0	14.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370455	RISK_PRISM_f	iCD	1.0	9.333333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370456	RISK_PRISM_f	iCD	1.0	8.666666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370458	RISK_PRISM_f	cCD	1.0	16.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370459	RISK_PRISM_f	iCD	1.0	12.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370460	RISK_PRISM_f	iCD	1.0	15.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370461	RISK_PRISM_f	iCD	1.0	14.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370462	RISK_PRISM_f	cCD	1.0	9.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370463	RISK_PRISM_f	UC	1.0	16.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370464	RISK_PRISM_f	cCD	1.0	14.16666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370465	RISK_PRISM_f	cCD	1.0	8.833333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370466	RISK_PRISM_f	CD	1.0	11.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370467	RISK_PRISM_f	iCD	1.0	10.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370468	RISK_PRISM_f	cCD	1.0	15.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370469	RISK_PRISM_f	cCD	1.0	9.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370470	RISK_PRISM_f	iCD	1.0	12.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370471	RISK_PRISM_f	UC	1.0	14.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370472	RISK_PRISM_f	cCD	1.0	16.41666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370473	RISK_PRISM_f	iCD	1.0	7.583333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370474	RISK_PRISM_f	iCD	1.0	11.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370475	RISK_PRISM_f	iCD	1.0	10.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370476	RISK_PRISM_f	iCD	1.0	15.0	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370477	RISK_PRISM_f	UC	1.0	12.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370478	RISK_PRISM_f	cCD	1.0	13.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370479	RISK_PRISM_f	no	0.0	11.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370480	RISK_PRISM_f	iCD	1.0	13.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370481	RISK_PRISM_f	IC	1.0	9.083333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370482	RISK_PRISM_f	iCD	1.0	9.916666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370483	RISK_PRISM_f	iCD	1.0	11.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370484	RISK_PRISM_f	cCD	1.0	11.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370485	RISK_PRISM_f	iCD	1.0	14.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370486	RISK_PRISM_f	cCD	1.0	7.833333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370487	RISK_PRISM_f	iCD	1.0	11.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370488	RISK_PRISM_f	UC	1.0	16.16666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370489	RISK_PRISM_f	iCD	1.0	14.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370490	RISK_PRISM_f	iCD	1.0	14.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370492	RISK_PRISM_f	no	0.0	15.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370493	RISK_PRISM_f	no	0.0	15.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370494	RISK_PRISM_f	iCD	1.0	8.833333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370495	RISK_PRISM_f	UC	1.0	16.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370496	RISK_PRISM_f	iCD	1.0	13.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370497	RISK_PRISM_f	iCD	1.0	13.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370498	RISK_PRISM_f	iCD	1.0	10.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370499	RISK_PRISM_f	iCD	1.0	3.833333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370500	RISK_PRISM_f	iCD	1.0	11.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370502	RISK_PRISM_f	IC	1.0	5.0	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370503	RISK_PRISM_f	iCD	1.0	10.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370504	RISK_PRISM_f	iCD	1.0	12.16666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370505	RISK_PRISM_f	no	0.0	14.25	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370506	RISK_PRISM_f	cCD	1.0	16.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370507	RISK_PRISM_f	iCD	1.0	9.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370508	RISK_PRISM_f	iCD	1.0	16.66666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370509	RISK_PRISM_f	iCD	1.0	15.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370510	RISK_PRISM_f	IC	1.0	16.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370511	RISK_PRISM_f	cCD	1.0	9.75	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370512	RISK_PRISM_f	cCD	1.0	10.66666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370513	RISK_PRISM_f	cCD	1.0	14.41666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370514	RISK_PRISM_f	iCD	1.0	9.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370515	RISK_PRISM_f	UC	1.0	11.58333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370516	RISK_PRISM_f	no	0.0	16.91666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370517	RISK_PRISM_f	iCD	1.0	8.333333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370518	RISK_PRISM_f	CD	1.0	14.33333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370519	RISK_PRISM_f	iCD	1.0	9.666666667	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370520	RISK_PRISM_f	IC	1.0	9.916666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370521	RISK_PRISM_f	IC	1.0	15.83333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370522	RISK_PRISM_f	cCD	1.0	13.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370523	RISK_PRISM_f	cCD	1.0	12.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370524	RISK_PRISM_f	UC	1.0	10.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370525	RISK_PRISM_f	iCD	1.0	11.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370526	RISK_PRISM_f	cCD	1.0	6.583333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370527	RISK_PRISM_f	iCD	1.0	12.33333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370528	RISK_PRISM_f	cCD	1.0	12.91666667	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370529	RISK_PRISM_f	iCD	1.0	12.5	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370530	RISK_PRISM_f	iCD	1.0	12.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370531	RISK_PRISM_f	iCD	1.0	11.08333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370532	RISK_PRISM_f	cCD	1.0	10.83333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370533	RISK_PRISM_f	CD	1.0	11.75	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370534	RISK_PRISM_f	iCD	1.0	8.083333333	male		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370535	RISK_PRISM_f	cCD	1.0	9.5	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370536	RISK_PRISM_f	CD	1.0	15.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370537	RISK_PRISM_f	IC	1.0	6.083333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1370538	RISK_PRISM_f	cCD	1.0	10.58333333	female		515F-806R	V4	Illumina MiSeq	USA			IBD		feces	
ERR1746341	qiita_1629	CCD	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.87569444
ERR1746342	qiita_1629	CCD	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.87569444
ERR1746343	qiita_1629	CCD	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.87569444
ERR1746344	qiita_1629	UC	1.0		female	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88819444
ERR1746345	qiita_1629	UC	1.0		female	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88819444
ERR1746346	qiita_1629	UC	1.0		female	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88819444
ERR1746347	qiita_1629	UC	1.0		female	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88819444
ERR1746348	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746349	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746350	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746351	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746352	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746353	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746354	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.88958333
ERR1746355	qiita_1629	UC	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.89652778
ERR1746356	qiita_1629	UC	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.89652778
ERR1746357	qiita_1629	UC	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.89652778
ERR1746358	qiita_1629	UC	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.89652778
ERR1746359	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.90972222
ERR1746360	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	67.90972222
ERR1746361	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746362	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746363	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746364	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746365	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746367	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746368	qiita_1629	ICD_r	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:69
ERR1746369	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:74
ERR1746370	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:74
ERR1746371	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:74
ERR1746372	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:74
ERR1746373	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746374	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746375	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746376	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746377	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746378	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746379	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746380	qiita_1629	UC	1.0		female	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:78
ERR1746381	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746382	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746383	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746384	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746385	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746387	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746388	qiita_1629	ICD_nr	1.0		female	33	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:93
ERR1746389	qiita_1629	ICD_r	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:105
ERR1746390	qiita_1629	ICD_r	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:105
ERR1746391	qiita_1629	ICD_r	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:105
ERR1746392	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746393	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746394	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746395	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746396	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746397	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746398	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746399	qiita_1629	UC	1.0		male	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746400	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:129
ERR1746401	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:129
ERR1746402	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:129
ERR1746403	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:129
ERR1746404	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746405	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746406	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746407	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746408	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746409	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:136
ERR1746410	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746411	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746412	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746413	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746414	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746415	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746416	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:138
ERR1746417	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:141
ERR1746418	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:141
ERR1746419	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:141
ERR1746421	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:141
ERR1746422	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:141
ERR1746423	qiita_1629	UC	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:143
ERR1746424	qiita_1629	UC	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:143
ERR1746425	qiita_1629	UC	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:143
ERR1746426	qiita_1629	UC	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:143
ERR1746427	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:147
ERR1746428	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746429	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746430	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746431	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746432	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746433	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746435	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746436	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746437	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746438	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746439	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:162
ERR1746440	qiita_1629	CCD	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:187
ERR1746441	qiita_1629	CCD	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:187
ERR1746442	qiita_1629	CCD	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:187
ERR1746443	qiita_1629	CCD	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:187
ERR1746444	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746445	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746446	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746447	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746448	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746449	qiita_1629	ICD_r	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:190
ERR1746450	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746451	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746452	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746453	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746454	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746455	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746456	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:191
ERR1746457	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746458	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746459	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746460	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746461	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746462	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746463	qiita_1629	CCD	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:193
ERR1746464	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:195
ERR1746465	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:195
ERR1746466	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:195
ERR1746467	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:195
ERR1746468	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746469	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746470	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746471	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746472	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746473	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746474	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746475	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:206
ERR1746476	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746477	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746478	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746479	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746480	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746481	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746482	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746483	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:211
ERR1746484	qiita_1629	ICD_r	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:217
ERR1746485	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746486	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746487	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746488	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746489	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746490	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746491	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746492	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:235
ERR1746493	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746494	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746495	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746496	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746497	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746498	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:242
ERR1746499	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746500	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746501	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746502	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746503	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746504	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746505	qiita_1629	ICD_r	1.0		female	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:245
ERR1746506	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:251
ERR1746507	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:251
ERR1746508	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:251
ERR1746510	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:260
ERR1746512	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:260
ERR1746513	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:260
ERR1746514	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:260
ERR1746515	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746516	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746517	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746518	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746519	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746520	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746521	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746522	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746523	qiita_1629	UC	1.0		male	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:264
ERR1746524	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:284
ERR1746525	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:288
ERR1746526	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:288
ERR1746527	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:288
ERR1746528	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:288
ERR1746529	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:288
ERR1746530	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746531	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746532	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746533	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746534	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746535	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746536	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:295
ERR1746537	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:304
ERR1746538	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:304
ERR1746539	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:304
ERR1746540	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:304
ERR1746541	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:304
ERR1746542	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746543	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746544	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746545	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746546	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746547	qiita_1629	ICD_r	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:315
ERR1746548	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746549	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746550	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746551	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746552	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746553	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746554	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746555	qiita_1629	UC	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:316
ERR1746556	qiita_1629	ICD_r	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:318
ERR1746557	qiita_1629	UC	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:319
ERR1746558	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:326
ERR1746559	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:326
ERR1746560	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:326
ERR1746561	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746562	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746563	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746564	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746565	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746566	qiita_1629	UC	1.0		male	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:336
ERR1746567	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:347
ERR1746568	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:347
ERR1746569	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:347
ERR1746570	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:347
ERR1746571	qiita_1629	ICD_r	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:352
ERR1746572	qiita_1629	ICD_nr	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:372
ERR1746573	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746574	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746575	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746576	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746577	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746578	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746579	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR1746580	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746581	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746582	qiita_1629	ICD_r	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746583	qiita_1629	ICD_r	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746584	qiita_1629	ICD_r	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746585	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:390
ERR1746586	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746587	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:122
ERR1746588	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746589	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746590	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746591	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746592	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746593	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:413
ERR1746594	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746595	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746596	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746597	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746598	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746599	qiita_1629	ICD_r	1.0		male	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:423
ERR1746600	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746601	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746602	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746603	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746604	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746605	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746606	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:427
ERR1746607	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:446
ERR1746608	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:446
ERR1746609	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:450
ERR1746610	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:450
ERR1746611	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:450
ERR1746612	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:450
ERR1746613	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746614	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746615	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746616	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746617	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746618	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746619	qiita_1629	UC	1.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:456
ERR1746620	qiita_1629	CCD	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:465
ERR1746621	qiita_1629	CCD	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:465
ERR1746622	qiita_1629	CCD	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:465
ERR1746623	qiita_1629	UC	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:467
ERR1746624	qiita_1629	UC	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:467
ERR1746625	qiita_1629	UC	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:467
ERR1746626	qiita_1629	UC	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:467
ERR1746627	qiita_1629	UC	1.0		male	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:467
ERR1746628	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746629	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746630	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746631	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746632	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746633	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746634	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746635	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:482
ERR1746636	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746637	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746638	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746639	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746640	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746641	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:487
ERR1746642	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746643	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746644	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746645	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746646	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746647	qiita_1629	ICD_nr	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:492
ERR1746648	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746649	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746650	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746651	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746652	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746653	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746654	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:507
ERR1746655	qiita_1629	ICD_r	1.0		female	missing: not provided	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:508
ERR1746656	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:521
ERR1746657	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:521
ERR1746658	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:521
ERR1746659	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:521
ERR1746660	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:521
ERR1746661	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746662	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746663	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746664	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746665	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746666	qiita_1629	ICD_r	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:525
ERR1746667	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746668	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746669	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746670	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746671	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746672	qiita_1629	ICD_r	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:543
ERR1746673	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:552
ERR1746674	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:552
ERR1746675	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:552
ERR1746676	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:552
ERR1746677	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:553
ERR1746678	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:553
ERR1746679	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:553
ERR1746680	qiita_1629	ICD_r	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:553
ERR1746681	qiita_1629	CCD	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:560
ERR1746682	qiita_1629	CCD	1.0		male	31	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:560
ERR1746683	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:564
ERR1746684	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:564
ERR1746685	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:564
ERR1746686	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:564
ERR1746687	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:564
ERR1746688	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746689	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746690	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746691	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746692	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746693	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746694	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:566
ERR1746695	qiita_1629	CCD	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:570
ERR1746696	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:575
ERR1746697	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:590
ERR1746698	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746699	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746700	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746701	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746702	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746703	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746704	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:629
ERR1746705	qiita_1629	UC	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:629
ERR1746706	qiita_1629	UC	1.0		male	37	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:634
ERR1746707	qiita_1629	UC	1.0		male	37	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:634
ERR1746708	qiita_1629	UC	1.0		male	37	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:634
ERR1746709	qiita_1629	UC	1.0		male	37	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:634
ERR1746710	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746711	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746712	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746713	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746714	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746715	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:640
ERR1746716	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:643
ERR1746717	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:643
ERR1746718	qiita_1629	ICD_nr	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:646
ERR1746719	qiita_1629	ICD_nr	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:646
ERR1746720	qiita_1629	ICD_nr	1.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:646
ERR1746722	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746723	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746724	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746725	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746726	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746727	qiita_1629	ICD_nr	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:651
ERR1746728	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:671
ERR1746729	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:671
ERR1746730	qiita_1629	ICD_r	1.0		male	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:671
ERR1746731	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746732	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746733	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746734	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746735	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746736	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746737	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:680
ERR1746738	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746739	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746740	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746741	qiita_1629	UC	1.0		female	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:768
ERR1746742	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746743	qiita_1629	UC	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746744	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746745	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746746	qiita_1629	UC	1.0		male	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746747	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746748	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746749	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746750	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746751	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746752	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746753	qiita_1629	UC	1.0		female	32	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746754	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:696
ERR1746755	qiita_1629	UC	1.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746756	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:696
ERR1746757	qiita_1629	UC	1.0		female	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:696
ERR1746758	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746759	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746761	qiita_1629	UC	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:683
ERR1746762	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746763	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746764	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746765	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746766	qiita_1629	ICD_r	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:739
ERR1746767	qiita_1629	ICD_r	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:739
ERR1746768	qiita_1629	ICD_r	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:739
ERR1746769	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:768
ERR1746770	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:768
ERR1746771	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746772	qiita_1629	UC	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:768
ERR1746773	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746774	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746775	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746776	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746777	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746778	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746779	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746780	qiita_1629	CCD	1.0		male	27	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:769
ERR1746781	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:789
ERR1746782	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:696
ERR1746784	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:789
ERR1746785	qiita_1629	UC	1.0		male	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:814
ERR1746786	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746787	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746788	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:693
ERR1746789	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746790	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746791	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746792	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746793	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:842
ERR1746794	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:846
ERR1746795	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:849
ERR1746796	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:849
ERR1746797	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:849
ERR1746798	qiita_1629	UC	1.0		male	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:850
ERR1746799	qiita_1629	UC	1.0		male	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:850
ERR1746800	qiita_1629	UC	1.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:857
ERR1746801	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746802	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746803	qiita_1629	UC	1.0		female	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:718
ERR1746804	qiita_1629	UC	1.0		male	19	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746805	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746806	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:862
ERR1746807	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746808	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746809	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746810	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746811	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746812	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746813	qiita_1629	CCD	1.0		female	29	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:875
ERR1746814	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:881
ERR1746815	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:881
ERR1746816	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:881
ERR1746817	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:881
ERR1746818	qiita_1629	UC	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:881
ERR1746819	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746820	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746821	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746822	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746823	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746824	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746825	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746826	qiita_1629	HC	0.0		male	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:882
ERR1746827	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:884
ERR1746828	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:884
ERR1746829	qiita_1629	CCD	1.0		male	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:884
ERR1746830	qiita_1629	UC	1.0		male	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:892
ERR1746831	qiita_1629	UC	1.0		male	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:892
ERR1746832	qiita_1629	UC	1.0		male	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:892
ERR1746833	qiita_1629	HC	0.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:893
ERR1746834	qiita_1629	HC	0.0		female	21	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:893
ERR1746835	qiita_1629	HC	0.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:895
ERR1746836	qiita_1629	HC	0.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:895
ERR1746837	qiita_1629	HC	0.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:895
ERR1746838	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746839	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746840	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746841	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746842	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746843	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746844	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:896
ERR1746845	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746846	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746847	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746848	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746849	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746850	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746851	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746852	qiita_1629	HC	0.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:898
ERR1746853	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746854	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746855	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746856	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746857	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746858	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746859	qiita_1629	HC	0.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:900
ERR1746860	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746861	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746862	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746863	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746864	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746865	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746866	qiita_1629	HC	0.0		female	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:901
ERR1746867	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:902
ERR1746868	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:902
ERR1746869	qiita_1629	CCD	1.0		female	24	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:905
ERR1746870	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746871	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746872	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746873	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746874	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746875	qiita_1629	HC	0.0		male	23	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:906
ERR1746876	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746877	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746878	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746879	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746880	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746881	qiita_1629	HC	0.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:908
ERR1746882	qiita_1629	ICD_r	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:910
ERR1746883	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:912
ERR1746885	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:912
ERR1746886	qiita_1629	UC	1.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:912
ERR1746888	qiita_1629	ICD_nr	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:913
ERR1746889	qiita_1629	ICD_nr	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:913
ERR1746890	qiita_1629	ICD_nr	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:913
ERR1746891	qiita_1629	UC	1.0		male	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:915
ERR1746892	qiita_1629	UC	1.0		male	20	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:915
ERR1746893	qiita_1629	CCD	1.0		female	18	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:916
ERR1746896	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:789
ERR1746913	qiita_1629	ICD_r	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:74
ERR1746926	qiita_1629	UC	1.0		female	34	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:471
ERR1746935	qiita_1629	UC	1.0		female	26	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:195
ERR1746940	qiita_1629	UC	1.0		female	30	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:152
ERR1746945	qiita_1629	HC	0.0		female	25	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:895
ERR1746961	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:623
ERR1746966	qiita_1629	UC	1.0		female	22	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:789
ERR1746979	qiita_1629	ICD_r	1.0		male	38	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:416
ERR1746993	qiita_1629	UC	1.0		male	28	Sweden	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1629:385
ERR2172357	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172358	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172359	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172360	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172361	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172362	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172363	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172364	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172365	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172366	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172367	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172368	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172369	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172370	qiita_2538	CD	1.0	17.0		25.3	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000000
ERR2172371	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172373	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172374	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172375	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172376	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172377	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172378	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172381	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172382	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172384	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172385	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172386	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172387	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172388	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172389	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172390	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172391	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172392	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172393	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172394	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172395	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172396	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172397	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172398	qiita_2538	Control	0.0	56.0		39.7	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000100
ERR2172399	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172400	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172401	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172402	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172403	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172404	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172405	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172406	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172408	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172409	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172410	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172411	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172412	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172413	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172414	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172415	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172416	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172417	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172418	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172420	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172421	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172422	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172423	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172425	qiita_2538	Control	0.0	49.0		24	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000200
ERR2172426	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172427	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172429	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172430	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172431	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172432	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172433	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172435	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172436	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172437	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172438	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172439	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172440	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172442	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172443	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172444	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172445	qiita_2538	Control	0.0	25.0		33.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000300
ERR2172446	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172447	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172448	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172449	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172450	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172451	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172452	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172453	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172454	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172455	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172456	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172457	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172458	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172459	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172460	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172461	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172462	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172463	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172464	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172465	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172466	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172467	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172468	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172469	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172470	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172471	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172472	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172473	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172474	qiita_2538	CD	1.0	15.0		22.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000400
ERR2172475	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172476	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172477	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172478	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172479	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172480	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172481	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172482	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172483	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172484	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172485	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172487	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172488	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172490	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172491	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172492	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172494	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172496	qiita_2538	Control	0.0	50.0		25.1	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000500
ERR2172497	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172498	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172499	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172500	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172501	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172502	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172503	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172504	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172505	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172506	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172507	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172508	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172509	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172510	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172511	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172512	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172513	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172514	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172515	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172516	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172517	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172518	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172519	qiita_2538	Control	0.0	44.0		60.5	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000600
ERR2172520	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172522	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172524	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172525	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172526	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172527	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172528	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172531	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172532	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172533	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172535	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172536	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172537	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172539	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172540	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172541	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172542	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172543	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172544	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172545	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172546	qiita_2538	Control	0.0	18.0		25	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000700
ERR2172548	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172549	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172550	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172553	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172554	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172555	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172558	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172559	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172562	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172563	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172565	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172566	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172567	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172568	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172569	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172570	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172571	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172572	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172573	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172575	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172576	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172577	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172578	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172579	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172580	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172581	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172582	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172583	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172584	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172585	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172586	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172587	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172589	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172590	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172591	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172592	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172593	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172595	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172596	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172597	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172598	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172599	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172600	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172601	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172602	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172603	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172604	qiita_2538	CD	1.0	31.0		41.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000800
ERR2172605	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172606	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172607	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172609	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172610	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172611	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172612	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172613	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172614	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172615	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172616	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172617	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172618	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172619	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172620	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172621	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172622	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172623	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172624	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172625	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172626	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172628	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172629	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172631	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172632	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172633	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172634	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172635	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172636	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172637	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172638	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172639	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172641	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172642	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172643	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172644	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172646	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172647	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172649	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172650	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172651	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172652	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172653	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172654	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172655	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172656	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172657	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172658	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172659	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172660	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172661	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172662	qiita_2538	Control	0.0	63.0		33.9	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1000900
ERR2172663	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172664	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172665	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172666	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172667	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172668	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172669	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172670	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172671	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172672	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172673	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172674	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172675	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172676	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172677	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172678	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172679	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172680	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172681	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172682	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172683	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172684	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172685	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172686	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172687	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172688	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172689	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172691	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172692	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172693	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172694	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172695	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172696	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172697	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172699	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172700	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172701	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172703	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172704	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172705	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172706	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172707	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172708	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172709	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172710	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172711	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172712	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172713	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172714	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172715	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172716	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172717	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172718	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172719	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172720	qiita_2538	Control	0.0	60.0		34.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001000
ERR2172721	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172722	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172723	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172725	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172726	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172727	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172728	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172729	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172730	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172731	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172732	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172733	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172734	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172735	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172736	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172737	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172738	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172739	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172740	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172741	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172742	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172743	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172744	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172745	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172746	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172747	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172748	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172749	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172750	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172751	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172752	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172753	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172754	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172755	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172756	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172757	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172758	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172759	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172760	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172761	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172762	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172763	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172764	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172765	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172766	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172767	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172768	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172769	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172770	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172771	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172772	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172773	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172774	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172775	qiita_2538	Control	0.0	33.0		33	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001100
ERR2172776	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172777	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172778	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172779	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172780	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172781	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172782	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172783	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172785	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172786	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172787	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172788	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172789	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172790	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172791	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172792	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172793	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172794	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172795	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172796	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172797	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172798	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172799	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172800	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172801	qiita_2538	CD	1.0	29.0		22.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001200
ERR2172802	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172803	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172804	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172805	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172806	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172807	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172808	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172809	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172810	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172811	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172812	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172813	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172814	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172815	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172816	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172817	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172818	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172819	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172820	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172821	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172824	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172825	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172826	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172827	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172828	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172829	qiita_2538	Control	0.0	59.0		29.6	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001300
ERR2172830	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172831	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172832	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172833	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172834	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172835	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172836	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172837	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172838	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172839	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172840	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172841	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172842	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172843	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172844	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172845	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172846	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172847	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172848	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172849	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172850	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172851	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172852	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172853	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172854	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172855	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172856	qiita_2538	Control	0.0	61.0		27.2	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001400
ERR2172857	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172858	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172859	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172860	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172861	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172863	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172864	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172866	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172868	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172869	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172870	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172871	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172873	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172874	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172875	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172876	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172877	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172879	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172880	qiita_2538	Control	0.0	29.0		22	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1001500
ERR2172881	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172882	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172883	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172884	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172887	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172888	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172889	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172890	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172891	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172892	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172893	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172895	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172897	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172899	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172900	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172903	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172905	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172906	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172908	qiita_2538	CD	1.0	30.0		22.09534	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002000
ERR2172911	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172912	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172913	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172914	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172915	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172916	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172917	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172918	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172920	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172921	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172922	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172923	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172924	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172925	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172927	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172928	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172931	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172932	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172935	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172937	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172938	qiita_2538	CD	1.0	33.0		18.04169	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002100
ERR2172939	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172940	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172941	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172942	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172944	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172945	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172946	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172948	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172949	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172951	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172952	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172954	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172955	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172957	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172959	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172961	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172965	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172966	qiita_2538	CD	1.0	23.0		24.05559	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002300
ERR2172969	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172970	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172971	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172972	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172974	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172975	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172976	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172977	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172978	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172979	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172980	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172981	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172982	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172983	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172984	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172985	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172986	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172988	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172990	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172991	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172992	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172993	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172994	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172995	qiita_2538	CD	1.0	30.0		20.88509	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002400
ERR2172998	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2172999	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173000	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173003	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173005	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173006	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173007	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173008	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173009	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173010	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173011	qiita_2538	CD	1.0	32.0		22.99698	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002500
ERR2173013	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173014	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173015	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173016	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173017	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173018	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173019	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173020	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173021	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173022	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173023	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173025	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173026	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173027	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173028	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173029	qiita_2538	CD	1.0	40.0		22.36366	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002600
ERR2173032	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173033	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173034	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173036	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173037	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173038	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173039	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173041	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173043	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173044	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173045	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173048	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173049	qiita_2538	CD	1.0	36.0		25.1545	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1002700
ERR2173050	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173052	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173053	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173054	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173055	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173056	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173057	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173060	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173061	qiita_2538	CD	1.0	23.0		24.12544	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003100
ERR2173063	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173064	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173065	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173066	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173067	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173068	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173069	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173070	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173071	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173073	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173074	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173075	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173076	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173077	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173078	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173079	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173080	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173081	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173084	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173087	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173089	qiita_2538	CD	1.0	52.0		22.08878	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003200
ERR2173090	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173091	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173093	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173095	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173096	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173097	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173098	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173099	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173100	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173101	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173102	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173104	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173105	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173106	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173108	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173109	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173110	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173111	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173112	qiita_2538	CD	1.0	21.0		23.46051	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003300
ERR2173126	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173129	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173131	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173134	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173135	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173136	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173137	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173139	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173144	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173147	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173148	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173149	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173150	qiita_2538	CD	1.0	24.0		18.42714	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173153	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003500
ERR2173155	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173163	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173164	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173165	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173167	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173169	qiita_2538	CD	1.0	22.0		20.50773	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003600
ERR2173170	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173171	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173172	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173173	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173174	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173175	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173176	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173177	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173178	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173179	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173180	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173181	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173182	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173183	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173184	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173185	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173186	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173187	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173188	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173189	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173190	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173191	qiita_2538	CD	1.0	33.0		25.23247	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003700
ERR2173192	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173195	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173196	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173198	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173199	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173201	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173204	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173207	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173208	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173209	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173210	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173211	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173212	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173213	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173214	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173215	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173216	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173217	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173218	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173219	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
ERR2173220	qiita_2538	CD	1.0	42.0		36.91389	USA	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina HiSeq 2000			IBD		feces	1003900
SRR5130755	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130756	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130757	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130758	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130759	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130760	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130761	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130762	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130763	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130764	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130765	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130766	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130767	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130768	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130769	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130770	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130771	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130772	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130773	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130774	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130775	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130776	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130777	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130778	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130779	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130780	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130781	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130782	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130783	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130784	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130785	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130786	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130787	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130788	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130789	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130790	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130791	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130792	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130793	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130794	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130795	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130796	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130797	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130798	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130799	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130800	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130801	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130802	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130803	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130804	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130805	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130806	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130808	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130809	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130810	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130811	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130812	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130813	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130814	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130815	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130816	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130817	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130818	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130819	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130820	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130821	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130822	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130823	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130824	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130825	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130826	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130827	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130828	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130829	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130830	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130831	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130832	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130833	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130834	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130836	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130837	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130838	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130839	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130840	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130841	PRJNA324147	uc	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130842	PRJNA324147	control	0.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130843	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5130844	PRJNA324147	cd	1.0				USA: Los Angeles			ILLUMINA			IBD		Feces	
SRR5218304	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218305	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218306	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218307	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218308	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218309	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218310	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218311	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218312	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218313	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218314	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218315	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218316	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218317	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218318	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218319	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218320	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218321	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218322	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218323	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218324	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218325	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218326	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218327	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218328	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218329	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218330	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218331	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218332	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218333	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218334	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218335	PRJNA368966	control	0.0							ILLUMINA			IBD		Feces	
SRR5218336	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218337	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218338	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218339	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218340	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218341	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218342	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218343	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218344	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218345	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218346	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218347	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218348	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218349	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218350	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218351	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218352	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218353	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218354	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218355	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218356	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218357	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218358	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218359	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218360	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218361	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218362	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218363	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218364	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218365	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218366	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR5218367	PRJNA368966	uc	1.0							ILLUMINA			IBD		Feces	
SRR6505418	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C258RP
SRR6505419	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C258IN
SRR6505420	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C258F
SRR6505421	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C257RN
SRR6505422	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C257IP
SRR6505423	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C257F
SRR6505424	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U101SN
SRR6505425	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U102F
SRR6505426	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U101F
SRR6505427	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U101RP
SRR6505428	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N24F
SRR6505429	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N25F
SRR6505430	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N02F
SRR6505431	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N01R
SRR6505432	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C121RN
SRR6505433	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U118IN
SRR6505434	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C124F
SRR6505435	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C134CAP
SRR6505436	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C133RN
SRR6505437	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C133F
SRR6505438	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C133CAP
SRR6505439	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C132IP
SRR6505441	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C132F
SRR6505442	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C131RN
SRR6505443	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C131IP
SRR6505444	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C131F
SRR6505445	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C128IN
SRR6505446	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C128RN
SRR6505447	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U227F
SRR6505448	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C129CAP
SRR6505449	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C129F
SRR6505450	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C129IN
SRR6505451	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C129RN
SRR6505452	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C130F
SRR6505453	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U102IN
SRR6505454	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C130RN
SRR6505455	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C118DP
SRR6505456	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U102RP
SRR6505457	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C122F
SRR6505458	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C106IN
SRR6505459	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C107CP
SRR6505460	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C103RN
SRR6505461	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C104F
SRR6505462	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C104IN
SRR6505463	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C104RP
SRR6505464	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C105F
SRR6505465	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C105IN
SRR6505466	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C105RP
SRR6505467	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C106F
SRR6505468	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U126IN
SRR6505469	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U105RP
SRR6505470	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U105IN
SRR6505471	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U126F
SRR6505472	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U104IN
SRR6505473	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U104F
SRR6505474	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U105F
SRR6505475	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U104RP
SRR6505476	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U103F
SRR6505477	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U103DP
SRR6505478	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U103RP
SRR6505479	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U103IN
SRR6505480	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C243F
SRR6505481	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C243IP
SRR6505482	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C241F
SRR6505483	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C241IP
SRR6505484	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C240IP
SRR6505485	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C240RN
SRR6505486	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C242IP
SRR6505487	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C242RN
SRR6505488	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C241RN
SRR6505489	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C242F
SRR6505490	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C117IN
SRR6505491	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C127IP
SRR6505492	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C124IP
SRR6505493	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C109F
SRR6505494	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C108IP
SRR6505495	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C109RP
SRR6505496	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C109IP
SRR6505497	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C107RN
SRR6505498	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C107F
SRR6505499	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C108F
SRR6505500	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C108CP
SRR6505501	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C126IP
SRR6505502	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U121IN
SRR6505503	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C110F
SRR6505504	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C110CP
SRR6505505	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C116F
SRR6505506	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C119RN
SRR6505507	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U108F
SRR6505508	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U108IN
SRR6505509	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C103CP
SRR6505510	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C103F
SRR6505511	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C121CP
SRR6505512	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U106F
SRR6505513	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U106IN
SRR6505514	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U106RP
SRR6505515	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U106TN
SRR6505516	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C101CP
SRR6505517	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C101F
SRR6505518	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C101IP
SRR6505519	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U108CP
SRR6505520	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C240F
SRR6505521	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C239RP
SRR6505522	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U231F
SRR6505523	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U230RP
SRR6505524	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C237IN
SRR6505525	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C237F
SRR6505526	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C238AP
SRR6505527	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C237RN
SRR6505528	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C238RN
SRR6505529	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C238F
SRR6505530	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C239IN
SRR6505531	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C239F
SRR6505532	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C123RN
SRR6505533	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U230F
SRR6505534	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U230IN
SRR6505535	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C112RN
SRR6505536	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C112SP
SRR6505537	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C112F
SRR6505538	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C112IP
SRR6505539	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C111F
SRR6505540	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C111IN
SRR6505541	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C110IP
SRR6505542	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C111DP
SRR6505543	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C126RN
SRR6505544	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C113AP
SRR6505545	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C113F
SRR6505546	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U110RN
SRR6505547	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U110IN
SRR6505548	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U110F
SRR6505549	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U110CP
SRR6505550	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U109RP
SRR6505552	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U109F
SRR6505553	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U108RP
SRR6505554	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U229RP
SRR6505555	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U229SN
SRR6505556	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U228RP
SRR6505557	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U229F
SRR6505558	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U228F
SRR6505559	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U228IN
SRR6505560	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U111IN
SRR6505561	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U111F
SRR6505562	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C128TP
SRR6505563	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C125IP
SRR6505564	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U227RP
SRR6505565	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U228CP
SRR6505566	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C250IP
SRR6505567	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C250RN
SRR6505568	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C249F
SRR6505569	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C249IP
SRR6505570	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C249RN
SRR6505571	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C250F
SRR6505572	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C247IP
SRR6505573	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C248F
SRR6505574	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C248IP
SRR6505575	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C248RN
SRR6505576	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C114F
SRR6505577	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C114CP
SRR6505578	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C113RP
SRR6505579	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C113IN
SRR6505580	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C115F
SRR6505581	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C115AP
SRR6505582	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C114RN
SRR6505583	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C114IP
SRR6505584	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C130IP
SRR6505585	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C115RP
SRR6505586	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C115IN
SRR6505587	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C123F
SRR6505588	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C117IP
SRR6505589	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U112IN
SRR6505590	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U112RP
SRR6505591	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U112DP
SRR6505592	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U112F
SRR6505593	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U113RP
SRR6505594	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U114F
SRR6505595	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U113F
SRR6505596	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U113IN
SRR6505597	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U126CP
SRR6505598	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U126CN
SRR6505599	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U114IN
SRR6505600	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U114RP
SRR6505601	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U125F
SRR6505602	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U125AP
SRR6505603	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U125RN
SRR6505604	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U125IN
SRR6505605	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C126CP
SRR6505606	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C116RN
SRR6505607	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C120RN
SRR6505608	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U227IN
SRR6505609	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C117F
SRR6505610	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C124RN
SRR6505611	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C247F
SRR6505612	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C246N
SRR6505613	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C118F
SRR6505614	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C118IP
SRR6505615	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C244RN
SRR6505616	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C244F
SRR6505617	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C244CP
SRR6505618	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C243RN
SRR6505619	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C246IP
SRR6505620	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C246F
SRR6505621	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C245IP
SRR6505622	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C245F
SRR6505623	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C117RN
SRR6505624	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C102CP
SRR6505625	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C102RN
SRR6505626	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C102F
SRR6505627	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C125F
SRR6505628	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U115IN
SRR6505629	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U115F
SRR6505630	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U116RP
SRR6505631	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U116F
SRR6505632	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U117AN
SRR6505633	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U116SN
SRR6505634	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U117IN
SRR6505635	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U117F
SRR6505636	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U118DN
SRR6505637	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U117RP
SRR6505638	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C127F
SRR6505639	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U107F
SRR6505640	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U118F
SRR6505641	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U124RP
SRR6505642	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U107IN
SRR6505643	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C121IP
SRR6505644	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U124IN
SRR6505645	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U107RP
SRR6505646	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U231RP
SRR6505647	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C101RN
SRR6505648	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C255RN
SRR6505649	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C256F
SRR6505650	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C255F
SRR6505651	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C255IP
SRR6505652	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C254IN
SRR6505653	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C254RN
SRR6505654	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C254CP
SRR6505655	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C254F
SRR6505656	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C119F
SRR6505657	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C118RN
SRR6505658	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U231IN
SRR6505659	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C119IP
SRR6505660	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C120IP
SRR6505661	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C120F
SRR6505662	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C256IP
SRR6505663	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C256RN
SRR6505664	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C121F
SRR6505665	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U122RP
SRR6505666	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U122IN
SRR6505667	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N22F
SRR6505668	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C102IP
SRR6505669	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N07R
SRR6505670	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N08F
SRR6505671	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N08R
SRR6505673	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N05R
SRR6505674	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N06F
SRR6505675	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N06R
SRR6505676	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N07F
SRR6505677	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C128F
SRR6505678	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N23F
SRR6505679	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N10F
SRR6505680	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N11F
SRR6505681	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C127RN
SRR6505682	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C252F
SRR6505683	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C251RN
SRR6505684	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C252RN
SRR6505685	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C252IP
SRR6505686	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C251CP
SRR6505687	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C250SP
SRR6505688	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C251IP
SRR6505689	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C251F
SRR6505690	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U119RP
SRR6505691	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U120F
SRR6505692	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U120IN
SRR6505693	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U120RP
SRR6505694	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C253IN
SRR6505695	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C253F
SRR6505697	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U119F
SRR6505698	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N05F
SRR6505699	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N05I
SRR6505700	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N02I
SRR6505701	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N02R
SRR6505702	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N03F
SRR6505703	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N03I
SRR6505704	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N03R
SRR6505705	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N04F
SRR6505706	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N04I
SRR6505707	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N04R
SRR6505708	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N15F
SRR6505709	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N14F
SRR6505710	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N13F
SRR6505711	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N12F
SRR6505712	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N19F
SRR6505713	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N18F
SRR6505714	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N17F
SRR6505715	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N16F
SRR6505717	PRJNA431126	Healthy	0.0				China	V4		Illumina MiSeq			IBD		feces	N20F
SRR6505718	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U121F
SRR6505719	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C134F
SRR6505720	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C134IP
SRR6505721	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C235AP
SRR6505722	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C235F
SRR6505723	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C235IN
SRR6505724	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C235RN
SRR6505725	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C236F
SRR6505726	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C236IN
SRR6505727	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C236IP
SRR6505728	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C237AP
SRR6505729	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U122F
SRR6505730	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U121RP
SRR6505732	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U123RP
SRR6505733	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U123IN
SRR6505734	PRJNA431126	UC	1.0				China	V4		Illumina MiSeq			IBD		feces	U123F
SRR6505735	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C116TP
SRR6505736	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C126F
SRR6505737	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C122IN
SRR6505738	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C122SP
SRR6505739	PRJNA431126	CD	1.0				China	V4		Illumina MiSeq			IBD		feces	C125RN
SRR8534034	PRJNA450340	cd	1.0	44.0	female		Canada: Winnipeg			ILLUMINA		Crohn’s disease (CD; N = 20), ulcerative colitis (UC; N = 19), multiple sclerosis (MS; N = 19) and rheumatoid arthritis (RA; N = 21) versus healthy controls (HCs; N = 23)	IBD		feces	
SRR8534035	PRJNA450340	cd	1.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534036	PRJNA450340	cd	1.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534037	PRJNA450340	cd	1.0	70.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534038	PRJNA450340	cd	1.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534039	PRJNA450340	cd	1.0	19.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534040	PRJNA450340	cd	1.0	70.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534041	PRJNA450340	cd	1.0	44.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534042	PRJNA450340	cd	1.0	44.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534043	PRJNA450340	control	0.0	52.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534044	PRJNA450340	control	0.0	30.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534045	PRJNA450340	control	0.0	38.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534046	PRJNA450340	control	0.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534047	PRJNA450340	control	0.0	46.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534049	PRJNA450340	control	0.0	38.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534050	PRJNA450340	control	0.0	46.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534055	PRJNA450340	cd	1.0	28.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534056	PRJNA450340	uc	1.0	48.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534057	PRJNA450340	cd	1.0	71.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534058	PRJNA450340	cd	1.0	28.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534059	PRJNA450340	uc	1.0	43.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534060	PRJNA450340	uc	1.0	46.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534061	PRJNA450340	uc	1.0	48.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534062	PRJNA450340	uc	1.0	43.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534063	PRJNA450340	uc	1.0	46.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534064	PRJNA450340	uc	1.0	53.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534065	PRJNA450340	control	0.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534069	PRJNA450340	uc	1.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534074	PRJNA450340	cd	1.0	42.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534075	PRJNA450340	uc	1.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534076	PRJNA450340	cd	1.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534077	PRJNA450340	control	0.0	34.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534079	PRJNA450340	control	0.0	22.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534080	PRJNA450340	control	0.0	22.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534081	PRJNA450340	control	0.0	56.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534082	PRJNA450340	control	0.0	56.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534084	PRJNA450340	control	0.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534085	PRJNA450340	cd	1.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534086	PRJNA450340	cd	1.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534087	PRJNA450340	control	0.0	30.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534088	PRJNA450340	cd	1.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534089	PRJNA450340	cd	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534090	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534091	PRJNA450340	cd	1.0	36.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534092	PRJNA450340	cd	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534093	PRJNA450340	cd	1.0	36.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534094	PRJNA450340	cd	1.0	36.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534095	PRJNA450340	cd	1.0	67.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534096	PRJNA450340	cd	1.0	67.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534097	PRJNA450340	cd	1.0	71.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534098	PRJNA450340	cd	1.0	71.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534099	PRJNA450340	control	0.0	26.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534100	PRJNA450340	control	0.0	26.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534109	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534114	PRJNA450340	control	0.0	28.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534123	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534124	PRJNA450340	cd	1.0		missing		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534125	PRJNA450340	cd	1.0	49.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534126	PRJNA450340	uc	1.0	58.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534127	PRJNA450340	control	0.0	34.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534128	PRJNA450340	uc	1.0	58.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534131	PRJNA450340	cd	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534133	PRJNA450340	control	0.0		male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534146	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534147	PRJNA450340	control	0.0		male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534148	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534159	PRJNA450340	control	0.0	32.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534160	PRJNA450340	control	0.0	28.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534171	PRJNA450340	cd	1.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534172	PRJNA450340	cd	1.0	42.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534173	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534182	PRJNA450340	control	0.0	32.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534185	PRJNA450340	control	0.0	28.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534186	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534187	PRJNA450340	control	0.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534188	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534199	PRJNA450340	uc	1.0	55.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534200	PRJNA450340	cd	1.0	49.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534201	PRJNA450340	uc	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534202	PRJNA450340	uc	1.0	58.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534203	PRJNA450340	cd	1.0	64.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534204	PRJNA450340	uc	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534205	PRJNA450340	uc	1.0	67.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534206	PRJNA450340	uc	1.0	55.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534207	PRJNA450340	uc	1.0	58.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534208	PRJNA450340	uc	1.0	67.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534209	PRJNA450340	control	0.0	28.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534210	PRJNA450340	control	0.0	52.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534213	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534214	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534215	PRJNA450340	control	0.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534216	PRJNA450340	control	0.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534217	PRJNA450340	control	0.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534218	PRJNA450340	control	0.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534219	PRJNA450340	uc	1.0	49.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534220	PRJNA450340	uc	1.0	49.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534221	PRJNA450340	uc	1.0	57.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534222	PRJNA450340	uc	1.0	57.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534223	PRJNA450340	uc	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534224	PRJNA450340	uc	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534225	PRJNA450340	uc	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534229	PRJNA450340	cd	1.0	47.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534230	PRJNA450340	cd	1.0	47.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534231	PRJNA450340	cd	1.0	25.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534232	PRJNA450340	uc	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534233	PRJNA450340	cd	1.0	49.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534234	PRJNA450340	uc	1.0	71.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534235	PRJNA450340	uc	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534236	PRJNA450340	cd	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534237	PRJNA450340	cd	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534238	PRJNA450340	cd	1.0	49.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534239	PRJNA450340	cd	1.0	66.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534240	PRJNA450340	control	0.0	34.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534241	PRJNA450340	cd	1.0	52.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534242	PRJNA450340	uc	1.0	44.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534243	PRJNA450340	uc	1.0	44.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534244	PRJNA450340	uc	1.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534245	PRJNA450340	uc	1.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534246	PRJNA450340	uc	1.0	29.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534247	PRJNA450340	uc	1.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534248	PRJNA450340	uc	1.0	27.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534249	PRJNA450340	uc	1.0	53.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534250	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534251	PRJNA450340	control	0.0	26.0	male		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534252	PRJNA450340	control	0.0		female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534253	PRJNA450340	uc	1.0	56.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR8534254	PRJNA450340	uc	1.0	56.0	female		Canada: Winnipeg			ILLUMINA			IBD		feces	
SRR6463032	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PN.5.0
SRR6463037	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PN.3.0
SRR6463039	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.58.0
SRR6463041	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.57.0
SRR6463046	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.59.0
SRR6463054	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.46.0
SRR6463059	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.48.0
SRR6463068	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.15.0
SRR6463074	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.13.0
SRR6463078	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.50.0
SRR6463081	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.49.0
SRR6463083	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.5.0
SRR6463084	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.51.0
SRR6463087	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.64.0
SRR6463088	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.49
SRR6463090	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.48
SRR6463092	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.47
SRR6463094	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.46
SRR6463096	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.50
SRR6463099	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.26.0
SRR6463102	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.25.0
SRR6463114	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.38.0
SRR6463117	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.39.0
SRR6463122	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.54
SRR6463123	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.53
SRR6463124	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.52
SRR6463125	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.51
SRR6463141	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.9.0
SRR6463142	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.7.0
SRR6463146	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.60.0
SRR6463148	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.61.0
SRR6463150	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.62.0
SRR6463152	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.63.0
SRR6463160	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.5.0
SRR6463161	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.51.0
SRR6463176	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.12.0
SRR6463178	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.11.0
SRR6463179	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.10.0
SRR6463189	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.1.0
SRR6463192	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.12.0
SRR6463196	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.43
SRR6463198	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.44
SRR6463200	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.41
SRR6463202	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.42
SRR6463208	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.45
SRR6463213	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.32.0
SRR6463215	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.37.0
SRR6463217	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.35.0
SRR6463221	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.30
SRR6463222	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.3.0
SRR6463227	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.31.0
SRR6463230	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.35.0
SRR6463243	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.25.0
SRR6463245	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.26.0
SRR6463249	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.23.0
SRR6463255	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.15.0
SRR6463258	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.5.0
SRR6463260	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.2.0
SRR6463265	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.3.0
SRR6463268	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.39
SRR6463269	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.40
SRR6463270	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.35
SRR6463271	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.36
SRR6463272	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.37
SRR6463273	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.38
SRR6463274	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.31
SRR6463275	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.32
SRR6463276	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.33
SRR6463277	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.34
SRR6463278	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.18.0
SRR6463283	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.17.0
SRR6463288	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.6.0
SRR6463292	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.54.0
SRR6463295	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.53.0
SRR6463308	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.40.0
SRR6463310	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.45.0
SRR6463313	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.47.0
SRR6463331	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.14.0
SRR6463332	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PN.7.0
SRR6463337	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PT.1.0
SRR6463344	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.10.0
SRR6463347	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.1.0
SRR6463349	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.44.0
SRR6463351	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.41.0
SRR6463355	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.39.0
SRR6463368	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.2.0
SRR6463371	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.17.0
SRR6463377	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.21.0
SRR6463379	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.55.0
SRR6463381	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.54.0
SRR6463383	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.53.0
SRR6463385	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.52.0
SRR6463388	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.56.0
SRR6463392	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.29
SRR6463393	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.24
SRR6463394	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.23
SRR6463395	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.22
SRR6463396	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.21
SRR6463397	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.28
SRR6463398	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.27
SRR6463399	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.26
SRR6463400	PRJNA422193	Healthy	0.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	H.25
SRR6463403	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.21.0
SRR6463408	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.20.0
SRR6463413	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.7.0
SRR6463418	PRJNA422193	CD	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	CD.SPA.PN.1.0
SRR6463424	PRJNA422193	UC	1.0				Spain:barcelona	V4	FWD:GTGCCAGCMGCCGCGGTAA; REV:GGACTACHVGGGTWTCTAAT	Illumina MiSeq			IBD		feces	UC.SPA.4.0
